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Abstract  
Chemicals are undoubtedly important and beneficial for our modern life. As a result, we are 
exposed to mixtures of chemicals in our daily life through applying them for food production 
and preservation and for supporting human and animal health and recreation. However, risk 
assessment for the consumer is usually based on a chemical-by-chemical approach. Among 
these chemicals, endocrine disruptors (EDs) are of concern, in particular because they are 
able to alter the function(s) of the endocrine system, leading to adverse health effects in 
organism or (sub) population levels. In vitro Chemically Activated LUciferase gene eXpression 
(CALUX) assays involving several transgenic reporter cell lines are interesting tools to study 
the impacts of exposure to mixtures of EDs and their components on the transcriptional activity 
of the master xenobiotic receptor, which is the aryl hydrocarbon receptor (AhR), as well as the 
steroid (estrogen (ER), androgen (AR), progesterone (PR), and glucocorticoid (GR)) 
receptors. Three mixtures were being investigated as examples of compound groups of 
human everyday exposure to chemicals: (1) the “total POP mixture” consisting of 29 POPs 
(persistent organic pollutants) prevalent in Scandinavian human blood, (2) the “ED mixture” 
containing 18 potential EDs dominantly found in Wallonia raw water intended for drinking 
water production, and (3) the “polyphenol mixture” containing seven food-based polyphenols. 
The concentration of each component in the mixture was based on human-relevant exposure 
such as fold human blood level (the POP mixture), fold maximum quantified concentration in 
raw water (the ED mixture), or fold recommended intake dose from food supplements (the 
polyphenol mixture). Specific aims of the project were: (a) evaluating species (rat and human) 
and/or tissue-specific (hepatocytes and mammary gland) AhR responses to the POP mixture 
and the polyphenol mixture and their components, (b) profiling the endocrine disrupting 
activities of the EDs and the mixture thereof prevalent in raw water using AhR and steroid 
receptors, (c) identifying interactions among the chemicals (additive, antagonistic or synergic 
effects) on the transcriptional activity of the receptors, (d) identifying the actual chemical(s) 
the most active in the mixtures, and (e) predicting the effect of the mixtures based on the 
activity of single compounds. The results showed that 16 out of 29 POPs contaminating human 
blood were AhR antagonists. The total POP mixture also showed an AhR antagonistic activity 
although it contained each compound at the concentration below its lowest-observed-effect 
concentration (LOEC). Chlorinated compounds were the drivers of the activity of the total POP 
mixture, among which PCB-118 and PCB-138 contributed for 90% of the total POP mixture 
effect. From the 18 EDs prevalent in raw water, chlorpyrifos, bisphenol A, fluoranthene, 
phenanthrene, and benzo(a)pyrene demonstrated significant activities on several receptors. 
Noticeably, benzo(a)pyrene mixed with dioxin TCCD induced a synergistic response in AhR-
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reporter human mammary gland cells (DR-T47-D), 10-fold higher than the cells’ response to 
TCDD alone, at a concentration which could be a realistic blood level after a food 
contamination incident or in a high exposed sub-population. The mixture of the 18 EDs 
compounds exerted AhR and ER agonistic activities, which can be explained by the activities 
of benzo(a)pyrene and bisphenol A in the mixture. While the rat AhR reporter cells (DR-H4IIE) 
was more sensitive to POP exposure, we showed for the first time that the AhR endogenous 
ligand FICZ, a tryptophan derivative was more potent than TCDD in the human AhR (DR-
HepG2) (40 times more potent than TCDD) while both exhibited a similar potency in the rat 
cells (after 6h exposure). Two isoflavones (daidzein and genistein) induced a higher AhR 
agonistic/synergistic activity in the rat cells, while the others (a flavonol (quercetin) and two 
flavones (baicalin and chrysin), curcumin, and the mixture of the seven polyphenols) caused 
a stronger AhR antagonistic response in the human cells. Quercetin and resveratrol were the 
strongest AhR antagonists in the human cells, which contributed most for the antagonistic 
activity of the polyphenol mixture. Dose-response curves were predicted successfully by 
concentration addition and general concentration addition models for the POP mixture, while 
both concentration addition and independent action performed well for estimating the effect of 
the polyphenol mixture, indicating the additive activity of the components in these mixtures. 
The results suggested that the endocrine disrupting activities of chemicals in human daily life 
exposure could involve more than one mechanism: their (anta-) agonistic effects on different 
receptors with the potential for additive, inhibitory or synergistic effects of mixtures thereof 
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Chapter 1: Introduction 
1. Human are exposed to mixtures of chemicals.  
Chemicals indispensably support our daily life and sustain our civilization. However, some 
chemicals can cause deleterious effects on our health and our living environment. With 
thousands of chemicals in the market and an accelerating production rate, more and more 
chemicals are used or even overused worldwide for improving quality of life (e.g. food 
production, supplies of goods and services). These currently used chemicals, together with 
already historical chemicals, are ubiquitous in the environment nowadays and become 
unavoidable in daily life. Indeed, humans are chronically exposed to multiple exogenous 
substances, directly through intended applications and uptakes of chemicals in personal care 
products or pharmaceuticals or food nutrients, or indirectly from contaminated food and feed 
or pollutants in water and air. The mixtures act in concert simultaneously in human bodies, 
possibly resulting in adverse health effects.  
 
1.1. Persistent organic pollutants  
Toxic chemicals can be persistent organic pollutants (POPs). During the industrialization after 
World War II, thousands of these synthetic chemicals were introduced into commercial use 
for pest and disease control, crop production, and industry. However, these compounds have 
unforeseen adverse effects on human and environment health1,2.  
 
POPs are typically halogenated (chlorinated, brominated, and fluorinated) organic compounds 
with high lipid solubility, high resistance to degradation and poor metabolization. They, 
therefore, are able to accumulate in the fatty tissues of living organisms for a long period of 
time, and they are susceptible to biomagnification and long-range transportation3–5. As a 
result, high trophic predatory, long-lived, and lipid-rich organisms (e.g., fish, marine mammals, 
and humans) can have POP accumulation at hazardous levels in their body6. Indeed, POPs 
can be detected at measurable concentrations virtually everywhere on our planet even in 
regions where they were never used2. For example, their capacity of transportation in the 
atmosphere and water, when adsorbed to particles, enables them to contaminate secondary 
sources even in remote areas, such as the Arctic7. The commonly detected POPs are 
persistent organochlorine pesticides (OCPs) applied intensively for agricultural production, 
polychlorinated biphenyls (PCBs) as industrial chemicals, flame retardant polybrominated 
biphenyl ethers (PBDEs) and surfactant perfluorinated compounds (PFCs) for improving 
product characteristics, as well as the unintentional by-products of many industrial processes, 
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especially polychlorinated dibenzo-p-dioxins (PCDD) and dibenzofurans (PCDF), commonly 
known as 'dioxins'8.  
 
A global treaty, the Stockholm Convention on Persistent Organic Pollutants (SCPOP), entered 
in force in 2004, aims at reducing and ultimately eliminating production, use, trade, release, 
and storage of POPs to protect humans and the environment from their adverse effects. 
Although the production and use of POPs have been generally stopped, POPs still remain as 
a global issue, currently posing threats to humans and wildlife due to their “already” ubiquitous 
distribution in the living organisms and the environment8. They have been detected in almost 
every human sample, including fetuses, embryos9, and human fluids10,11, and also are found 
frequently in feed12 and food13, including for example tuna14, Atlantic Salmon15, seals16, 
humpback dolphins17, dugongs18, etc. Exposure to POPs can lead to homeostatic disorders, 
cardiovascular diseases19,20, and metabolic diseases such as obesity and diabetes21–23. Some 
food-borne POPs cause cancers and hypospadias for fetal and infant males, breast cancer, 
cystic ovaries, and endometriosis for females24. Among the POPs, dioxins, PCBs, PBDEs, 
PFCs and OCPs, typically contaminating human bodies will be briefly discussed. 
 
Dioxins (PCDDs and PCDFs) and dioxin-like PCBs (dl-PCBs) belong to the highest toxicity 
group, with their general chemical structures shown in Figure 1. Among them, 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD) has been classified in group 1 of carcinogenic 
compounds to humans (IARC, International Agency for Research on Cancer). Dioxins and dl-
compounds are persistent, ubiquitous and toxic byproducts of various industrial, combustion, 
and natural processes such as waste incineration, home heating, and the production of 
organic chemicals containing chlorines such as OCPs and PCBs. Humans are exposed to 




Figure 1: General chemical structures of PCDDs, PCDFs, and PCBs. The possible positions 
of chlorine atoms on the benzene rings are designated by numbering the carbon atoms37. 
Chapter 1: Introduction 
 3 
Dioxins exert toxic effects even at very low concentrations. The lethal doses cause slow death 
as a result of a wasting syndrome, while nonlethal doses cause reproductive and 
developmental effects, tumor promotion, immunity suppression, and skin lesions28. Several 
“dioxin” crises have been recorded in the past years, such as contaminations through the 
Agent Orange used by the United States during the war in Vietnam (1962–1971)29, a mass 
food poisoning termed “Yusho” due to PCDFs in Japan in 196830, a severe industrial accident 
in Seveso, Italy, in 1976, releasing up to kilograms of dioxins into the air31, and the notorious 
“Belgian” dioxin crisis which resulted from an episode of feed contamination  in 199932–34. 
TCDD cannot be rapidly metabolized and thereby inactivated by detoxification enzymes, such 
as cytochrome p450 (CYPs) enzymes35,36. TCDD in humans and organisms can last for years, 
with half-lives on average of 1.6 years for persons < 18 years old, and 3.2 years for those ≥ 
18 years of age36. 
 
Table 1: Dl-PCBs, PCDDs and PCDFs and non dl-PCBs levels in human milk, in several 
countries: arithmetic means and minimum and maximum within brackets38.  
 
 
Occurring normally at higher concentration than dioxins and dl-compounds, other groups of 
chlorinated compounds including non dl-PCBs and OCPs are also found in human bodies 
(Table 1)39. PCBs were introduced in the 1880s and came into commercial use in 1929, while 
OCPs appeared between the 1940s and 1950s. Most of their production was banned in the 
late 1970s and 1980s due to their adverse health effects. Even at low doses of exposure, they 
can adversely affect health and normal biological function, especially during disease stages 
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such as cancer40 or during development stages such as childhood or pregnancy41. Since their 
ban, the levels of most POPs have been declining over time, however, the levels of PCBs and 
dl-compounds in human milk are still one to two orders of magnitude higher than the threshold 
values proposed by WHO (Table 1)38. 
 
PCBs were widely used as dielectric and coolant fluids in electrical devices, carbonless copy 
paper, and in heat transfer fluids42. Although no longer in use, PCBs may still leak from old 
equipment and building materials43. The insecticide dichlorodiphenyltrichloroethane (DDT) 
and γ-HCH/lindane (γ-hexachlorocyclohexane) are among those OCPs still in limited use, 
mainly as a low-cost solution for malaria control44,45. DDT and its main environmental 
degradation product, dichloro-diphenyldichloroethylene (DDE)46 are persistent and 
bioaccumulative compounds that are highly soluble in lipid and found commonly in human 
bodies38. Several OCPs such as hexachlorobenzene (HCB), α-HCH, and β-HCH are by-
products of the manufacturing of other chemicals. Meanwhile, chlordanes, aldrin, and dieldrin 
have been banned in Europe and the United States, but are still being used in Asian and 
African countries47. Their isoforms, α(cis)- and γ(trans)-chlordane, trans-nonachlor48, and their 
metabolites oxy-chlordane49 and dieldrin are currently detected in human samples. The 
structure of several typical OCPs are shown in Figure 2. 
 
 
Figure 2: Examples of OCPs listed in SCPOPs. 
 
There is increasing evidence showing the link between health problems and exposure to PCBs 
and OCPs. For example, an increased mortality risk in humans was associated with higher 
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levels of highly chlorinated PCBs, especially for cardiovascular diseases50. Meanwhile, high 
levels of OCPs resulted in increased non-cancer, non-heart/cerebrovascular disease in US 
elderly51. Indeed, OCPs can alter the endocrine system and cause adverse effects on the 
reproductive, neurological and immune systems, increasing the risk of developing hormone-
dependent cancers and affecting sexual differentiation, growth and development52–54.  
 
Flame retardants introduced since the 1960s, such as PBDEs, have been applied in textiles, 
electrical and electronic products55. Figure 3 illustrates several common structures of the flame 
retardants. There are three commercial mixtures of congeners with different levels of 
bromination namely: penta-BDE (dominated by BDE-47, BDE-99 and BDE-100), octa-BDE 
(dominated by BDE-183, BDE-153 and BDE-154) and deca-BDE (dominated by BDE-209). 
The other brominated compound, hexabromocyclododecane (HBCD) has been used in 
polystyrene industry56. PBDEs have been detected in increasing levels in human (breast milk) 
and wildlife samples56. Exposure to these chemicals can lead to endocrine disruption56–58, 
developmental neurotoxicity59, and delayed mental and psychomotor development in infants 
due to maternal exposure60. The three commercial PBDE mixtures and HBCD are currently 
listed under SCPOP. 
 
 
Figure 3: Chemical structures of PBDEs, tetrabromobisphenol A (TBBP-A), and HBCD61. 
 
The perfluorinated compounds (PFCs), which were first synthesized in the 1940s–1950s, have 
received increasing attention since the early 2000s due to their frequent detection in human 
and environmental samples62,63 and their associated health concerns. In a Scandinavian 
study, they have been shown to be the most abundant group contaminating human blood11. 
They consist of a hydrophobic alkyl chain of various length (typically from 4 carbon atoms (C4) 
to 16 (C16)) and a charged/neutral hydrophilic end group that is fully fluorinated, resulting in 
their amphiphilic character (Figure 4). Due to their many useful properties such as chemical 
inertia, non-wetting, very slippery, nonstick, highly fire resistant, very high temperature ratings, 
and highly weather resistant, they have been applied widely in fluoropolymer-coated 
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cookware, sports clothing, extreme weather resistant military uniforms, food handling 
equipment, medical equipment, motor oil additives, fire-fighting foams, paint and ink as well 
as water-repellent products38.  
 
Exposure to PFCs can lead to metabolism disorders, immunotoxicity, potential 
carcinogenicity64, possible neurodevelopmental defects65, risk of miscarriage66, and cancer in 
humans67. Currently, only perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid 
(PFOA) and their salts are listed under SCPOP. Meanwhile, other PFCs such as 
perfluorononanoic acid (PFNA), perfluorodecanoic acid (PFDA), and perfluoroundecanoic 
acid (PFUnDA) as well as perfluorohexane sulfonic acid (PFHxS) are also highly persistent 
with long half-lives in humans (Figure 4)62,68,69. 
 
 
Figure 4: Structures of PFOS, PFAS and other related PFCs. 
 
1.2. Non-persistent organic pollutants  
Non-persistent organic pollutants belong to the emerging group of hazardous chemicals. 
These chemicals are readily decomposed in the environment and rapidly metabolized in the 
body. However, owing to their toxicity, they can cause harmful effects on human health and 
the environment. Among non-persistent organic pollutants, polycyclic aromatic hydrocarbons 
(PAHs), non-persistent pesticides and herbicides, and bisphenol A (BPA), typically 
contaminating water sources will be briefly discussed. 
PFOS (CAS 1763-23-1) PFHxS (CAS 355-46-4)
PFOA (CAS 335-67-1)
PFNA (CAS 375-95-1) PFUnDA (CAS 2058-94-8)
PFDA (CAS 335-76-2)
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PAHs are generated during incomplete combustion of organic materials found in wood, 
tobacco smoke, smog, ambient air pollution and charcoal-grilled and overcooked meats. They 
are considered as the most potent carcinogens70. PAHs, such as benzo(a)pyrene (BaP), are 
rapidly metabolized and thereby quickly eliminated from the body. Due to their lipophilic 
nature, many PAHs undergo the full biotransformation, i.e. enhancing polarity (phase I), 
conjugating to hydrophilic moieties (phase II), and eliminating across the cell membrane 
(phase III)71. For example, the metabolite of BaP, BaP-7,8-diol-9,10-epoxide which is able to 
form DNA-adducts, is highly mutagenic (genotoxic), considered as the “ultimate carcinogenic” 
derivative72. It is the product of hydroxylation of BaP by CYP1 isoenzymes, preferentially 
CYP1A1. Hence, the generation of highly genotoxic metabolites by CYP1A1-mediated 
oxidation of BaP and related PAHs depends on the capacity of the phase II enzyme system73–
75. However, the dose, route and duration of exposure significantly influences the detoxifying 
or toxifying action of CYP1A1. The structures of BaP, fluoranthene, and phenanthrene are 
shown in Figure 5.  
 
 
Figure 5: Examples of PAHs prevalent in Wallonia raw water76. 
On the other hand, the wide use of non-persistent organic pesticides results in human 
exposure. Currently used and banned pesticides and herbicides and their metabolites can be 
found in water sources. Chlorpyrifos, an organophosphate pesticide, is currently used in the 
US and has been recently banned in the EU. Its application is in agriculture and households 
for control of a number of pests, including insects and worms. It inhibits acetyl cholinesterase 
in the nervous system, resulting in respiratory, myocardial and neuromuscular transmission 
impairment, leading to acute effects. However, it can be mutagenic, carcinogenic, cytotoxic, 
genotoxic, teratogenic, and immunotoxic for humans77,78.  
Common herbicides including chloroacetanilides (metolachlor), triazines (atrazine, 
chloridazon), and metazachlor have been detected in water samples (Figure 6)76,79–81. 
Fluoranthene (CAS 206-44-0) Phenanthrene (CAS 85-01-8) Benzo(a)pyrene (CAS 50-32-8)
Chapter 1: Introduction 
 8 
Chloridazon is authorized for use on sugar and fodder beets that might be fed to livestock. In 
rats, mice and dogs, it can affect body weight and displays liver and kidney toxicity, and it 
affects the gastric mucosa in dogs at very high dose after short-time administration82. 
Chloridazon and its main metabolite (desphenyl chloridazon) are stable after pasteurisation, 
baking/brewing/boiling and sterilization83, and have been found to be the most abundant 
contaminants in Wallonia raw water (frequency of detection = 82% in 100 samples, Cmax = 
21500 ng/L)76.  Metolachlor is used extensively in the US for the control of annual grass weeds, 
broadleaf weeds, and yellow nutsedge, and is also commonly used in corn, soybean, and 
peanut cultivation. It is more persistent in the soil than the other acetanilide herbicides and 
has been detected in groundwater ranging from 0.08 to 4.5 µg/L in the US84 and also in the 
EU85. Moreover, it has been detected in edible fish species, threatening human and wildlife 
health86,87. Atrazine is used to prevent broadleaf weeds in crops such as maize and sugarcane. 
Exposure to atrazine is associated with fetal developmental defecits88 or carcinogenic 
effects89. While the three above herbicides have been banned in the EU, the other herbicide 
metazachlor is still currently in use. It is a cell division inhibitor widely used for controlling 
broad-leaved weeds and annual grasses85. Chronic consumer exposure scenarios to 
metazachlor have shown that the metazachlor intake is well below the established 
toxicological reference values in EU90. 
 




Desethylatrazine (CAS 6190-65-4)Simazine (CAS 122-34-9)
Atrazine (CAS 1912-24-9)
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Bisphenol A (BPA) (Figure 7) is an extensively used chemical in the production of epoxy 
resins, polycarbonate plastics, and flame retardants91. It is one of the most commonly 
produced chemicals in the world with an industrial production volume of approximately 2.9 
billion kilograms per year90, therefore it became a worldwide contaminant92. Humans from all 
age groups are exposed to BPA mainly via food consumption93, but other sources of exposure 
such as of air/dust and water also exist90. BPA has adverse effects on female and male 
reproductive systems in humans and animals94, and it interferes with the development of the 
fetus and young children by interacting with estrogen, androgen and thyroid receptors90, 
among other effects38.  
 
Figure 7: Structure of Bisphenol A. 
 
1.3. Natural active compounds: polyphenols  
Diets provide the major source of natural active compounds such as polyphenols95–100. 
Polyphenols are secondary metabolites of plants with a common polyphenol structure (i.e. 
several hydroxyl groups on aromatic rings). They are abundant in our diet originating from 
plants like fruits, vegetables, cereals, and coffee. They are naturally produced to aid host 
defenses against herbivores, insects, ultraviolet radiation, and microorganisms101. They 
include several thousands of molecules with a wide range of complex structures102,103. Based 
on the number of phenolic rings, polyphenols can be classified in many classes but mainly as 
phenolic acids, flavonoids, stilbenes, phenolic alcohols and lignans (Figure 8)102. 
 
The chemical structures of polyphenols determine their biological properties and 
bioavailability102. Most of the polyphenols display low oral bioavailability due to gastro-
intestinal absorption and extensive metabolism. Polyphenols are popular in research and food 
manufacture since they have significant antioxidant properties and potential roles in 
preventing various diseases associated with oxidative stress such as cancer, cardiovascular, 
and neurodegenerative diseases104. Also, they are responsible for the activities of many 
medicinal plants by modulating the activity of a wide range of enzymes and receptors105. 
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Figure 8: Polyphenol classifications104. 
 
Phenolic acids include two classes namely hydroxycinnamic and hydroxybenzoic acids, 
derivatives of cinnamic acid and benzoic acid, respectively. They are found in free forms in 
vegetables and fruits and in bound forms as β-glycosides (i.e. bound to one or more sugar 
molecules) in hull, bran, and seed. Curcumin is a well-known member of the family of 
hydroxycinnamic acids. It is extracted from turmeric, a spice derived from the rhizomes of the 
plant Curcuma longa Linn. Turmeric has been used in Asia for medicinal purposes for 
centuries due to its anti-inflammatory and anticancer activities106.  
 
Curcumin is poorly bioavailable primarily due to poor absorption, rapid metabolism and 
elimination, leading to its extremely low serum levels107,108. Therefore, instead of curcumin 
itself, the metabolites are detected in plasma or serum following oral consumption109. 
Curcumin concentration was shown to peak at 0.41 to 1.75 μM after one hour of oral intake of 
4 to 8 g of curcumin in a clinical trial conducted in Taiwan110. Curcumin is metabolized mainly 
in liver111. Curcuminoids, as shown by clinical trials, are safe even at doses between 4000 and 
8000 mg/day112. Curcumin is well known as a strong antioxidant by scavenging free radicals 
or modulating the enzymatic activity of antioxidant pathways, and also as an anti-inflammation 
agent in most diseases by blocking nuclear factor kappa-light-chain-enhancer of activated B 
cells (NF-κB)113. 
 
Flavonoids include two benzene rings connected with three carbon chains from the nearby 
pyran ring with more than 5000 identified compounds. According to the variation in the type of 
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heterocycle involved, they are further classified into six classes: flavanones, flavanols, 
flavonols, isoflavones, flavones, and anthocyanidins (Figure 9). The estimation of the overall 
concentration of all flavones and isoflavones in circulation in human bodies is in the 
micromolar range114. Most flavonoids in edible plants and foods are in bound forms as β-
glycosides115. Even after food processing and cooking, most flavonoid glycosides can reach 
the small intestine intact. While flavonoid aglycones (not bound to a sugar molecule) and a 
few flavonoid glycosides (bound to glucose) can be easily absorbed in the small intestine116, 
glycosylated flavonoids have to penetrate into the mucus layer of the intestine to be 
deglycosylated on the cell surface prior to absorption. Otherwise, they may be hydrolyzed by 
bacterial enzymes in the colon117, thus limiting their absorption in the colon118. Flavonoids are 
likely to appear as metabolites (e.g. of the phase II metabolites) in the bloodstream and urine 
due to rapid and extensive catabolism by the intestinal and liver cells119. 
 
 
Figure 9: Basic structure of flavonoids120.  
 
The class of flavonols is the major class of flavonoids available in different food sources 
including onions, broccoli, apples, berries, teas, and leeks. Production of flavonols is activated 
by light, thus the flavonol content varies due to the light exposure of different parts of the plant 
103. Quercetin is a flavonol found frequently in onions, apples, broccoli, and berries121,122. Its 
daily intake by an US adult is 50 to 800 mg123. It is poorly soluble in water, but quite soluble in 
lipids. Quercetin has relatively low bioavailability due to its low absorption, extensive 
metabolism and/or rapid elimination (3% to 17% in healthy individuals receiving 100 mg)122. 
Quercetin is similar to curcumin, well known as a long lasting anti-inflammatory and strong 
anti-oxidant121,124. 
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Flavones (e.g. chrysin and baicalin) are relatively less frequent flavonoids, found abundantly 
in fruit peel or skin (e.g. mandarin) and parsley, thyme, celery, and hot peppers. Chrysin is 
found in various medicinal plants including, for example, blue passion flower (Passiflora 
caerulea), but also in propolis and honey. It is poorly absorbed in the intestine. It can reach 
maximum concentrations of 12 to 64 nM in human serum within an hour after oral 400 mg 
doses of chrysin114. Chrysin suppresses the inducible nitric oxide synthase (iNOS) and NF-
kB125, and activates estrogen receptor126. It also has several other pharmacological 
activities127. Baicalin is also a flavone isolated from the root of Scutellaria baicalensis Georgi 
(Huang Qin). Due to baicalin's poor solubility in water, it is moderately absorbed in the stomach 
and poorly absorbed in the small intestine and colons, leading to an absolute bioavailability 
after oral administration of only 2.2%128. Baicalin plays a role in various pharmacological 
activities, especially preventing several cancers129. 
 
Isoflavones (e.g. daidzein and genistein) share structural similarities with estrogens with the 
presence of an –OH group in between C4 and C7 (Figures 9 and 10). They are able to bind 
to the estrogen receptor. Therefore, regular consumption of soybean-based products were 
showed to be associated with breast cancers  and other deseases130,131. Their main source is 
soybeans, with dried soybean seeds containing approximately 1 g/kg of both daidzein and 
genistein132. The absolute bioavailability is 9–14% for genistein and 29–34% for daidzein in 
aglycone forms, but it has been shown to be close to 90% after oral administration of soy 
protein isolate in female Balb/c mice both using an administration of 1.2 mg/kg genistein and 
0.55 mg/kg daidzein133. Barnes et al., (1995)134 calculated that the level of genistein in the 
blood of a person consuming 35 g/day of soybeans (the average amount consumed by the 
Taiwanese) can reach 3.3 pM, corresponding to an intake of 50 pg (185 pM) genistein with 
total body water (56 liters). Because both genistein and daidzein are relatively hydrophobic, 
they will be taken up by cells, therefore their distribution in the blood and tissues are relatively 
similar134.  
 
Resveratrol is a polyphenolic stilbene, naturally found in red grapes, red wine, peanuts, and 
groundnuts135. These plants produce resveratrol in response to stress, injury, fungal infection, 
or ultraviolet (UV) radiation136. Resveratrol usually occurs in trans and cis molecular 
configurations as glucosides137. Resveratrol appears to be well absorbed by humans when 
taken orally, but as the previous polyphenols, it has a poor bioavailability due to its rapid 
metabolism138. The blood concentration of resveratrol can peak at about 1.8 to 2 μM after one 
hour of a single administration of an oral dose of 25 mg of trans-resveratrol to healthy 
volunteers, depending on whether resveratrol is administered in wine, vegetable juice, or 
grape juice137. Resveratrol in red wine was initially thought to be responsible for red wine’s 
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beneficial cardiovascular effects (the so-called “French Paradox”137), however, there is no 
strong evidence139. Resveratrol is recorded as an antioxidant and anti-inflammatory 
compound140. It also displays an estrogenic activity as it is able to compete with the estrogenic 
diethylstilbestrol for binding to the estrogen receptor, due to its similar chemical structure140. 
Figure 10 displays the structure of the seven polyphenols selected in this work, based on their 
common commercial availability as food supplements. 
 
Figure 10: Structures of seven polyphenols. 
 
2. Aryl hydrocarbon receptor and steroid receptors: Targets of these chemicals 
Toxic chemicals can cause several health and environmental hazards, especially 
carcinogenesis and endocrine disruption. Endocrine disrupting activity is one of the main 
mode of actions and the most concerning adverse effect of these toxic compounds for the 
health of the current and future generations and the environment141. They are so-called 
endocrine disruptors (EDs). In 2002, the World Health Organization (WHO) defined EDs as 
“an exogenous substance or mixture that alters function(s) of the endocrine system and 
consequently causes adverse health effects in an intact organism, or its progeny, or (sub) 
populations”142,143.  
 
Since our endocrine system requires a the hormone-coordinated harmonious development 
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trillion to per billion range), exposure to EDs during vulnerable periods (development and 
reproduction) can induce adverse effects in the short and long terms, even at very low 
doses141. These compounds may interfere or interact with several target transcription factors 
that regulate gene expression including the master xenobiotic receptor, aryl hydrocarbon 
receptor (AhR) and the steroid receptors (glucocorticoid, androgen, estrogen, and 
progestogen receptors)141,144.  
 
2.1. Aryl hydrocarbon receptor 
2.1.1. Evolution and function of aryl hydrocarbon receptor  
Poland et al., (1976)145 discovered the intracellular protein responsible for the aryl hydrocarbon 
hydroxylase activity in mouse liver treated with dioxin (TCDD). This protein appeared to be a 
receptor able to bind TCDD with an extremely high affinity. Therefore, it was called the dioxin 
receptor or the aryl hydrocarbon receptor (AhR).  
 
AhR is a member of the basic Helix-Loop-Helix/Per-Arnt-Sim (bHLH/PAS) superfamily of 
transcription factors. Ligand-activated PAS proteins control circadian rhythm and regulate 
responses to environmental changes including both primary intracellular and secondary 
physico-chemical stimuli such as gas molecules, redox potential or photons146,147. Meanwhile, 
bHLH transcription factors in animal kingdom are involved in numerous developmental 
programs including cell migration and adhesion, DNA damage control and protection from 
oxidative stress, environmental adaptation, organogenesis, hematopoiesis, myogenesis, 
neurogenesis and sex determination148. In plants, they control growth, development, and 
stress adaptation by participating in various signal-sensing processes including detecting the 
signals of diatomic O2, small metabolites e.g. phytoalexins and light149.  
 
AhR has been highly conserved throughout evolution150. Its homologs are present in almost 
all major groups of animals including the bilaterians, cnidarians and placozoans. Their last 
common ancestor, living approximately 600 million years ago, already possessed an AhR 
homolog151. AhR orthologs in C. elegans152 and D. melanogaster153 have no ligand binding 
capacity. Instead, they rather contribute to the neural development. Thus, it is likely that AhR 
evolved from a factor required for normal development and homeostasis regarding origin and 
evolutionary points of view, while the ligand activation may be the secondary and acquired 
function arising during vertebrate evolution154,155.  
 
Early researches on AhR mainly focused on understanding the molecular basis of toxicity 
induced by the typical AhR ligand, the dioxin TCDD156. Recent studies have shown that AhR 
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is a vital regulator of many essential biological processes such as immune responses, stem 
cell regulation, inflammation, cell differentiation and proliferation, apoptosis, reproduction, and 
tumor suppression, acting in response to endogenous ligands from diet, host cells or 
microbiota157. The toxicity resulting from exposure to dioxins or other xenobiotics is the 
consequence of the disruption of these processes. Therefore, AhR is considered as a sensor 
for environmental chemicals, which connects external environmental signals to cellular 
processes158.  
 
2.1.2. Structure of the aryl hydrocarbon receptor 
The AhR structure consists of a N-terminal bHLH domain, a central PAS domain, and a C-
terminal variable functional domain (Figure 11). The N-terminal bHLH domain functions as the 
DNA-binding domain and supports dimerization of the receptor with its their partners, for 
example the AhR translocation proteins (ARNT)159. The amino-acid sequence of this domain 
is extremely variable among species160–162. The bHLH domain helps AhR to bind to the 
cognate DNA sequences (5′-T(N)GCGTG-3′) called dioxin responsive elements (DREs) in the 
promotors of AhR regulated genes163. In this domain, AhR has a nuclear localization signal 
(NLS) and a nuclear export signal (NES) for nucleocytoplasmic shuttling. 
 
The C-terminal segment of the AhR contains the transcriptional activation domain. This 
sequence contains three subdomains enriched with either acidic residues 
(glutamate/aspartate), or with glutamine (Q-rich) or with serine, threonine and proline (S/T/P). 
This segment is the interaction site for co-activators and co-repressors of AhR164,165.  
 
The PAS domain of the AhR has two imperfect repeats, PAS A and PAS B associated with 
DNA recognition, ligand binding and chaperone interactions. This domain, along with the N 
bHLH region, also supports the heterodimerization of the AhR with the ARNT166,167. The PAS 
B region of the AhR contains a ligand binding domain (LBD) and a binding site for heat shock 
protein 90 (Hsp90) (Figure 11)168. AhR is essentially expressed ubiquitously in mammalian 
tissues at various levels across tissues with liver, thymus, lung, kidney, spleen, and placenta 
being the tissues where AhR is the most expressed169.  
 
 
Figure 11: The functional domains of the AhR proteins. 
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2.1.3. The aryl hydrocarbon receptor signaling pathway 
The inactive AhR forms a complex in the cytosol with a co-chaperone phosphoprotein p23, an 
AhR-interacting protein (AIP) also known as hepatitis B Virus X-associated protein 2 (XAP-
molecule 2) and two Hsp90 proteins170 (Figure 12). The AhR chaperone complex helps to 
stabilize the AhR in the cytosol and maintains its correct folding, thereby allowing the receptor 
to recognize the ligand properly, and subsequently ensuring the transcriptional activity of the 
AhR171. Several exogenous and endogenous AhR ligands from the environment, diet, host 
metabolism and gut microbiome can activate the AhR and induce its conformational alteration. 
Ligand-activated AhR translocates from the cytosol into the nucleus (Figure 12). 
 
Two signaling pathways are possible, the canonical and the noncanonical (Figure 12). In the 
canonical signaling pathway, AhR dimerizes with ARNT to form an active heterodimer 
complex. The AhR/ARNT complex binds to the DREs in the promotors of AhR regulated 
genes163, such as CYP1A (CYP1A1, CYP1A2, CYP1B1) or AHRR coding for a repressor (AhR 
repressor). That triggers the recruitment of various components of the transcriptional 
machinery to activate transcription172. Later, the AhR is exported back to the cytosol, followed 
by proteasomal degradation173.  
 
According to the noncanonical AhR pathway, regulation of the expression of genes lacking 
DREs could be explained by a direct AhR-DNA binding (without a binding site) or to a site 
distinct from the consensus DREs, the non-consensus DREs (e.g. 5′-GGGA-3′), or 
importantly, via a crosstalk with other signaling pathways (estrogen receptor (ER), NF-κB and 
retinoblastoma (RB)) (Figure 13)174. AhR can also function as an E3 ubiquitin ligase for 
proteasomal degradation, for instance, of ERα175.  
 
The best-studied AhR-responsive genes are detoxification enzymes for drug and xenobiotic 
metabolism70. They play an essential role in the overall responses of animals to toxic 
chemicals. Their activity is easy to measure, particularly in the case of CYPs such as CYP1A1, 
due to their low basal expression and tremendously rising expression induced by many dioxin-
like chemicals. Thus, assessments of the actions of dl-chemicals based on this approach have 
provided very unambiguous and well-definable markers for AhR specific actions176. Indeed, 
methods measuring the expression of CYP1A1 are widely accepted for determining AhR 
transcriptional activation177. Therefore, risk assessments in this field of science and the 
worldwide regulatory guidelines have been developed based primarily on the classical mode 
of action of the ligand-activated AhR176. 
 
Chapter 1: Introduction 
 17 
 
 Figure 12: AhR modes of action in mammalian cells and the putative mechanism of AhR 
activation as described in the text178.  
 
2.1.4. The aryl hydrocarbon receptor ligands 
Although the AhR is initially linked to toxic halogenated aromatic compounds (e.g. PAHs, 
dioxins, POPs), more recent studies show that the AhR interacts with more structurally diverse 
ligands179,180. AhR ligands can be endogenous or exogenous (natural or synthetic) compounds 
(Figure 13). According to their spatiotemporal availability, AhR ligands act differentially or 
similarly, depending on the context resulting in species-specific, ligand-binding specific and 
ligand-specific AhR functionality181,182. 
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Figure 13: Exogenous and endogenous ligands of AhR183. 
 
The essential amino acid tryptophan (Trp) is the precursor for the synthesis of AhR ligands. 
Its catabolism either by the host or by the microbiota yields numerous physiologically relevant 
AhR ligands. The first observation was the production of endogenous AhR ligands causing 
AhR activity in vitro and in vivo after exposure to ultra-violet radiation184,185. Later, some 
photooxidized Trp derivatives were discovered to be endogenous ligands of AhR, suggesting 
a role for AhR in the skin186. FICZ, the product of irradiation of Trp solutions by ultraviolet and 
visible light187–189, is considered as the highest affinity AhR ligand up to date190,191 with an 
estimated Kd of 0.07 nM (TCDD Kd = 0.48 nM). In addition, the kynurenine pathway (KP) 
accounting for > 90% of the degradation of the dietary Trp, which transforms Trp into 
nicotinamide adenine dinucleotide and different intermediate byproducts, has been revealed 
as the major physiological route from Trp to produce AhR ligands192. These Trp derivatives 
are potential AhR ligands, while kynurenine has been identified as an AhR ligand precursor, 
which requires further chemical conversions to act as a AhR agonist192 (Figure 14). 
 
Studies of xenobiotic agonists like the dioxins (e.g. TCDD) and PAHs (e.g. benzo[a]pyrene; 
BaP) show that AhR prefers elongated planar compounds with large lateral extensions and 
small medial extensions along with specific medial H-bond potential194,195. However, 
thousands of xenobiotic compounds and cellular metabolites with diverse shapes and 









Emerging: benzimidazode, pesticides, 
primaquine, kinase inhibitors, synthetic 
flavonoid
New synthetic CH223191, GNF315, VAF347
Polyphenols: resveratrol, curcumin, 
quercetin, chrysin, baicalin, daidzein, 
genistein 
Glucobrassicin derived I3C, I3ACN, ICZ, DIM
Tryptophan derivatives: FICZ, CICZ
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elongated planar shape and some barely have any AhR ligand structural signature. This 
suggests that a flexible extended loop of AhR, named the “belt,” is longer and more flexible 
than other PAS family transcription factors, allowing the unique ability of AhR to interact with 
diverse ligands192 (Figure 15). 
 
Figure 14: Kynurenine pathway of tryptophan degradation. KATs: kynurenine 
aminotransferases; KYNU: kynureninase; KMO: kynurenine 3-monooxygenase, IDO1/2: 2,3-




Figure 15: Chemical structures of well-known AhR ligands: TCDD, FICZ, BaP, and 
kynurenine, compared with tryptophan. TCDD and FICZ have chemical signatures of medial 
H-bond potential, facing lateral extension and the belt of the AhR192. 
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On the other hand, polyphenols have various biological functions in addition to antioxidant 
properties which are yet poorly understood103, especially their interaction with the AhR. 
Botanicals have been previously shown to affect AhR activation, and the major active 
compounds were polyphenols. For example, a concentration of 10 μM resveratrol has been 
shown to induce a 6-fold AhR activation in human mammary epithelial cells, MCF-10A cells197. 
Coffee, as a source of polyphenols, has been shown to inhibit BaP-induced production of 
oxidative stress via the activity of AhR198. Polyphenol extracts of strobiles of Humulus lupulus, 
e.g. L., Cannabaceae are able to upregulate CYP1A1 via the AhR mediated up-regulation of 
CYP1A1199,200. 
 
2.2. Steroid receptors 
2.2.1. Evolution of steroid receptors 
Nuclear receptors belong to a superfamily of transcriptional regulators which play key roles in 
animal development, physiology, and reproduction. Many nuclear receptors are activated by 
a specific ligand e.g. hormone or other small molecule, but also by postranslational 
modifications, and association with other proteins or DNA, depending on the cellular 
context201.  
 
Steroid receptors are members of the type I nuclear receptors, which are receptors for 
classical steroid hormones. Steroid hormones are small, lipophilic hormones synthesized from 
a common precursor molecule, cholesterol. They are produced by seemingly subtle 
modifications of the four fused rings of the sterol skeleton and side chains through a complex 
biosynthetic process in tissues and glands throughout the body. They activate the steroid 
receptors at levels as low as nanomolars202. Although mineralocorticoids, glucocorticoids, 
estrogens, progesterones, and androgens share structural similarities, they interact 
specifically with their own receptor to exert their biological effects (mineralocorticoid receptor 
(MR), glucocorticoid receptor (GR), estrogen receptor (ER), progesterone receptor (PR), and 
androgen receptor (AR))203 (Figure 16). From the discovery of ER by Jensen at the end of 
the 1950’s, through Gustafsson's description of the three-domain structure of GR in 1978, 
followed by the evidence that  that the receptors act by binding to DNA at steroid hormone 
responsive elements (HREs), to the identification of a large family of nuclear receptors, 
comprising many “orphan receptors” without a known ligand; the study of nuclear receptors 
has been pioneering in many aspects of molecular Biology research, as summarized by 
Gustafsson (2016)204.  
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Steroid receptors regulate the transcriptional activation of their downstream genes by 
recruiting co-regulators/co-activators to the pre-initiation machinery. They regulate genes 
which control a wide variety of biological processes such as cell proliferation, development, 
metabolism, and reproduction. They display well-described functions in the reproductive tract 
and endocrine system, but also play distinct physiologic roles205. Although ERα, ERβ, PR, and 
AR are crucial for sexual differentiation and reproduction via their hormone ligands, they 
regulate fundamental cellular functions such as growth, metabolism and homeostasis in both 
sexes206. Meanwhile, GR primarily regulates general physiology such as maintaining general 
homeostasis, whereas MR controls electrolyte balance and fluid transport.  
 
2.2.2. Structure of steroid receptors 
The structure of steroid receptors, typical for the nuclear receptors, contains five distinct 
domains including a variable amino-terminal region (A/B), a highly conserved DNA-binding 
domain (DBD) (C), a highly variable hinge region (D), a moderately conserved ligand-binding 
domain (LBD) (E), and an extremely variable C-terminal domains (F) (Figure 16). DBD and 
LBD contain specific crucial amino acid residues which determine the dimerization and 
function of the receptors. Finally, there are also one or two regions called activation function 
1 and 2 (AF1 and AF2) for transactivating gene expression. AF1 located in the A/B domain is 
usually ligand-independent, whereas AF2 in the LBD is predominantly ligand-dependent205. 
 
Hydrophobic ligand binding pockets (LBPs) within the LBDs are composed of roughly 30 
amino acids, and intended for binding lipophilic steroid hormones. The amino acids sequence 
is highly specific for binding to particular classes of steroid hormones so that minor changes 
can lead to dramatic changes in the hormone specific activation of the steroid receptors207. 
For example, a conserved cysteine residue in the human PR, GR, and MR appears to be 
critical for interacting with the C20 keto group in progesterons, glucocorticoids, and 
mineralocorticoids. A substitution of a threonine in the AR by a cysteine allows the receptor to 
have a high affinity for progesterone and corticoids and decreases its affinity for androgens208.  
 
The DBD is very highly conserved, showing 60–95% homology among the steroid 
receptors209. The function of the DBD is to bind to specific hormone response elements (HREs) 
in the promoters of their unique sets of target genes. The DBD contains two Cys4 zinc fingers: 
the first finger (C1) interacts with the HREs, while the second (C2) participates in receptor 
dimerization and stabilizes DNA binding210. HREs have a palindromic (symmetrical) sequence 
with two “half-sites” from which each half is in contact with a monomer in the homodimer 
complex. 
Chapter 1: Introduction 
 22 
 
Figure 16: Primary structures of a generic steroid receptor and its functional domains, their 
isoforms, and their physiological ligands. Region A/B contains transactivation function 1 
domain (AF1). (C): containing the DNA-binding domain (DBD); (D): the various hinge region; 
(E): containing the ligand-binding domain (LBD); (F): containing the transactivation function 2 
(AF2) domain. AR: Androgen receptor; ER: estrogen receptor; GR: glucocorticoid receptor; 
MR: mineralocorticoid receptor; PRA: progestin receptor isoform A; PRB: progestin receptor 
isoform B205. 
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2.2.3. The steroid receptor signaling pathway 
The canonical signaling pathway of steroid receptors also involves the binding to DNA 
consensus sequences, the HREs. The overall distribution of steroid receptors in specific cell 
compartments remains controversial211. The early model assumed that unbound steroid 
receptors are in the cytoplasm, bound to a chaperone complex (hsp90 and hsp70). The 
chaperone complex maintains the proper folding of the receptors in inactive conformation and 
facilitates hormone binding. The binding of the hormones to the ligand binding pocket (LBP) 
triggers conformational changes of the receptors and dissociation of the chaperones, resulting 
in the exposure of the nuclear localization domain, resulting in the dissociation of the 
chaperones. After that, the ligand-activated steroid receptors are translocated into the nucleus 
to bind their HREs and stimulate or inhibit transcription of their target genes (Figure 17). Most 
of the steroid receptors (such as ERs) have to form homodimers to be transcriptionally active 
(Figure 18)212,213. The homodimerization of the receptors rely crucially on LBD and DBD during 
ligand inducible conformational change205.  
 
While in the absence of ligand, GR and MR have been reported to reside in the cytoplasm in 
association with the chaperone hsp90, hsp70, and other receptor-associated proteins211,214, 
ERα214, ERβ215, PR216, and AR216 and the nuclear receptor type 2 have been reported to be 
located in the nucleus, bound to DNA in the absence of hormones (Figure 17). The more 
recent model suggests that these receptors are inactive while they are bound to a complex of 
corepressor proteins217,218 to keep chromatin in a more condensed conformation by 
association with proteins functioning as histone deacetylase.  
 
While ER binds to a specific estrogen response element (ERE), 5′-GGTCAnnnTGACC-
3′GR216, the four other receptors AR, PR, MR, and GR share the same HRE called the 
glucocorticoid response element (GRE), 5′-GGTACAnnnTGTTCT-3′ (with n = any 
nucleotide)219, due to their highly conserved DBD. Although these four receptors share a 
common high-affinity consensus DNA-binding site in vitro220, differential specific binding to 
HREs may be caused by the discrimination through nucleotides in the spacer and flanking 
regions of the half-sites and by asymmetries in the half sites220. 
 
Differences in the DNA binding sequence affect GR conformation and regulatory activity221. 
Such an allosteric regulation has also been seen for ERs with an effect on the recruitment of 
coactivators222,223. The distance between the HREs and the promoter of the target gene has 
been shown to affect the transcriptional activity of steroid receptors224. There is also a tissue- 
or gene-selective effect of the steroid receptors depending on their modulators, especially in 
case of compounds modulating the activities of GRs and ERs225. Some selective ER 
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modulators (SERMs) can induce estrogenic activity in some tissues, but anti-estrogenic 
activity in other tissues. For example, tamoxifen is an ER agonist in the bone and uterus, 
whereas it is an antagonist in breast and endometrium225. The reason lies in the variable 
tissue-specific coregulator pools or the variable conformation of ER upon SERM binding, 




Figure 17: General mechanism of action for cytoplasmic steroid receptors as described in the 
text. SR: Steroid receptors; HRE: hormone response element211.  
 
 
Figure 18: The ERs are dimers with or without the endogenous ligand, 17β‐estradiol (E2), the 
binding of which induces conformational changes in the receptors212,213. 
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2.2.4. The steroid receptor ligands 
The steroid receptors are activated by their endogenous ligands such as mineralocorticoids, 
glucocorticoids, estrogens, progesterone, and androgens from which they take their name 
from (mineralocorticoid receptor (MR), glucocorticoid receptor (GR), estrogen receptor (ER), 
progestin receptor (PR), and androgen receptor (AR)). However, a wide range of synthetic 
chemicals can affect the activity of the steroid receptor signaling pathways. For example, 
benzo(a)pyrene (BaP) is known as a potent endocrine and growth disruptor, able to alter 
multiple endocrine and growth factor pathways227, whereas bisphenol A is an estrogenic 
endocrine disrupting compound, shown to activate the ER-mediated pathways228–230. Indeed, 
the steroid receptors are primary targets of EDs. EDs have been shown to bind to the steroid 
receptors with affinities ranging from sub-nanomolar to high micromolar in several biochemical 
and cell-based assays with some mechanisms being revealed by structural analyses144. 
3. Cell-based Chemical Activated LUciferase gene eXpression (CALUX) assays 
One of the modes of action of EDs is to bind and alter the activity of the steroid receptors231 
which could be extended to AhR considering its versatile role of AhR in development and 
homeostasis. To evaluate the health effects of these chemicals, the transcriptional activity of 
the receptors induced by the chemicals can be investigated. Transactivation gene expression 
assays, also called reporter gene assays, have been introduced as less expensive, more high-
throughput-amenable, and more routinely applicable screening technics. They have been 
internationally validated to provide mechanistic and semi-quantitative data (by Environmental 
Protection Agency (EPA) of the US as well as by the Organization for Economic Cooperation 
and Development (OECD))232,233. The mechanistic data from the in vitro assays about the 
interaction between the receptors and chemicals could serve as the first-line screening 
method for narrowing down further in-depth bioanalytical investigations on the chemicals. 
Indeed, a good correlation has been reported between in vitro and in vivo results, when 
available234,235. 
 
The Dioxin Responsive Chemical Activated LUciferase gene eXpression DR-CALUX assays 
measure the transcriptional activity of the AhR through the expression of a luciferase reporter 
gene under the control of a recombinant promotor containing DREs. It is one of the most 
commonly used assays for screening toxicity of compounds via the canonical AhR signaling 
pathway (Figure 19). The induction of gene expression resulting from the activation of the AhR 
signaling pathway responding to chemicals is the basis of this bioassay system236. The 
recombinant cells are stably transfected with an AhR-inducible firefly luciferase reporter gene 
which carries several DREs. The DREs can be synthetic237 or from native AhR-regulated 
genes such as the CYP1A1 promotor238 to respond to dioxins and any other chemical(s) that 
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can bind to and activate the AhR. Induction of the luciferase gene expression is directly 
dependent on the presence of transcriptionally active AhR; it will reflect the appearance of 
activated AhR in a time-, dose-, and chemical-dependent manner, also reporting the potency 
of the tested chemicals239. The DR-CALUX assay has been devoted for detecting the AhR 
ligands (mainly dioxins and dl-compounds) in food and feed240,241, as well as in human and 
wildlife samples242–244. It can detect dioxins and dl-PCBs in feed at part per trillion (ppt) levels, 
which is comparable to High Resolution Gas Chromatography Mass Spectrometry (HR-
GC/MS)12. Similarly, the steroid receptor reporter cell lines are also based on their canonical 





Figure 19: Molecular mechanism of induction of gene expression by TCDD and related AhR 
agonists as described in the text239. 
 
The reporter gene assays offer some advantages over the other currently used in vitro assays 
which are also based on the canonical signaling pathway of the steroid receptors. For 
example, the reporter gene assays reproduce accurately the signaling pathway of a compound 
(e.g. via DREs or HREs controlling gene expression), while the comparable gene expression 
assays show directly the transcription of the genes without evaluating further the 
transcriptional pathway248. The reporter gene assays are able to discriminate between 
agonistic and antagonistic activity (by the co-exposure with a typical agonist) while the 
comparable receptor-binding assays did not245. Moreover, the reporter gene assays are 
“untargeted” and able to reveal the complex response of mixture effects245,249,250.  
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4. Mixture effects of chemicals 
While, the present chemical risk assessment mainly relies on a chemical-by-chemical 
approach251, understanding mixture toxicity is crucial to assess the potential adverse effects 
resulting from a real life exposure to mixtures of chemicals252. Mixture toxicity is the adverse 
effect of mixtures of chemicals after simultaneous or sequential exposure, also named as 
combination effect, combined effect or joint action253. The effects can be additive, synergistic, 
or antagonistic depending on whether they are equal, stronger, or weaker than the sum of the 
effects of individual components, respectively254. Kortenkamp et al., (2009)253 introduced the 
concept called "something from nothing" and "a lot from a little" to describe the mixture effect. 
This concept suggests that a mixture containing several compounds, each at a concentration 
at which they have no effect individually, can have an effect. 
 
Generally, mixture studies can be approached by “whole mixture” or “component based” 
methods. The former assesses the toxicity for a given mixture of chemicals as a whole, 
considering its activity as the activity of this specific mixture. The approach seems to be cost 
effective and feasible for many types of mixtures. However, there are many possible mixtures 
and the mixtures themselves can change their compositions and doses255. Therefore, a 
component-based approach, which estimates the mixture toxicity based on the studying of its 
components, gains favor in evaluating mixture toxicology. This approach allows to focus on 
modes of action and prediction of the mixture effects based on the activity of each 
components, and also allows to reveal the most active compound(s) in the mixtures. 
 
4.1. Predictions and assessments of the combined toxicity of mixtures of chemicals 
based on the component approach  
Due to the countless combinations of doses and components that one mixture can be 
composed of, mathematical models have been applied to establish the quantitative 
relationship between the toxicities of single compounds and that of their mixtures. Hence, the 
mixture effect can be predicted by using the toxicity data of the individual compounds. The 
non-interaction or additivity assumes that the chemicals in the mixture act together but do not 
interact i.e. inhibiting or enhancing the toxicity of the others. This assumption becomes the 
default for predicting and assessing the mixture effect. Dose concentration addition (CA) and 
independent action (IA) are described by the additivity expectation. The deviations from the 
expected additive effects could be synergisms or antagonisms, but their magnitude cannot be 
formulated. Without evidence of synergisms or antagonisms, additivity will be applied. 
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Concentration addition (CA). CA introduced by Loewe and Muischneck (1926)256, has been 
applied for the chemicals with the same mode of actions (MOAs). The CA model assumes 
that all the chemicals behave as if they are simply the dilution of one another. CA has been 
successfully applied for mixtures of chemicals with an identical, well-defined molecular target 
such as mixtures of organophosphorus pesticides, photo-synthesis-inhibiting herbicides and 
polychlorinated dioxins and furans, and also estrogenic agents etc., however, it has also 
proven powerful for mixtures with dissimilar compounds257–259. 
 
The predicted concentration to obtain a specific effect by the mixture (ECmix) can be calculated 
by taking into account the concentration partition (p i) of compound i and its respective activity 
(ECi)256,257,260. CA is also known as “Toxic unit summation”261, in which “toxic unit” (TUi) is the 
ratio of the actual concentration/dose (ci) of a substance in the mixture to cuase an equivalent 
effect (ECi) of the substance if present alone (Eq. 1). Toxic units reflect the effect of a given 
concentration of a substance to its toxicity and the additivity assumption means that they can 
be totally or partially replaced by the other without changing the overall effect of the mixture. 
Therefore, the mixture effect (ECmix) (the following Eqs. 2, 3, 4, and 5) is simply the sum of the 
toxic units, and the contribution of individual chemicals to the mixture effect is in proportion to 
its toxic unit (i.e. its concentration and potency)262.  
































where both ECmix, the concentration of the mixture and ECi, the concentration of the chemical 
i, exert the same specific effect, pi is the fraction of chemical i in the mixture, cmix is the total 
mixture concentration.  
 
The “Toxic Equivalence Factor” (TEF) for the assessment of PCDD/F250 is one example of 
using CA model to predict the mixture effect from the effect of the individual components. In 
DR-CALUX assays, the doses of all PCDD/F congeners can be expressed in terms of the 
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dose of TCDD (the reference compound) needed to generate the same equivalent effect. 
Therefore, the toxicity of the mixture can be predicted simply by adding up all equivalent dose 
of TCDD. Besides TEF, several other CA derived methods have been suggested for mixture 
risk assessment such as the Hazard Index (HI), Point of Departure Index (PODI), Relative 
Potency Factors (RPF) and Generalized concentration addition (GCA). Hazard Index263 can 
be expressed as the ratio between the exposure level and the reference/acceptable level. This 
method can use flexible uncertainty factors when defining reference levels. Point of Departure 
Index264, on the other hand, is also based on the fraction of exposure levels but relative to their 
respective points of departure (PODs), which could be No Observed Adverse Effect Levels 
(NOAELs), or No Observed Effect Concentrations (NOECs) or Benchmark doses (BMDLs). 
By that, it removes different uncertainty factors from the calculation. GCA assumes that the 
hillslope for each component is equal to 1 and considers also their maximum activities, 
therefore GCA allows to generate the full dose-response curve of the mixture using only the 
data from testing the individual compounds265. 
 
Independent action (IA). The model, first applied for biological data by Bliss (1939)266, is based 
on a probabilistic evaluation of independent random events with the joint probability S(ci, ci+1) 
for the survival/tolerance of an individual exposed to a combined concentration cmix = ci + ci+1: 





The probability of the deadth of the individual is D = 1 - S, thus, the probability of dying of the 
individual when co-exposed to substance i and i+1 is:    
(8)𝑆(𝑐𝑚𝑖𝑥) = 1 −  
𝑆(𝑐𝑖 , 𝑐𝑖+1) = 1 − [
𝑆(𝑐𝑖)




From that, the resulting combined effect can be calculated from the effects of each component 
and was successful in some applications260,262. At a specific concentration, Emix is the effect of 
the mixture; Ei and Ei+1 are the effects of chemicals i and i+1 at that specific concentration. 
(9)𝐸𝑚𝑖𝑥 = 1 − ((1 − 𝐸𝑖)(1 −  𝐸𝑖+1)) 
 
The IA model (Eq. 9) considers that replacing one component by another may or may not be 
equivalent. The mixture effect at a specific concentration can be predicted from the dose 
response curve of each constituent applied independently266. Since IA is based on probabilistic 
background, it assumes strictly the range of 0 to 1 (0% to 100%) for an Euclidean-type effect 
parameter and a monotonic effect (entirely non-increasing or entirely non-decreasing) 
concentration-response curves for the individual mixture components262. It is applied to 
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estimate the combined effect of dissimilar compounds, assuming that chemicals act 
completely independently and have no influence on each other. 
 
4.2. Grouping criteria 
Grouping chemicals with similar toxicity is equally important in evaluating the toxicity of the 
mixture. Chemicals with similar MOAs in both nature and major biochemical events have been 
grouped according to “Toxicologic similarity”, as proposed by U.S. EPA (2000)267 and other 
bodies. It listed the criteria for grouping chemicals within the same MOAs with extensive 
guidance, for example pesticides. A recent approach for chemical toxicity classification has 
been introduced based on common adverse outcomes. This approach acknowledges the 
occurrence of a similar toxicological effect of chemicals despite different toxic mechanisms 
(i.e. metabolism, distribution and elimination) and broadens the grouping criterion based on 
MOAs. 
In human toxicology, MOAs have been applied widely, so that chemicals acting via common 
mechanisms are often grouped together. The common mechanism of toxicity is considered 
when similarities exist in both nature occurrence and sequence of major biochemical events. 
However, it is not clear how precise MOA should be when classifying chemicals into a common 
group sharing the same MOAs, either based on their chemical structures or mechanistic 
subsequences. Therefore, grouping based on their MOA can be unrealistically narrowed and 
exclude chemical-induced effects. Presently, grouping criteria are established by focusing on 
common adverse outcomes. Although chemicals can act through different mechanisms, with 
different molecular details, biological effects can be similar, sharing a common endpoint or 
adverse outcomes. The approach of common adverse outcomes broadens the grouping 
scope, moving the focus to effect instead of mechanism. 
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Scopes and objectives 
This PhD work was performed in the frame of  the PROTECTED project funded by the 
European Union’s Horizon 2020 research and innovation program under the Marie 
Skłodowska-Curie grant agreement No. 722634. “PROTECTion against Endocrine Disruptors; 
Detection, mixtures, health effects, risk assessment and communication”.  
 
The PROTECTED project aims to develop expertise and protective capabilities for developing 
novel tools/concepts and training for the detection, analysis and improved risk assessment of 
endocrine disruptors (EDs), especially in mixture forms. The project focuses on several 
methodologies including multiplexed analysis, mixture modelling, mechanistic and exposure 
studies, explants and cell or whole organism bioassays. The PhD candidate is the early stage 
researcher (ESR) number 9 among 15 ESRs. The work specifically addresses the work 
packages 7 for Biological Analytical Tools – “In vitro bioassays for the ED and toxicity risk 
assessment of EDs and their mixtures”.  
 
Chemicals are indispensable in human daily life. We are exposed to mixtures of chemicals 
through several routes mainly via food and water consumption. Therefore, understanding 
mixture toxicology is necessary for evaluating the risk of exposure to these mixtures of 
chemicals, especially EDs. It is also crucial to be able to identify the main culprit(s) of the 
mixture effect and to predict the mixture effect, thereby protecting the wellbeing of both 
humans and wildlife.  
 
This research aims to study the impacts of exposure to chemicals in individual and in mixture 
forms on the transcriptional activity of the aryl hydrocarbon receptor (AhR) and the four steroid 
(estrogen, androgen, progesterone, and glucocorticoid) receptors, representing the targets for 
endocrine disruptors (EDs) using in vitro Chemical Activated LUciferase gene eXpression 
(CALUX) assays. Three mixtures covering several exposure routes of humans in daily basis, 
are being investigated:  
(1) a mixture consisting of 29 POPs (persistent organic pollutants) prevalent in Scandinavian 
human blood 
(2) a mixture of 18 potential EDs dominantly found in Wallonia raw water intended for drinking 
water production, and 
(3) a mixture of seven dietary polyphenols selected on the basis of their commercial availability 
as food supplements.  
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Specific aims of the project are:  
(a) evaluating species and tissue-specific AhR responses of the POP mixture and the 
polyphenol mixture and their components 
(b) profiling the endocrine disrupting activities of EDs prevalent in raw water using AhR and 
steroid receptors  
(c) identifying interactions among the chemicals (additive, antagonistic or synergic effects) on 
the AhR activity 
(d) identifying the most active chemical(s) in the mixtures 
(e) predicting the effect of the mixtures based on the activity of single compounds.  
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Chapter 2 
The Aryl hydrocarbon receptor (AhR) is involved in xenobiotic metabolism and controls many 
biological pathways. AhR functions can be dysregulated by inappropriate ligand activation or 
inhibition, leading to the subsequent health concerns. Many potential AhR ligands are 
persistent organic pollutants (POPs). They are persistent and widely distributed in the 
environment and in animal bodies, resulting in toxic health effects to both humans and wildlife. 
Humans are exposed to mixtures of POPs; however, their risk assessment is usually based 
on a chemical-by-chemical approach. Therefore, to assess the health effects associated with 
mixed exposures, knowledge on mixture toxicity and how to predict mixture effects are 
required. There are three mathematical models developed for predicting the mixture effects: 
i) the concentration addition (CA) model designed for chemicals with similar mode of actions; 
ii) independent action (IA) applied for chemicals with different mode of actions; and iii) the 
generalized concentration addition (GCA), a CA modified model developed for predicting the 
effects of mixtures containing partial agonists. 
 
The chapter 2 assessed the AhR transcriptional activity of a defined mixture of 29 POPs (the 
total POP mixture) constructed based on their presence and concentration in blood of a 
Scandinavian population. Both AhR agonistic and antagonistic activities of 29 POPs 
individually and in mixtures were evaluated by using three transgenic cell lines (rat hepatoma 
DR-H4IIE, human hepatoma DR-HepG2 and human mammary gland carcinoma DR-T47-D). 
The aims were to (a) assess both AhR agonistic and antagonistic activities after exposing the 
cell lines to the 29 POPs and to the mixtures, (b) identify the main compound(s) responsible 
for the observed effects of the mixtures, and (c) predict the mixture activity by applying 
available mathematical models (IA, CA and GCA). 
 
The results obtained were published in Environmental Pollution (Doan et al., 2019). Doan, 
T.Q.; Berntsen, H.; Zimmer, K.; Verhaegen, S.; Ropstad, E.; Connolly, L.; Igout, A.; Muller, M.; 
Scippo, M. A. Realistic Mixture of Persistent Organic Pollutants (POPs) Inhibits the 
Transactivation Activity of the Aryl Hydrocarbon Receptor (AhR) in Vitro. Environ. Pollut. 2019, 
254, 113098. https://doi.org/10.1016/j.envpol.2019.113098 
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A mixture of persistent organic pollutants relevant for human exposure inhibits 
the transactivation activity of the aryl hydrocarbon receptor in vitro 
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Abstract 
While humans are exposed to mixtures of persistent organic pollutants (POPs), their risk 
assessment is usually based on a chemical-by-chemical approach. To assess the health 
effects associated with mixed exposures, knowledge on mixture toxicity is required. Several 
POPs are potential ligands of the Aryl hydrocarbon receptor (AhR), which involves in 
xenobiotic metabolism and controls many biological pathways. This study assesses AhR 
agonistic and antagonistic activities of 29 POPs individually and in mixtures by using 
Chemical-Activated LUciferase gene eXpression bioassays with 3 transgenic cell lines (rat 
hepatoma DR-H4IIE, human hepatoma DR-Hep G2 and human mammary gland carcinoma 
DR-T47-D). Among the 29 POPs, which were selected based on their abundance in 
Scandinavian human blood, only 4 exerted AhR agonistic activities, while 16 were AhR 
antagonists in DR-H4IIE, 5 in DR-Hep G2 and 7 in DR-T47-D when tested individually. The 
total POP mixture revealed to be AhR antagonistic. It antagonized EC50 TCDD inducing AhR 
transactivation at a concentration of 125 and 250 and 500 fold blood levels in DR-H4IIE, DR-
T47-D and DR-Hep G2, respectively, although each compound was present at these 
concentrations lower than their LOEC values. Such values could occur in real-life in food 
Chapter 2: Mixture effect of the persistant organic pollutants (POPs) 
 55 
contamination incidents or in exposed populations. In DR-H4IIE, the antagonism of the total 
POP mixture was due to chlorinated compounds and, in particular, to PCB-118 and PCB-138 
which caused 90% of the antagonistic activity in the POP mixture. The 16 active AhR 
antagonists acted additively. Their mixed effect was predicted successfully by concentration 
addition or generalized concentration addition models, rather than independent action, with 
only two-fold IC50 underestimation. We also attained good predictions for the full dose-
response curve of the antagonistic activity of the total POP mixture. 
 
Keywords: Persistent Organic Pollutants; Aryl hydrocarbon Receptor; Antagonistic activity; 
Human relevant mixture; Generalized concentration addition model 
 
Capsule: A mixture of persistent organic pollutants relevant to human exposure antagonized 
the transcriptional activity of the Aryl hydrocarbon receptor in vitro, whose activity could be 
predicted. 
 




- Mixed exposure is more realistic for human exposure to POPs. 
- Total POP mixture relevant for human exposure is AhR antagonistic.  
- Chlorinated compounds are the drivers of the activity of the total POP mixture. 
- PCB-118 and PCB-138 contribute for 90% of the total POP mixture effect. 
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1. Introduction 
The aryl hydrocarbon receptor (AhR) was originally characterized as a xenobiotic mediator1. 
It is often called the “dioxin receptor” as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and 
several dioxin-like (dl) compounds are AhR agonists. Adverse health effects associated with 
exposure to these AhR agonists are widely studied, including abnormal reproduction and 
development, impaired immune system, liver toxicity and cancers2. 
 
AhR physiological roles have recently gained more attention since AhR is activated by a wide 
range of structurally diverse endogenous and exogenous compounds3. Also, AhR-deficient 
rodents suffer from various physiological defects in the immune system4, liver5, kidney4,6, 
cardio-vascular system7, urinary bladder8, etc. Additionally, AhR homologs are preserved in 
animal evolution for 600 million years9, while invertebrate AhR homologues cannot bind 
dioxin10, indicating that dioxin detection was not the primary role of this protein. Increasing 
evidence supports important roles of AhR in normal development and homeostasis, while 
toxicity induced by AhR xenobiotic ligands could be due to perturbation of these normal 
processes11. 
 
Upon ligand binding, the AhR is translocated from cytosol into the nucleus where it joins its 
dimerization partner, aryl hydrocarbon receptor nuclear translocator (ARNT). This AhR/ARNT 
complex then binds to a DNA sequence called dioxin responsive element (DRE) to activate 
the expression of a battery of genes, including both phase I and phase II xenobiotic 
metabolism enzymes, of which cyp1a1 is the best characterized. Hence, methods measuring 
cyp1a1 gene expression are widely accepted for determining AhR activation12, among which 
cell-based screening methods such as Chemical-Activated LUciferase gene eXpression 
(CALUX) are the most common13–15. Many potential AhR ligands are persistent organic 
pollutants (POPs). POPs are resistant to degradation and widely distributed in the 
environment. They can be detected in almost every human sample, including fetuses and 
embryos16. They tend to bioaccumulate and biomagnify in living organisms, resulting in toxic 
health effects to both humans and wildlife17. 
 
Presently, chemical risk assessment mainly relies on a chemical-by-chemical approach18. In 
real life, humans are exposed not to an individual POP, but to highly complex POP mixtures19. 
Understanding mixture toxicity is crucial to assess the potential adverse health effects 
associated with such real life exposure to mixtures of POPs20. The mixture effects may be 
additive, synergistic, or antagonistic depending on whether they are equal, stronger, or weaker 
than the sum of the effects of individual components, respectively21. The concepts called 
"something from nothing" and "a lot from a little" were introduced to describe the mixture 
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effect22 and proved in a study on fish when a significant effect was observed for a mixture 
combining individual compounds each at "no observed effect" concentrations23. 
 
Due to the various mixture forms and doses, models using the information of components to 
predict the combined effects are required. Three mathematical models have been developed 
for this purpose: i) the concentration addition (CA) model was designed for chemicals with 
similar mode of actions (MOAs)24, but has also proven useful for mixtures with dissimilar 
compounds23,25,26; ii) independent action (IA)27, successful in several applications28,29, applies 
for chemicals which act independently and have different MOAs; and iii) the generalized 
concentration addition (GCA)30, a CA modified model, was developed for predicting the effects 
of mixtures containing partial agonists30–32. 
 
In an effort to fill the gap in the knowledge of mixture toxicology, a defined mixture of 29 POPs 
(total POP mixture) was constructed based on their prominence in blood and/or food and 
breastmilk with the concentration being average blood values from recent Scandinavian 
studies33–35 published prior to 201236. To mimic the exposure of cells (in a tissue) to chemicals 
that are in the blood stream, in this study, the AhR transcriptional activities of the selected 29 
POPs were determined individually and in mixtures (the total POP mixture and six sub-
mixtures36) using reporter gene assays involving cancer cell lines from different tissues (liver 
and mammary gland) and species (rat and human). The aims were to (a) assess both AhR 
agonistic and antagonistic activities after exposing the cell lines to the 29 POPs and to the 
mixtures, (b) identify the main compound(s) responsible for the observed effects of the 
mixtures, and (c) predict the mixture activity by applying the three available models (IA, CA 
and GCA). 
 
2. Materials and Methods 
2.1. Chemicals and suppliers 
The total POP and six sub-mixtures were designed and premade by the Norwegian University 
of Life Sciences, Oslo, Norway as described36. The former consists of 29 POPs, where most 
of them are listed as POPs under the Stockholm Convention on Persistent Organic Pollutants, 
belonging to three groups: six perfluorinated compounds (PFAAs), seven brominated 
compounds (BFRs), and 16 chlorinated compounds with seven polychlorinated biphenyls 
(PCBs) and nine organochlorine pesticides (OCPs). The latter consist of either one single 
class of compounds (PFAA, Br and Cl) or two combined classes (Cl+Br, Cl+PFAA, Br+PFAA). 
This way of mixture preparation was to enable the study of the effect of adding or removing 
one chemical group on different endpoints. As the design of the mixtures was focused on 
compounds occurring at high concentrations, most dl-PCBs (with the exception of PCB-118) 
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and polychlorinated dibenzodioxins/polychlorinated dibenzofurans (PCDD/PCDF) were 
deliberately excluded. These compounds were also omitted due to their high toxicity at low 
concentrations in several systems to allow the study of the effect of the non-dl and most 
prevalent compounds. The components included in the mixtures and their respective 
concentrations are given in Table S1. 
 
Along with the mixture testing, 29 POPs from the total POP mixture were also examined 
individually. They were bought from Sigma Aldrich (Missouri, USA) except o-chlordane from 
Toronto Research Chemicals (North York, Canada) and PCB-118 from Dr Ehrenstorfer 
(Augsburg, Germany). All chemicals were dissolved in dimethylsulfoxide (DMSO) (Acros 
Organics, Molinons, France), except HCB in hexane (Merck, Massachusetts, USA). 
 
The 29 individual POPs and the mixtures were stored as stock solutions at -20oC. Working 
solutions were prepared from the stock solutions to reach the concentrations mentioned in 
Table S1. The highest tested concentration was 50 µM for all PCBs and PFAAs and 20 M 
for BFRs except BDE-100, BDE-153, BDE-154 and BDE-209 (1 M) due to stocks available. 
OCPs were tested at the maximum concentration of 100 M for γ-HCH and dieldrin, or 80 M 
for all the others. The concentrations for mixture exposure are presented as "fold blood levels", 
relative to the average contaminant levels found in human blood of the Scandinavian 
population. The total POP mixture and sub-mixtures were tested at concentrations between 
the estimated concentrations in human blood and maximum 3000 fold blood levels. 
 
2.2. Determination of aryl hydrocarbon receptor agonistic and antagonistic activities  
2.2.1. Cell-based assays 
Rat and human dioxin responsive (DR) cell lines were used. Rat hepatoma DR-H4IIE cells 
were from BioDetection System (Amsterdam, The Netherlands) while both human cell lines 
(hepatoma DR-Hep G2 and mammary gland carcinoma DR-T47-D) were previously home-
made (Liege, Belgium)37. A vector containing an AhR-controlled luciferase reporter gene was 
stably integrated into these cells. The vector integrated into DR-H4IIE cells contained four 
native DREs (from the upstream promotor of the mouse cyp1a1 gene), leading the MMTV 
(Mouse Mammary Tumour Virus) promoter38, while both DR-T47-D and DR-Hep G2 cells were 
transfected with a vector containing four synthetic DREs regulating the thymidine kinase 
promoter37. The cells were routinely cultured in MEM (Thermo Fisher Scientific, 
Massachusetts, USA) supplemented with 10% v/v fetal bovine serum (Greiner, 
Kremsmünster, Austria), 50 IU/mL penicillin and 50 g/mL streptomycin (Sigma Aldrich, 
Missouri, USA), and incubated in a H20 saturated atmosphere containing 5% CO2, at 37°C. 
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Table S1: Composition of the total POP mixture and the six sub-mixtures (PFAA, Br, Cl, Cl+Br, 
Cl+PFAA, Br+PFAA). The minimum (Min) and maximum (Max) tested concentrations of each 
compound in individual compound testing and the concentrations of each compound 
corresponding to 1000 fold blood levels in the mixture testing are also given. 
Compounds C Individual testing: 
tested (µM) 
Mixture testing: individual concentrations in the mixture 
corresponding to 1000 fold blood levels (µM) Min ax Total POP PFAA Br Cl Cl+Br Cl+PF
AA 
Br+PFAA 
PCB-28 0.01 50 0.031 
  
0.031 0.031 0.031 
 
PCB-52 0.01 50 0.021 
  
0.024 0.021 0.021 
 
PCB-101 0.01 50 0.025 
  
0.025 0.021 0.025 
 
PCB-118 0.01 50 0.14 
  
0.13 0.12 0.13 
 
PCB-138 0.01 50 0.43 
  
0.45 0.39 0.42 
 
PCB-153 0.01 50 0.70 
  
0.73 0.63 0.67 
 
PCB-180 0.01 50 0.34 
  
0.38 0.33 0.35 
 
p,p'-DDE 0.5 50 1.066 
  
1.088 0.95 1.006 
 
HCB 0.075 60 0.23 
  
0.24 0.21 0.22 
 
α-chlordane 0.4 80 0.024 
  
0.029 0.032 0.032 
 
o-chlordane 0.4 40 0.34 
  
0.034 0.029 0.029 
 
t-nonachlor 0.5 50 0.099 
  
0.099 0.101 0.101 
 
α-HCH 0.5 50 0.017 
  
0.017 0.017 0.017 
 
β-HCH 0.5 50 0.076 
  
0.076 0.069 0.069 
 
γ-HCH 0.5 100 0.017 
  
0.021 0.017 0.017 
 
Dieldrin 0.5 100 0.055 
  
0.063 0.060 0.058 
 






















































PFHxS 0.5 50 7.809 6.71 
   
7.41 6.91 
PFOS 0.5 50 41.52 18.19 
   
40.83 16.37 
PFOA 0.5 50 4.209 7.24 
   
4.42 6.69 
PFNA 0.5 50 1.092 1.76 
   
1.036 1.74 
PFDA 0.5 50 0.38 0.72 
   
0.44 0.66 
PFUnDA 0.5 50 0.34 0.32 





59.048 34.94 0.091 3.43 3.101 57.51 32.75 
POPs: persistent organic pollutants. PFAA: perfluorinated compounds. Br: brominated 
compounds. Cl: chlorinated compounds. PCB: polychlorinated biphenyl. DDE: 
dichlorodiphenyldichloroethane. HCB: hexachlorobenzene. HCH: hexachlorocyclohexane. 
BDE: brominated diphenyl ether. HBCD: hexabromocyclododecane. PFHxS: 
perfluorohexanesulfonic acid. PFOS: perfluorooctanesulfonic acid. PFOA: perfluorooctanoic 
acid. PFNA: perfluorononanoic acid. PFDA: perfluorodecanoic acid. PFUnDA: 
perfluoroundecanoic acid. 
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The methodology for the DR-CALUX (Dioxin Responsive Chemical-Activated LUciferase gene 
eXpression) bioassays was described in detail elsewhere37,39. Briefly, cells were first seeded 
in white clear-bottomed 96 well microplates (Greiner, Kremsmünster, Austria) and incubated 
for 24h to reach about 90% of confluence in the well. After 24-hour exposure, the cells were 
washed with phosphate buffered saline (Sigma Aldrich, Missouri, USA) and treated with lysis 
solution (containing Triton X100, Sigma Aldrich, Missouri, USA). Luciferin (Promega, 
Wisconsin, USA) and ATP (Roche Diagnostics, Rotkreuz, Switzerland) were then added to 
the cell lysate to produce luminescence, which was measured by using a luminometer (ORION 
II, Berthold Detection System, Pforzheim, Germany). The cells were exposed, in triplicates, to 
a dilution series of the tested compound/mixture in both agonistic and antagonistic tests. For 
the latter, the cells were co-exposed with a constant concentration of 15 pM, 150 pM and 650 
pM TCDD corresponding to TCDD EC50 in DR-H4IIE, DR-T47-D and DR-Hep G2 cells, 
respectively. 
 
In order to verify whether AhR antagonists compete for the same, single site on the AhR with 
the agonist (TCDD), additional antagonistic tests were performed for selected compounds by 
co-exposing DR-H4IIE cells to different concentrations of the tested compounds and a 
constant saturating TCDD concentration (20 nM). Using the agonist (TCDD) at clearly 
saturating concentrations would make it impossible for a lower affinity antagonist to affect 
transcriptional activation at all.  
 
All the exposure experiments were repeated at least three times independently. The final 
concentration of DMSO in the culture medium for the single POPs was 0.2% and 0.3% for 
agonistic and antagonistic tests, respectively, while they were 0.3% and 0.4% for the mixtures. 
For quality control, a TCDD reference curve was performed on each plate. 
 
MTT cell viability and LDH cell cytotoxicity were performed along with visual inspection of cell 
morphology and attachment. The former was carried out in a replicate plate to the DR-CALUX 
assays. After 24-hour exposure, 25 L MTT dye solution (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide, 5 mg/ml, Sigma Aldrich, Missouri, USA) was added into each 
well, followed by a 4-hour incubation at 37°C to form insoluble purple formazan. Then, 100 L 
isopropanol (Merck, Massachusetts, USA) was added into the plates to dissolve the formazan 
for two hours. The MTT formazan absorbance was read at 550/630 nm by a 
spectrophotometer (ELx800TM BioTek, Winooski, USA). Because the MTT data need to be 
interpreted with caution and is not necessarily related to cell death, we performed the LDH 
cell cytotoxicity as well. The Pierce™ LDH Cytotoxicity Assay Kit was purchased from Thermo 
Chapter 2: Mixture effect of the persistant organic pollutants (POPs) 
 61 
Fisher Scientific (Massachusetts, USA) and operated according to the manufacturer's 
instructions (absorbance at 490/630 nm). 
 
2.2.2. Calculations of EC50, IC50 and efficacy (RPCMax) 
Final results were presented as relative responses, i.e. percentages of the cell response to 
the tested compound/mixture compared to the maximum response of the cells to TCDD on 
the same plate for agonistic activities, or to spike-in TCDD EC50 for antagonistic activities. 
Dose-response curves were generated by Graphpad PRISM software, version 7 (San Diego, 
California, USA) by fitting a four-parameter non-linear regression for agonistic (Eq. 1) or 
antagonistic (Eq. 2) tests. 
(1) 𝑌𝑎𝑔𝑜𝑛𝑖𝑠𝑡𝑖𝑐 = 𝐵 +  
𝑥𝐻(𝑇 −  𝐵)
𝑥𝐻 + 𝐸𝐶50
𝐻 
(2) 𝑌𝑎𝑛𝑡𝑎𝑔𝑜𝑛𝑖𝑠𝑡𝑖𝑐 = 𝐵 + 
𝑇 −  𝐵





where x is the concentration of a tested compound/mixture inducing the relative response 
Yagonistic or Yantagonistic. EC50 and IC50 are the half maximal effective concentration for an agonist 
and antagonist, respectively40. B = bottom, T = Top, H = Hillslope. 
 
The lowest observed effect concentration (LOEC) is the lowest tested concentration at which 
a significant effect (p < 0.05) was observed. The maximum observed effect concentration 
(MOEC) is the lowest tested concentration causing the maximum effect (p < 0.05). ANOVA 
(Graphpad PRISM) was used to determine statistical significance. Prior to ANOVA, tests for 
homogeneity of variance and normal distribution (transformation if needed) were performed. 
When no full dose-response curve was achieved, MOEC was considered as the highest 
concentration of the test series. Efficacy was determined as RPCMax (%), which is the 
maximum effect induced by the tested compound40: AhR agonistic RPCMax was the maximum 
relative response of the compound/mixture compared to the maximum TCDD response, while 
AhR antagonistic RPCMax was the minimum relative response observed by the maximum 
inhibition of the test compound/mixture to the spike-in TCDD EC50. The compound/mixture 
was accepted as active when its relative response was higher than the threshold level RPCMax 
 10% for AhR agonists and lower than RPCMax  70% for AhR antagonists40. 
 
2.2.3. Calculations of the predicted mixture antagonistic effects 
Concentration addition (CA). CA model is based on a dilution principle, all the chemicals 
behave as they are simply the dilution of one another in the mixture. Hence, the effect 
contribution of one compound to the mixture effect can be totally or partially replaced by the 
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effect of the other. It calculates the effect concentration (ICmix,j) of the mixture inducing a 
specific antagonistic effect j (from 1% to 100%) by considering the concentration partition (p i) 
of compound i and its respective effect concentration (IC ij) inducing the same effect j (Eq. 3). 
Previously published formulae were adapted24,25,29: 








The concentration partition pi can either consider or not the non-active (NA) compounds. 
Because nonactive compounds do not give ICij, n is the number of the active compounds.  
 
For each compound i, ICij inducing the effect j is calculated using its IC i,50 and hillslope (Hi) 
from their fitted curves using Eq. 4 (Graphpad PRISM): 







Because the CA model allows only the calculation of ICmix,j, to generate the full dose-response 
curves, we proposed several possible methods to calculate the hillslope and bottom (Hmix and 
Bmix) of the mixture response, while the top was set to 100% as no response. 
 
- the Weighted Mean Hillslope and Bottom (WMHB) (Eq. 5a) considering pi to weight the 
hillslope and bottom of the individual compounds: 














- the Averaged Hillslope and Bottom (AvBH) considering the average of the hillslope and 













- the Formulated Hillslope and Bottom (FoBH) (Eq. 5c) using the formulae of the CA:  
















Independent action (IA). This method assumes that the effect of each component is an 
independent event27. Thus, the probability to exert a specific effect of the mixture is the joint 
probability of the effect of each compound applied independently.  For calculating the relative 
response of the mixture, the data for individual compounds were converted into a probability. 
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An antagonistic effect induced by compound i is obtained by subtracting the measured relative 
response (Rik) from 100% (100% being the relative response of TCDD EC50) and then 
converted into a probability (scale 0-1, by dividing by 100). The relative response of the mixture 
(0%-100%) is calculated from the combination of individual probabilities of each compound 
using the adapted formula (Eq. 6)28,29: 







At a specific concentration k, Rmix,k is the relative response of the mixture; Rik  is the relative 
response of compound i at that concentration k of the mixture, n is the number of the active 
components. 
 
Generalized concentration addition (GCA). GCA (Eq. 7) assumes that the hillslope for each 
component is equal to 1 and considers also their RPCMax31. It was adapted for AhR 
antagonistic activity similarly to the IA model by assuming 100% as no effect: 












where Rmix,k is the relative response of the mixture at a specific concentration k, C ik is the 
concentration of compound i in the mixture at that specific mixture concentration k. RPCMax,i is 
the maximum effect of compound i and IC50i is the IC50 of compound i. 
 
3. Results 
In DR-H4IIE cells, while -chlordane caused cytotoxicity at the highest tested concentration 
of 80 M, t-nonachlor already did at 62.5 M in three cytotoxicity tests (data not shown). They 
were also cytotoxic for the DR-T47-D at lower concentrations of 30 and 30.5 M, respectively. 
These cytotoxic concentrations were excluded from the data analyses. None of the other 
compounds or mixtures induced cytotoxicity at any tested concentration. 
 
3.1. Aryl hydrocarbon receptor activities of the 29 POPs 
AhR – mediated agonistic activities. Only four out of the 29 tested POPs presented AhR 
agonistic activities (RPCMax  10%). BDE-153, PCB-138, and PCB-118 were active in DR-
H4IIE, while BDE-99 was active in DR-T47-D. BDE-99 and BDE-154 were able to trigger a 
weak agonistic activity (5% < RPCMax < 10%) in DR-H4IIE, as well as -HCH in DR-T47-D 
(Table S2). No agonistic response was recorded in DR-Hep G2 cells for any of the 29 POPs. 
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Table S2: EC50, RPCMax and relative potency for AhR agonistic compounds in DR-H4IIE and 
DR-T47-D cells (n = 3, 0.2% DMSO). 
Cell lines DR-H4IIE DR-T47-D 
Compounds BDE-99 BDE-153 BDE-154 PCB-118 PCB-138 BDE-99 γ-HCH 
EC50 ± SE (µM) 4 ± 0.8 ND ND 25 ± 13 28 ± 6.4 1.9 ± 1.8 > 50 
RPCMax (%) 7.3 15.2 8.9 61.3 28.2 11 6 
Relative potency 0.0000038 - - 0.00006 0.000054 0.000013 0.000033 
EC50: concentration inducing half of the maximum response, extrapolated; RPCMax: observed 
efficiency of the maximum tested concentration expressed in % of the maximum response of 
TCDD; Relative potency: ratio between the EC50 of TCDD and the EC50 of the tested 
compound, with TCDD EC50 = 15 pM in DR-H4IIE and 150 pM in DR-T47D; SE: Standard 
Error; ND: not determined. 
 
AhR – mediated antagonistic activities. Sixteen out of the 29 individually tested POPs 
displayed AhR antagonisms. No antagonistic activities were observed for any of the PFAAs in 
all three cell lines. In contrast, in DR-H4IIE cells, AhR antagonistic responses were recorded 
for 16 POPs including all PCBs, most of the OCPs (except p,p’-DDE, -HCH and -HCH), and 
three out of the seven BRFs (BDE-47, BDE-99 and HCBD) (Table 1). PCB-118 and PCB-138 
displayed a V-shaped dose-response curve, switching from antagonistic to agonist behavior 
at concentrations above 3.5 µM and 27.5 µM, respectively. Hence, their IC50 values were 
determined by only the antagonistic part of the curve. The dose-response curves obtained 
from DR-H4IIE cells co-exposed to TCDD EC50 and the 16 AhR antagonistic POPs are shown 
in Figure S1 (solid lines) with a detail in Table S3.  
 
DR-Hep G2 cells were less responsive to the POPs than DR-H4IIE, with only five compounds 
exerting antagonistic activities, namely PCB-28, PCB-118, PCB-138, HCB and BDE-47 (Table 
1). PCB-28 was the most potent compound, almost completely abolishing the activity of 650 
pM TCDD in DR-Hep G2, displaying an RPCMax of 7.2 ± 3.6% and an IC50 of 6.1 ± 1.4 µM. In 
DR-T47-D cells, seven out of the 29 POPs showed AhR antagonistic activities (PCB-28, PCB-
118, PCB-138, HCB, -chlordane, t-nonachlor and -HCH). The highest potencies were found 
for -chlordane and t-nonachlor with RPCMax of 7.4 ± 12.5% and 27.8 ± 3.5%, respectively. 
 
Evaluating competitive inhibition of 16 antagonists in DR-H4IIE. The AhR antagonistic 
activities were abolished for all compounds (except -chlordane and t-nonachlor with RPCMax 
of 56.6% and 56.8%, respectively) when co-exposing with excessive 20 nM TCDD, indicating 
they are possible AhR competitive antagonists (Figure S1, dashed lines). 
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Figure S1: Dose-response curves obtained from DR-H4IIE cells co-exposed to 15 pM TCDD 
(solid lines) or 20 nM TCDD (dashed lines) and PCBs (A1 and A2), OCPs (B1 and B2) and 
BRFs (C) (Mean  SD, n = 3, 0.3% DMSO). 
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Table 1. AhR antagonistic responses (LOEC, MOEC, IC50 and RPCMax) of 16 POPs in DR-H4IIE, DR-Hep G2 and DR-T47-D cell lines (n = 3, 
0.3% DMSO). 





















IC50 ± SE 
(µM) 
RPCMax (%) 
PCB-28  2.5 25 6.8 ± 1.7 36.6 ± 4.3 2.5 25 6.1 ± 1.4 7.2 ± 3.6 3.5 25 11.4 ± 1.5 48.3 ± 5.9 
PCB-52  2.5 50* 7.3 ± 1.2 17.1 ± 5.5 - - - - - - - - 
PCB-101  12.5 50* 17.9 ± 3.8 54.3 ± 3.6 - - - - - - - - 
PCB-118  0.5 2.5 0.3 ± 0.05 67 ± 4.7 12.5 25 9 ± 2.7 38.3 ± 16.5 12.5 27.5 13.6 ± 2.4 49.2 ± 4.9 
PCB-138 0.5 2.5 0.6 ± 0.07 42.8 ± 2.8 3.5 25 ND 50.2 ± 9.5 12.5 50* ND 42.6 ± 2.5 
PCB-153  0.01 50* 18.5 ± 2.8 16.7 ± 4.6 - - - - - - - - 
PCB-180  1 50* 7.4 ± 3.3 16 ± 1.4 - - - - - - - - 
HCB 0.075 37.5 17.9 ± 11.6 42 ± 8.7 3.75 37.5 4.5 ± 2.3 39.4 ± 12.7 0.075 30 16.4 ± 2.1 51.7 ± 6.7 
α-Chlordane 0.4 50* 28.3 ± 3.3 15 ± 1.1 - - - - 10 30 20.2 ± 2.1 7.4 ± 12.5 
-chlordane 20 40* 26.5 ± 19.4 26.3 ± 1.5 - - - - - - - - 
t-nonachlor 25 50* 34.3 ± 1.8 34.2 ± 8.1 - - - - 25 25 16.8 ± 2 27.8 ± 3.5 
γ-HCH  0.5 50 27.5 ± 2.7 40.7 ± 3.5 - - - - 50 75 61.2 ± 2.9 65.4 ± 13.7 
Dieldrin 6.25 50 22.4 ± 11.4 59.6 ± 1.9 - - - - - - - - 
BDE-47 0.25 20* 3.1 ± 0.5 17.9 ± 2.7 1.25 12.5 ND 55.3 ± 7.2 - - - - 
BDE-99 0.25 10 5.2 ± 1.9 36.3 ± 1.5 - - - - - - - - 
HBCD  0.25 15 35.8 ± 63.9** 58.1 ± 3.1 - - - - - - - - 
LOEC: lowest observed effect concentration (p < 0.05); MOEC: maximum observed effect concentration (p < 0.05); IC50: the concentration 
inducing half of the maximum inhibition response; SE: Standard Error; RPCMax : observed efficacy expressed as a percentage of the cell response 
exposed to 15 pM, 650 pM and 150 pM TCDD, respectively for DR-H4IIE, DR-Hep G2 and DR-T47-D, corresponding to the MOEC; ND: Not 
Determined. * Corresponds to the highest tested concentration. ** IC50 estimated beyond tested concentrations. -: no response.  
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Table S3: Four parameters obtained in the dose-response curves (Graphpad PRISM) of the 16 active AhR antagonists in the rat DR-H4IIE cells. 
Parameters BDE-47 BDE-99 HBCD PCB-28 PCB-53 PCB-101 PCB-118 PCB-138 
Bottom (%) 0.2 ± 7.05 16.9 ± 12.4 0 20.3 ± 7.4 8.2 ± 5.5 47.2 ± 7.4 67.2 ± 1.4 43.1 ± 1.5 
Top (%) 100.7 ± 2.6 93.1 ± 3.3 80.7 ± 1.4 104.2 ± 1.8 107.6 ± 1.2 99.5 ± 1.3 104.2 ± 1.8 92.9 ± 2.1 
HillSlope 0.9 ± 0.1 0.9 ± 0.2 1.3 ± 0.5 1.1 ± 0.2 1.1 ± 0.1 1.5 ± 0.3 2.2 ± 0.5 2.4 ± 0.6 
IC50 (M) 3.1 ± 0.5 5.2 ± 1.9 35.8 ± 63.9 6.8 ± 1.7 7.3 ± 1.2 17.9 ± 3.8 0.3 ± 0.05 0.6 ± 0.07 
Parameters PCB-153 PCB-180 HCB α-Chlordane o-chlordane t-nonachlor γ-HCH Dieldrine 
Bottom (%) 0 5.1 ± 14.7 33.01 ± 13.4 0 0 25.8 ± 5.8 23.2 ± 4.6 45.6 ± 11.5 
Top (%) 89.9 ± 1.1 102.9 ± 3.2 74.6 ± 2.6 89.1 ± 1.2 101.4 ± 4.8 89 ± 1.0 94.4 ± 1.6 96.7 ± 3.3 
HillSlope 1.4 ± 0.2 0.9 ± 0.2 1.1 ± 0.5 2.4 ± 0.4 2.2 ± 1.5 4.98 ± 0.9 1.8 ± 0.3 0.8 ± 0.3 
IC50 (M) 18.5 ± 2.8 7.4 ± 3.3 17.9 ± 11.6 28.3 ± 3.3 26.5 ± 19.4 34.3 ± 1.8 27.5 ± 2.7 22.4 ± 11.4 
 
Table 2. AhR antagonistic responses (LOEC, MOEC, IC50 and RPCMax) of the total POP mixture and Cl containing sub-mixtures (Cl, Cl+Br, 
Cl+PFAA) in DR-H4IIE, DR-T47-D and DR-Hep G2 cells (n = 3, 0.4% DMSO).  

























POP 125 1000 374 ± 52 52.5 ± 2.1 500 1000 ND 80.1 ± 5.8 250 1000 ND 86.6 ± 2.2 
Cl 250 1000 562 ± 54 53 ± 0.9 250 2000 ND 59 ± 1.6 - - - - 
Cl+Br 125 2000 468 ± 38 64.6 ± 1.7 500 1000 534 ± 253 76.1 ± 3.9 - - - - 
Cl+PFAA 75 2000 461 ± 78 41 ± 1.3 500 500 243 ± 104 77 ± 3.8 500 500 ND 77 ± 3.8 
LOEC: lowest observed effect concentration (p < 0.05); MOEC: maximum observed effect concentration (p < 0.05); IC50: the concentration 
inducing half of the maximum inhibition response; SE: Standard Error; RPCMax : relative response at MOEC expressed in % of the response of 
TCDD EC50 15 pM, 650 pM and 150 pM TCDD (respectively for DR-H4IIE, DR-Hep G2 and DR-T47-D) corresponding to the MOEC; x bl: fold 
blood levels; ND: Not Determined. -: no response. 
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3.2. Aryl hydrocarbon receptor activities of the POP mixtures 
AhR – mediated agonistic activities. Exposure to the total POP mixture or to the six sub-
mixtures described in Table S1 did not induce any significant (RPCMax  10%) AhR agonistic 
response in any of the cell lines (data not shown). 
 
AhR – mediated antagonistic activities. The total POP mixture triggered an AhR 
antagonistic response in all cell lines (Table 2, Figure 1A). At a concentration in the culture 
medium corresponding to the blood level, the total POP mixture did not interfere with the 
response of the cells to EC50 TCDD. In contrast, significant and dose-dependent antagonistic 
responses were already observed at concentrations of 125, 250 and 500 fold blood levels, 
respectively, for DR-H4IIE, DR-T47-D and DR-Hep G2, although the concentrations of all 29 
compounds were below their respective LOEC at these levels or even at 1000 fold blood levels 
(Table S1). In DR-H4IIE, the POP mixture displayed a significantly high AhR antagonistic 
efficacy of 52.5  2.1% at 1000 fold blood levels and an IC50 = 374 ± 52 fold blood levels, while 
in both human cell lines, a significant response was observed, but did not reach below 80%, 
making the calculation of an IC50 not possible. 
 
   
Figure 1. (A) Dose-response curves obtained from DR-H4IIE, DR-T47-D and DR-HepG2 cells 
co-exposed to 15 pM, 150 pM and 650 pM TCDD, respectively, and the total POP mixture. 
(B) Dose-response curves obtained from DR-H4IIE cells co-exposed to 15 pM TCDD, and the 
total POP mixture, or the Cl, Cl+Br and Cl+PFAA sub-mixtures (Mean  SD, n = 3, 0.4% 
DMSO). 
 
In parallel, six complementary sub-mixtures (PFAA, Br, Cl, Cl+Br, Cl+PFAA, Br+PFAA) were 
also tested to study the possible interactions between these groups of compounds. 
Antagonism was seen for all Cl containing mixtures (the total POP, Cl, Cl+Br and Cl+PFAA 
mixtures) in DR-H4IIE and DR-Hep G2, while only the total POP and Cl+PFAA mixtures 
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In DR-H4IIE cells, the three Cl containing sub-mixtures and the total POP mixture gave more 
or less similar responses with IC50  400 to 500 fold blood levels and RPCMax  50%. This 
indicates that the chlorinated compounds were responsible for the antagonism of all mixtures 
where they are present. Also, the antagonistic response curve of Cl+PFAA mixture overlapped 
that of the total POP mixture, which placed below those of the Cl and Cl+Br (Figure 1B). These 
observations suggest that the effect of the Cl mixture was somehow enhanced in the Cl+PFAA 
mixture, resulting in a dose-response curve overlapping that of the total POP mixture. 
 
3.3. Predictions of the rat aryl hydrocarbon receptor antagonistic activities of the total 
POP mixture and Cl containing sub-mixtures 
We evaluated the capacity of the three different mathematical models (concentration addition 
(CA), independent action (IA), and generalized concentration addition (GCA)) to predict the 
IC50 and dose-response curves of the total POP mixture in the most sensitive cell line, the DR-
H4IIE. 
 
Calculation of bottom and hillslope values. Because the 16 rat AhR antagonists 
contributed only 4.3% for the mass of the total POP mixture, along with considering all of the 
29 POPs to calculating pi, we also considered only the active compounds, subtracting the 
weight of the non-active compounds (sNA) as mentioned in section 2.2.3. WMBH method was 
unable to predict both bottom and hillslope values. AvBH and FoBH showed reasonable 
predicted values, especially AvBH and sNA FoBH for the total POP mixture and the three Cl 
containing sub-mixtures (Table S4). 
 
Prediction of mixture effects of the three models. The results obtained after running the 
three models are shown in Figure 2. While the IA predicted a really strong response even at 
the lowest concentrations of the mixture, far out of the range of the measured curve, both the 
CA (CA-AvBH and CA-sNA FoBH) and GCA predictions resulted in calculated curves 
comparable to the measured curve. This refers that the 16 active compounds in the total POP 
mixture acted additively rather than independently. 
 
The measured IC50 of the total POP mixture (374 ± 52 fold blood levels) was lower than the 
predicted value (784 fold blood levels for both the GCA and CA models), while the IA model 
predicted IC50 = 2153 fold blood levels. Thus, both CA and GCA models underestimated IC50 
of the total POP mixture by about two folds, much less than one order of magnitude.  
 
Concerning the calculated dose-response curves, the two additive models appeared to 
diverge: GCA produced a somewhat better prediction in the low concentration range, both CA 
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(CA-AvBH and CA-sNA FoBH) closely followed the experimental curve and only diverged at 
concentrations higher than around 1000 fold blood levels (Figure 2). Similar predictions were 
also shown for the three active Cl, Cl+Br, Cl+PFAA sub-mixtures (Table S4, Figure S2). 
 
Table S4: Measured and predicted bottom, hillslope and IC50 of the CA models with several 
methods for the total POP mixture and Cl, Cl+Br, Cl+PFAA sub-mixtures.  
Methods Measured WMBH AvBH FoBH sNA WMBH sNA FoBH 
Total POP mixture 
Bottom (%) 52.5 5 21 0 100 0 
Hillslope 1.3 0.5 1.7 34.2 -10.9 1.5 
IC50 (x bl) 374 784 784 784 784 784 
Cl sub-mixture 
Bottom (%) 53 83 25 0 100 0 
Hillslope 2.1 6.9 1.8 2.1 -10.6 1.4 
IC50 (x bl) 500 786 786 786 786 786 
Cl+Br mixture 
Bottom (%) 64.6 83 21 0 100 0 
Hillslope 2.1 7 1.7 2.1 -10.6 1.4 
IC50 (x bl) 500 875 875 875 875 875 
Cl+PFAA mixture 
Bottom (%) 41 5 25 0 100 0 
Hillslope 1.4 0.4 1.8 38.6 -10.7 1.4 
IC50 (x bl) 576 840 840 840 840 840 
WMBH = weighted mean, AvBH = averaged, formulated hillslope and bottom (FoBH), sNA = 
substracted nonactive compounds. x bl: fold blood levels. 
 
Figure 2. Measured and predicted dose-response curves obtained from rat DR-H4IIE cells co-
exposed to 15 pM TCDD and the total POP mixture, and from three prediction models. CA = 
Concentration addition, IA = Independent action, GCA = Generalized concentration addition, 
AvBH = averaged hillslope and bottom, and sNA FoBH = subtracted nonactive compounds, 
formulated hillslope and bottom. Green dashed lines represent the 95% confidence interval of 
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Figures S2: Predicted full dose-response curves of the concentration addition models with 
several methods to calculate the bottom and hill-slope for the total POP mixture (A) and Cl 
(B), Cl+Br (C), Cl+PFAA (D) sub-mixtures. WMBH = weighted mean, AvBH = averaged, 
formulated hillslope and bottom, sNA = subtracted nonactive compounds. 
 
  
Figure 3. (A) Distribution of toxic units of the 16 active AhR antagonists. (B) Dose-response 
curves obtained from rat DR-H4IIE cells co-exposed to 15 pM TCDD and the total POP mixture 
or a binary mixture consisting of PCB-138 and PCB-118 (Mean  SD, n = 3, 0.4% DMSO). 
 
Toxic units. Deriving from CA model, toxic units (i.e. the ratio of the concentration partition of 
a compound to its IC50 (pi/IC50,i)) scales the concentrations of the mixture components to its 
toxicity, represented by the transcriptional activity of the Cyp1a1 promotor. Thus, it has been 
applied to identify the main driver(s) for mixture effects in CA model24,28,41. Figure 3A clearly 
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the total POP mixture, constituting to 90% of the total combined activity. Since they were also 
partial agonists, it is likely that, in the presence of TCDD, they behaved mainly as antagonists 
especially at low concentrations. Following this prediction, a binary mixture of PCB-138 and 
PCB-118 was generated according to their concentration in the total POP mixture. The dose-
response curve of this mixture followed that of the total POP mixture very closely, with an IC50 




AhR transactivation activities of the 29 POPs and the mixtures. This study shows that a 
majority of the chemicals composing the realistic total POP mixture are actually AhR 
antagonists (16 in DR-H4IIE, five in DR-Hep G2 and seven in DR-T47-D cells). As expected, 
the total POP mixture and the Cl containing mixtures were also shown to be antagonistic. 
These activities were AhR-dependent, and seemed to act through competition for the TCDD 
binding site, except for t-nonachlor and -chlordane.  
 
In our study, we tested the AhR transcriptional activity of POPs and POP mixtures using a 
transcriptional reporter assay, which basically reports the canonical AhR-driven pathways via 
AhR-ARNT-DRE interactions. However, we observed that two of the compounds (α-chlordane 
and t-nonachlor) do not seem to exert their antagonistic effect through competitive binding to 
AhR. Several possible non-canonical AhR-driven pathways could contribute to the observed 
results, such as crosstalk with other nuclear receptors, regulation of cell cycle and MAP kinase 
cascades, or novel AhR DNA-binding partners42,43. Further studies of these mechanisms are 
required, but were outside of the scope of this paper. 
 
Our results concerning single compound testing are in general consistent with previously 
published studies, where available. For agonistic activity, PCB-118 displayed highest RPCMax 
= 61.3% at 50 µM, with EC50 = 25 ± 13 µM similar to previously finding (9.3 ± 2.5 µM)44. EC50 
= 4 ± 0.8 µM of BDE-99 was lower than previous report (EC50 > 15 µM)45. For PCB-138, we 
observed an agonistic effect with a high EC50 = 28 ± 6.4 µM, which was not reported before44 
(Table S2). 
 
For antagonistic activities, in this study, IC50 of PCB-28 and PCB-138 were 6.8 ± 1.7 and 0.6 
± 0.07 µM (Table 1), close to previous estimates of 9.0 ± 2.9 µM and 1.4 ± 0.1 µM, 
respectively44. BDE-47 activity (IC50 = 3.1 ± 0.5 µM) was similar to those previously reported 
(2.7 ± 0.7 µM)45 and (3.7 ± 0.8 µM)44. However, the IC50 = 5.2 ± 1.9 µM for BDE-99 found in 
this study was lower than that previously reported (13 ± 0 µM)45. This study reports for the 
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first-time data for the AhR transcriptional activity of the 29 POPs in both human mammary 
gland carcinoma DR-T47-D and hepatoma DR-Hep G2 cells. 
 
Differences in our IC50 or EC50 values and in those in the previous findings44,45 may result from 
differences in the experimental design and the regression methods ( i.e. the number of 
concentration points, availability of a maximum effect if a full curve is generated, extrapolation 
if the maximum effect is not reached, and the regression function used with either four or three 
parameters). Our study not only confirms and consolidates previous findings44,45, but it also 
contributes new data including full dose-response curves with four parameter fit (see Table 
S3) which can be used for further data treatment or calculation of the joint effect of any mixture 
made from these 29 POPs for the rat DR-H4IIE cells. 
 
We observed species and tissue differences in the AhR transcriptional activities of the 
individual POPs and of the mixtures. In general, the rat DR-H4IIE cells were more sensitive 
than the two human cells towards the effects on AhR transactivation when exposed to 
individual POPs or POP mixtures. Several considerations may explain this result. Interspecies 
differences in AhR structure will obviously shape the sensitivity. Rats are 1000 folds more 
sensitive to TCDD than guinea pigs46. Mouse AhR has a higher affinity than human AhR due 
to the different position of the important amino acid Valine (V381 in humans corresponding to 
V375 in mice)47. Human AhR has shown a higher relative affinity for certain structurally 
compounds i.e. endogenous ligands or polyphenols48. Moreover, the difference in genetic 
modification (origins of the integrated promotor and DREs) of the rat DR-H4IIE compared to 
the two human cell lines could also play a role for the specific responses. Differences in 
regulatory processes downstream of AhR binding may be responsible, such as differential 
binding to transcriptional coactivators49. Finally, in the antagonistic tests, the POPs have to 
compete with increasing TCDD concentration (15 pM, 150 pM and 650 pM, respectively for 
DR-H4IIE, DR-T47-D and DR-Hep G2), which could lead to the lower sensitivity to detect an 
antagonistic activity of the POPs in the two human cells compared to the rat cells. 
 
Mixtures relevant for human exposure antagonize AhR activation. The most striking 
result of this study is that the total mixture of 29 POPs, derived from concentrations found in 
the blood of a Scandinavian population, and sub-mixtures thereof were found to exert only 
antagonistic effects on AhR. This observation is consistent with our results obtained from 
testing each compound alone, revealing a majority of antagonistic compounds. AhR 
antagonism of POPs has been observed in several screening studies44,45 and mixture 
studies50,51. However, while the AhR agonistic activity of POPs has been studied for decades, 
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the antagonistic counterpart has not yet received much attention, especially regarding its 
physiological consequences on an organism’s health.  
 
This finding challenges the method of using toxic equivalency factors (TEFs) and toxic 
equivalent quantities (TEQ) for risk assessments of mixtures of AhR ligands. The World Health 
Organization assigned TEFs for PCDDs/PCDFs/dl-PCBs, expressed as relative effect 
potencies compared to the most toxic form TCDD. Regarding their additive mechanism, TEFs 
are also used to estimate TEQ for a mixture of compounds by adding up the TEF fraction and 
the concentration of each compound within the mixture52. However, PCB mixtures alone or in 
combination with PCDDs/PCDFs (usually TCDD) have shown additive but also non-additive 
responses53,54. Also, several environmentally abundant biphenyls antagonize the cyp1a1 
induction by TCDD12, while some dl-mono-ortho-substituted PCBs revealed both agonistic and 
antagonistic properties55,56. In many environmental samples, the ratio between PCBs and AhR 
agonists is above 1000, indicating that antagonisms, resulting from interactions between AhR 
agonists and PCBs57, are not irrelevant. Therefore, the antagonistic effect of these compounds 
should be also considered to calculate the effect of mixtures. Since they are more abundant 
in real-life mixtures, their antagonisms may undermine or even abolish the overall dioxin 
potency of the environmental mixtures12. 
 
Our finding also raises the issue of the biological significance of a predominantly AhR 
antagonistic mixture in the blood of a human population. We found antagonistic activities at 
levels of 125 fold blood levels in rat liver cells or 250 or 500 folds in human mammary gland 
and liver cells, levels that may realistically be reached after an accident or in exposed 
populations. 
 
It is important to note that in the total POP mixture used here36, no dioxins and dl-compounds 
were included. That allows us to study the antagonism of the human-exposure relevant POP 
mixtures by isolating them from the dioxin and dl-compounds. But the roles of the dioxin and 
dl-compounds in human exposure should have also been considered. Therefore, we 
attempted to estimate the effect of the total POP mixture in a real-life situation. According to 
Kvalem et al.58 , the median of dl-compounds in Norwegian human blood was 33.1 pg TEQ/g 
lipid, which is equal to 0.6 pM in blood assuming that blood contains 0.6% fat and 1 ml blood 
= 1 g. Thus, the respective LOECs (for the POP mixture AhR antagonistic activity) in DR-
H4IIE, DR-T47-D and DR-Hep G2 of 125, 250, and 500 fold human blood level correspond to 
75 pM, 150 pM and 300 pM of dl-compounds, respectively. This concentration is close to the 
TCDD EC50 (15 pM TCDD in DR-H4IIE, 150 pM in DR-T47-D and 650 pM in DR-Hep G2 cells) 
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used in our antagonistic assays. Therefore, it is likely that the total POP mixture would 
antagonize the activity of these dl-compounds in the Scandinavian population. 
 
Furthermore, the question arises whether an overall AhR antagonistic exposure would actually 
cause health problems by interfering with the normal AhR function. Increasing evidence 
suggests that endogenous AhR ligands exist59,60, complemented by dietary phytochemical-
derived AhR agonists/antagonists61,62. AhR induced functions are essential for a variety of 
normal physiological functions. In mammary tissue, AhR likely plays a physiological role in 
coordinating development, differentiation, cell growth, and signaling of hormones63–67. Knock 
out mice or mice with low affinity AhR variants display impaired survival, growth, fertility, liver 
function and innate and adaptive immunity68. It is thus conceivable that the presence of highly 
stable POPs may interfere with the essential function of AhR controlled by mostly short-lived 
endogenous and dietary ligands, and thus impair cellular AhR mediated processes. The risk 
caused by AhR antagonism as the major effect of POPs could well exceed that due to their 
agonistic effect, however the health effect associated to AhR antagonism is unclear and 
deserves further investigation. 
  
Predictions of mixture effects. Risk assessment for mixture exposure is crucial to protect 
the health of both humans and wildlife. The individual chemical approach underestimates the 
mixture exposure and decreases the accuracy of risk assessment22,23,69. In addition, the risk 
of exposure to multiple chemicals at doses below their threshold, which is the most common 
case in real-life, should not be underestimated or assumed as no-effect. 
 
In this study, the best prediction results were obtained using the CA (concentration addition) 
and GCA (generalized concentration addition) models. They performed well in predicting 
ICmix,50 = 784 fold blood levels within two folds from the measured value (374 fold blood levels). 
This is considered as well accepted in predicting the combined effect of complex mixtures i.e. 
the total POP mixture with its components present at low concentration (lower than their 
LOECs at 1000 fold blood levels) and belonging to different compound groups. 
 
CA is often chosen as the default model70 for predicting mixture activities, first for mixtures 
with similar compounds24 then expended to dissimilar compounds23,25,26. Previous studies 
have shown the capability of the CA model to predict the mixture effect using the information 
of individual chemicals obtained in vitro25,41,71,72, ex vivo73 or in vivo23,25. In vitro research has 
mainly focused on an equimolar mixture with less than ten components and at high exposure 
concentrations. Birkhøj et al.25 successfully applied the CA model to predict the antiandrogenic 
effect of a mixture of five commonly used pesticides at 10 M each. In contrast, the CA model 
Chapter 2: Mixture effect of the persistant organic pollutants (POPs) 
 76 
was unable to predict the effect on thyroid hormone function and AhR transactivation of 
another mixture of five different pesticides at the maximum concentration of 50 M each, due 
to the presence of an inhibitory compound71. Other studies focused on more complex mixtures 
with multiple components at lower doses, typically below their threshold doses, or on human 
or environmentally relevant exposure scenarios. Two complex mixtures of 17 estrogenic 
chemicals were screened for estrogenic activities, reporter-gene (ERLUX) and cell 
proliferation (ESCREEN) endpoints41. This represents one of the most comprehensive studies 
on the effects of mixtures where they were able to predict the effects of the two mixtures. 
 
GCA, on the other hand, has been recently developed and proven useful specifically for 
calculating mixtures containing partial agonists30–32, but has not been applied before to 
calculate the activity of AhR antagonists. It allows to consider theoretically the fact that some 
agonists never reach the full activity of TCDD, or that some antagonists present partial 
agonistic activities. 
 
The difference between CA and GCA models resides in the predicted dose-response curve of 
the mixture and in the maximum predicted activity of the total POP mixture (Figure 2). GCA 
predicting the mixture response, allows to generate the full dose-response curve of the mixture 
using only the data from testing the individual compounds (i.e. RPCMax, concentration and 
IC50). The reason why this predicted curve diverged from the experimental curve at higher 
concentrations could result from the assumption that the hillslopes of all components, and so 
of the POP mixture, are equal to 1, which is clearly not the case (Table S3). However, GCA 
predicted the bottom (RPCMax = 52%) very close to the observed value for the total POP 
mixture (52.5%) thanks to its consideration of the RPCMax. 
 
On the other hand, CA provides a prediction of ICmix,j without the full dose-response curve. 
Therefore, we calculated the hillslope and the bottom values for the mixture response based 
on its components by formulating several possibilities. The dose-response curve generated 
by CA with averaged bottom hillslope (CA-AvBH) resulted in the best fit with reasonable 
hillslope and bottom values (1.7 and 21%) compared to 1.3 and 52.5%, respectively of the 
measured POP mixture curve. Subtracted non-activated compounds and formulated bottom 
hillslope (sNA FoBH) predicted an overlapped curve with the observed up to 1000 fold blood 
levels because of its closer Hmix = 1.5, but overestimated the extension of antagonism at higher 
concentration, leading to the prediction of Bmix = 0% for the total POP mixture. Bmix is important 
when predicting the activity of a mixture for risk assessment. Therefore, CA-AvBH rather than 
CA-sNA FoBH was chosen as a more suitable prediction in our case. The CA model also 
provides a good prediction of ICmix,50 for the response of the DR-H4IIE cells to the active sub-
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mixtures as to the total POP mixture, and reasonable predicted dose-response curves (Table 
S4, Figure S2). 
 
Finally, IA (independent action) was designed specifically for mixtures of compounds with 
clearly different MOAs to combine probabilities of action of individual compounds. Previous 
studies showed that IA outperformed CA23 or was comparable to CA with equal29 or not more 
than five-fold differences28,74 in predicting the combined effects for chemicals having different 
MOAs. The bad performance of IA to predict either ICmix or the dose-response curve clearly 
results from the mixture studied here, where we showed that most components act through 
the same MOAs. At low doses, accumulation of the individual, low probabilities derived for a 
high number of individual compounds presumably resulted in the dramatic overestimation of 
the antagonistic effect. 
 
Conclusions 
We tested the AhR agonistic and antagonistic activities of 29 POPs shown to contaminate 
human blood, both in individual and mixture forms. AhR transactivation activities in three 
reporter cell lines exposed to the 29 POPs and the mixtures were different due to the species 
and tissue-specific responses. The predominant individual activities of the POPs were AhR 
antagonism, as shown for 16 compounds out of 29 in rat DR-H4IIE cells, and for seven and 
five compounds in human DR-T47-D and DR-Hep G2, respectively. The total POP mixture 
already induced a significant AhR antagonistic activity at concentrations of 125, 250, and 500 
fold human blood levels, respectively in DR-H4IIE, DR-T47-D and DR-Hep G2, although each 
individual compound was present at concentrations lower than its LOEC at these levels. Such 
blood levels of POPs could realistically occur in food or environmental contamination incidents 
or in highly exposed sub-populations. Chlorinated compounds, among which PCB-118 and 
PCB-138 contributed 90% to the activity of the total POP mixture, were the drivers for AhR 
antagonism in DR-H4IIE cells. Finally, CA and GCA proved to be good tools to predict the 
mixed effect of the total POP mixture with only two-fold underestimated IC50 and acceptable 
does response curves. Hence, the compounds acted additively in the mixtures. Although 
limitations remain to fully describe the effects of realistic mixtures due to biological complexity, 
the predictions obtained using CA and GCA seem suitable for establishing general regulatory 
guidelines for mixture toxicity assessments. In addition, the data generated in this study for 
individual compounds will be useful to predict the effect of other complex mixtures constituted 
by these compounds. 
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Chapter 3 
As mentioned before, the Aryl hydrocarbon receptor (AhR) is involved in xenobiotic 
metabolism and controls many biological pathways. AhR functions can be dysregulated by 
inappropriate ligand activation or inhibition, leading to subsequent health concerns. Recently, 
AhR physiological roles have gained more attention since AhR is activated by a wide range of 
structurally diverse endogenous and exogenous compounds. Among them, 6-
formylindolo[3,2-b]carbazole (FICZ), a tryptophan derivative is considered the highest affinity 
AhR ligand to date which is produced endogenously by the host or by the symbiotic microbiota, 
while polyphenols represent the largest source of AhR natural modulators in the human diet. 
 
These new findings prompted us to compare the responses of human and rat AhR towards 
endogenously produced (FICZ) versus exogenous (TCDD) AhR ligands. Furthermore, we 
wanted to investigate different subclasses of natural AhR modulators, the polyphenols, that a 
human population could be in contact with. 
 
Thus, in chapter 3, we studied the AhR transactivation by FICZ/TCDD in vitro in a time-
dependent and species-specific manner using CALUX assays based on two cancer cell lines 
deriving from rat (DR-H4IIE) and human (DR-HepG2) hepatoma. The aims were to: (a) study 
species-specific (rat versus human) responses of AhR to FICZ or TCDD in the presence or 
absence of endogenous ligands (by comparing medium with Trp versus without Trp, Trp being 
the major source of AhR endogenous ligands), (b) evaluate the effect of polyphenols, and a 
mixture thereof, either alone or co-exposed with FICZ or TCDD to mimic human realistic 
exposure to mixtures of AhR modulators, and (c) reveal the most active polyphenol(s) and 
possible interactions among these compounds in the mixture.  
 
The results obtained have been submitted to Environmental Pollution. 
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Abstract 
TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) and several other environment/food-borne toxic 
compounds induce toxicity via aryl hydrocarbon receptor (AhR). AhR is also modulated by 
various endogenous ligands e.g. highly potent tryptophan (Trp)-derivative FICZ (6-
formylindolo[3,2-b]carbazole) and natural ligands abundant in the human diet e.g. 
polyphenols. Therefore, evaluating AhR responses and its activity in different species, is 
crucial for understanding the physiological functions of AhR, establishing a risk assessment, 
and exploring further applicability of AhR mediators in drug and food industry towards human-
based usages. We studied the AhR transactivation of FICZ/TCDD in vitro in a time-dependent 
and species-specific manner using two DR-CALUX assays derived from the rat (DR-H4IIE) 
and human (DR-HepG2) hepatoma cancer cell lines. We observed for the first time that FICZ 
potency was similar in both cell lines, but FICZ was 40 times more potent than TCDD in human 
cells. Depleting Trp-derivative endogenously produced ligands by using culture medium 
without Trp, resulted in 3-fold higher AhR activation upon adding FICZ in rat cells, in contrast 
to human cells which revealed a fast degradation of FICZ from 10h induction to complete 
disappear after 24h. Seven polyphenols and a mixture thereof, chosen based on commercially 
recommended doses and adjusted to human realistic exposure, caused rat and human 
species-specific AhR responses. Two isoflavones (daidzein and genistein) induced a rat AhR 
synergistic effect with FICZ and/or TCDD EC50, while quercetin, the flavones (baicalin and 
chrysin), curcumin, and the mixture exerted a strong human AhR inhibitory effect. The non-
flavonoid resveratrol acted as an agonist on both cell lines. Strikingly, resveratrol and 
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quercetin at their realistic nanomolar concentrations acted additively in the mixture to abolish 
human AhR activation in presence of various TCDD concentrations. Taken together, these 
results illustrate the species-specific complexity of AhR transactivation by various ligands and 
highlight the need for studies of human-based approaches. 
 
Keywords: Aryl hydrocarbon Receptor; rat and human; polyphenols; quercetin; antagonisms 
 
Capsule: Diet-borne endogenous and exogenous AhR modulators act differentially in human 






- Tryptophan-derivative FICZ is 40-fold more potent than dioxin to induce human AhR. 
- FICZ-induced human AhR activation is completely vanished at 24h post-exposure. 
- Rat AhR responds strongly to endogenously produced ligands derived from tryptophan. 
- Daidzein and genistein synergize with FICZ and/or dioxin in activating rat AhR. 
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1. Introduction 
Aryl hydrocarbon receptor (AhR) is known for its role as a xenobiotic mediator1. 
Environment/food-borne contaminants like 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 
induce their toxicity via the AhR signaling2,3. Ligand (TCDD)-activated AhR undergoes a 
translocation from cytosol to nucleus and binds to its heterodimerization partner aryl 
hydrocarbon receptor nuclear translocator (ARNT). This AhR/ARNT heterodimer binds to DNA 
sequences called dioxin responsive elements (DREs) to activate the expression of AhR 
inducible genes, including the phase I drug-metabolizing enzymes, the cytochrome p450 
(CYP) family (e.g. CYP1A1). Therefore, the methods measuring DRE–regulated gene 
expression are widely accepted for determining AhR activation4, among which cell-based 
screening methods such as Chemically Activated LUciferase gene eXpression (CALUX) are 
the most common5. 
 
The Ah receptor is also activated by a wide range of diet-borne endogenous and natural 
ligands to regulate several essential physiological functions in development and homeostasis, 
including immune responses, cell differentiation and proliferation, reproduction, and tumor 
suppression6. Indeed, AhR is considered as a sensor, connecting external environmental 
signals to cellular processes6,7. Catabolism of the essential amino acid tryptophan (Trp) either 
by the host or by the symbiotic microbiota yields numerous physiologically relevant AhR 
ligands8,9. Among them, 6-formylindolo[3,2-b]carbazole (FICZ) is considered the highest 
affinity AhR ligand to date with an estimated dissociation constant Kd of 0.07 nM, which is 
significantly lower than the TCDD Kd of 0.48 nM, measured in a competitive binding assay 
performed in rat hepatic cytosol10. It is produced by photochemical reactions under ultraviolet 
and visible light11,12 or by enzymatic and oxidative pathways11,13, thus ubiquitously distributed 
in most cell types13 to perform several essential functions especially in immunity14. FICZ is 
able to activate AhR in various species such as fish15, frog16, and birds17,18. However, little is 
known about its potency and mode of action compared to the widely studied AhR ligand 
TCDD. 
 
On the other hand, polyphenols represent the largest source of natural AhR modulators in the 
human diet19. They are secondary metabolites of plants with a common polyphenol structure 
and diverse chemical entities20. They are popular in research and food manufacture due to 
their significant antioxidant ability which could be useful to prevent various diseases 
associated with oxidative stress e.g. cancer, cardiovascular, and neurodegenerative 
diseases21,22. Besides, they are also able to modulate the activity of several enzymes and 
receptors23. For example, polyphenols have been shown to affect AhR activity in several ways 
including directly as AhR functional agonists or antagonists, indirectly by interfering with AhR 
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translocation, AhR-ARNT heterodimerization, AhR-DNA binding, or altering co-activators and 
co-repressors19. 
 
AhR normal functions can be dysregulated by inappropriate ligand activation or inhibition7, 
leading to subsequent health concerns19. Thus, AhR signaling needs to be tightly controlled 
by several mechanisms. For example, different susceptibility to metabolic feedback likely 
determines the mode of action of TCDD and FICZ in vivo24. AhR ligands, except metabolically 
stable ligands such as TCDD, activate AhR to induce their own oxidative metabolism via 
induction of AhR downstream genes e.g. CYP1 isoenzymes, and subsequently, their 
clearance from the body25. TCDD induces persistent AhR responses, while FICZ, which is 
rapidly metabolized by CYP1 isoenzymes11,26, causes only transient AhR signaling. Moreover, 
while most of the risk assessment data for humans are based on rodent models, there are 
large interspecies differences in susceptibility to toxic effects induced by dioxins27, and 
potentially by these endogenous and natural AhR ligands. Therefore, evaluating AhR 
responses depending on exposing species is crucial to understanding the physiological 
functions of this receptor as well as to establish the risk assessment and further applicability 
of AhR endogenous and natural mediators in drug and food industry towards human-based 
usages. 
 
In this study, reporter gene assays involving two cancer cell lines derived from, respectively 
rat and human hepatoma were used to study the effect of FICZ versus TCDD and seven 
commonly commercialized polyphenols on the transcriptional activity of AhR. The aims were 
to: (a) examine species-specific (rat versus human) responses of AhR to FICZ or TCDD in the 
presence or absence of endogenous ligands (by comparing medium with Trp versus without 
Trp, Trp being the major source of AhR endogenous ligands), (b) evaluate the effect of 
polyphenols, and a mixture thereof, either alone or co-exposed with FICZ or TCDD to mimic 
human realistic exposure to mixtures of AhR modulators, and (c) reveal the most active 
polyphenol(s) and possible interactions among these compounds in the mixture. 
 
2. Materials and methods 
2.1. Chemicals and suppliers 
FICZ was bought from Sigma Aldrich (Missouri, USA), while TCDD in DMSO was obtained 
from Wellington Laboratories (Ontario, Canada). Seven polyphenols: daidzein, quercetin, 
resveratrol, genistein, baicalin, curcumin, and chrysin were selected based on their common 
commercial availability as food supplements. They were purchased from Sigma Aldrich and 
dissolved in dimethylsulfoxide (DMSO) (Acros Organics, Molinons, France). Their detailed 
description is given in Table S1. A mixture of these seven polyphenols was designed to reflect  
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Classification Commercial sellers (food 
supplements) 
Recommended 





Quercetin Q4951 Flavonols Nature's Best, UK 500 0.33 
Resveratrol R5010 Stilbenes Pureclinica, UK 500 0.44 
Curcumin 78246 Hydroxycinnamic 
acid 
Nature's Best, UK 1000 0.54 
Chrysin 95082 Flavones Swanson, UK 500 0.39 
Baicalin 572667 Flavones Supersmart, Luxembourg 1000 0.45 
Genistein G6649 Isoflavones Vital Nutrients, USA 500 0.37 
Daidzein D7802 Isoflavones Ultimate Nutrition, USA 100 0.079 
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the realistic mixture exposure scenario of humans based on food supplement consumption or 
via their diet. The mixture contained each polyphenol at a concentration corresponding to a 
theoretical blood level arbitrarily calculated considering that the recommended ingested dose 
is diluted in five liters of blood, with an additional 1000-fold dilution factor to consider the 
intestinal absorption and the high metabolic rate of polyphenols. The polyphenols had 
nanomolar as their concentrations in the mixture at blood level (Table S1), relevant to human 
exposure28. To make up the mixture, after dissolving each compound individually in ethanol 
(Merck, Massachusetts, USA), the ethanolic solutions were pooled together to obtain the 
desired concentrations of the polyphenols in the mixture. The ethanol was removed under 
nitrogen flow to near dryness. Then the mixture was left overnight at ambient temperature and 
protected from light to complete dryness. DMSO was added to the dried residue to obtain the 
final solution. The stock solutions and working solutions of the polyphenols and the mixture 
were stored at -20oC and protected from light. Six successive two-fold dilutions were prepared 
from the stock solution right before use to obtain the tested concentrations which did not 
exceed 50 M for the polyphenols and 65 M for the mixture. 
 
2.2. Determination of aryl hydrocarbon receptor transcriptional activities 
2.2.1. Cell lines and DR-CALUX assays 
Two dioxin responsive (DR) hepatoma cell lines were used, rat DR-H4IIE from BioDetection 
System (Amsterdam, The Netherlands), and human DR-HepG2 previously produced within in 
the laboratory of Prof. Scippo (Liege, Belgium)29. These cells were stably transformed with a 
vector containing four DREs, either from the mouse Cyp1a1 promotor for the rat cells or 
synthetic for the human cells, upstream of, respectively the mouse mammary tumor virus 
promoter30 or the thymidine kinase promoter29 which control the transcription of a luciferase 
reporter gene. The cells were cultivated in MEM supplied by Thermo Fisher Scientific 
(Massachusetts, USA) with 10% v/v fetal bovine serum (Greiner, Kremsmünster, Austria) and 
50 IU/mL penicillin and 50 g/mL streptomycin (Sigma Aldrich). The cells were maintained in 
a water saturated atmosphere containing 5% CO2 at 37°C. 
 
We used the DR-CALUX assays to study the AhR transcriptional activity of FICZ compared to 
TCDD and of the polyphenols and the mixture alone or co-exposing with TCDD/FICZ EC50 
(more details about each experiment see section 3). The assays were carried out by following 
the method described elsewhere5,29. Briefly, after 24h of seeding in white clear-bottomed 96 
well microplates (Greiner) and reaching 90% confluence, the cells were exposed to the test 
compounds/mixture for various times in medium with Trp (MEM, 10mg/l L-Tryptophan) and 
without Trp (DMEM w/o Trp, Biomol, Hamburg, Germany). For exposure, the culture medium 
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was replaced by freshly prepared medium with test compounds and exposure was carried out 
with protection against direct light. After exposure, the cells were washed with phosphate 
buffered saline (Sigma Aldrich) and lysed by a solution containing Triton X100 (Sigma Aldrich). 
Light production was triggered by adding luciferin (Promega, Wisconsin, USA) and ATP 
(Roche Diagnostics, Rotkreuz, Switzerland) to the cell lysate and measured by a luminometer 
(ORION II, Berthold Detection System, Pforzheim, Germany). Each experiment was repeated 
at least three times independently in triplicate wells, together with a reference curve of 
TCDD/FICZ for quality control. The final DMSO concentrations were 0.1% and 0.2%, 
respectively for the activation and the co-exposure experiments. Cytotoxicity was assessed 
by visual inspection of cell morphology and attachment under microscope. 
 
2.2.2. Calculations of fold induction (FI), relative response (RR), EC50, and IC50 
Luciferase activities in the reporter gene assays were recorded as relative light units (RLU). 
The final results in the activation tests were presented as fold induction (FI). In the co-exposure 
tests which mainly focused on the inhibition potency of the compounds/mixture to the AhR 







𝑅𝐿𝑈𝑖 −  𝑅𝐿𝑈𝐷𝑀𝑆𝑂
𝑅𝐿𝑈𝑇𝐶𝐷𝐷/𝐹𝐼𝐶𝑍 − 𝑅𝐿𝑈𝐷𝑀𝑆𝑂
 
The fold induction (FIi) in an activation test was the ratio (fold) between the response of the 
tested compound/mixture (i) (RLUi) and the response of DMSO in the same plate (RLUDMSO) 
(Eq. (1)). The relative response (RRi) in a co-exposure test was the percentage (%) of the 
response of the cells to the tested compound/mixture (i) compared to the spike-in TCDD/FICZ 
EC50, subtracting from the baseline DMSO response (Eq. (2)). Non-linear regressions of the 
four-parameter equations for agonistic activation (Eq. (3)) or antagonistic inhibition (Eq. (4)) 
effects (FI or RR, respectively) were used to fit the dose-response curves (Graphpad PRISM 
software, version 7, San Diego, California, USA): 
(3) 𝐹𝐼𝑖(𝑎𝑐𝑡𝑖𝑣𝑎𝑡𝑖𝑜𝑛) = 𝑏𝑜𝑡𝑡𝑜𝑚 +  




(4) 𝑅𝑅𝑖(𝑐𝑜−𝑒𝑥𝑝𝑜𝑠𝑢𝑟𝑒) = 𝑏𝑜𝑡𝑡𝑜𝑚 + 
𝑡𝑜𝑝 −  𝑏𝑜𝑡𝑡𝑜𝑚





where x was the concentration of the tested compound/mixture. The corresponding EC50 and 
IC50 were the concentrations of the tested compound/mixture exerting half the maximal 
effect31. Data from tests revealing cytotoxicity were excluded from the analyses. 
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3. Results 
3.1. Rat and human aryl hydrocarbon receptor transcriptional activation of FICZ/TCDD 
In a first experiment, the dose-dependent AhR transcription activated by FICZ and TCDD was 
determined in a time series (2h – 24h) in rat DR-H4IIE and human DR-HepG2. To investigate 
the role of endogenously produced AhR ligands, we compared the cells’ response in the 
standard medium containing Trp (MEM) and in the medium without Trp (DMEM w/o Trp), 
with Trp being the main precursor of these compounds. FICZ strongly induced the AhR 
transcriptional activity, to a similar extent (FImax = 10- to 15-fold at 250 pM FICZ) compared to 
TCDD in both cell lines, however with different response patterns (Figures 1 and 2). 
 
The response of the rat DR-H4IIE to FICZ and TCDD was influenced by the presence of Trp 
in the culture medium. In MEM, rat AhR activation was low (the maximum fold induction FImax 
 5-fold induction until 10h exposure) with a gradual increase for both TCDD and FICZ 
exposure, reaching a maximum of 12  0.2 and 9  0.2 fold, respectively, after 24h exposure 
(Figure 2A1). In DMEM w/o Trp, although the cells responded faster and more strongly to 
FICZ than to TCDD, reaching fold induction as high as 14  0.4 already after 2h exposure 
(Figure 1A1), their response to both FICZ and TCDD after 4h exposure was comparable 
(Figure 1B1) and remained similar until 24h exposure (Figure 1G1), although the dose-
response curves of rat AhR response to FICZ started to degrade after 8h induction with much 
steeper curves. Both FImax and EC50 remained relatively similar for FICZ and TCDD (Figure 2-
1). 
 
In contrast, the AhR transcriptional activation of the human DR-HepG2 mainly depended on 
the added agonist (FICZ or TCDD), largely irrespective of the presence or absence of Trp in 
the culture medium. Human AhR activation induced by TCDD in both culture media increased 
over time and reached a maximum of 21-fold induction after 24h exposure (Figures 1G2 and 
2A2). In contrast, the response activated by FICZ increased during the first 4h exposure, 
remained stable between 4h and 8h exposure, then decreased and completely vanished after 
24h exposure (Figure 1-2). The rapid decrease of FICZ-induced AhR activation (resulting in 
steeper curves and low FImax) after 10h exposure indicated a fast metabolism of FICZ in the 
human cells. The human cells were also dramatically more sensitive to FICZ than to TCDD. 
For example, in DMEM w/o Trp, FICZ elicited the maximal 11-fold induction after 6h exposure 
to 250 pM FICZ, while the cells at this time required 10,000 pM of TCDD (Figure 1C2) to have 
the same effect, indicating a 40-fold higher potency of FICZ compared to TCDD. The FICZ 
EC50 in human cells (exposed in DMEM w/o Trp) were 11  2.4 pM, 40-fold lower than TCDD 
EC50 = 403  29 pM after 6h exposure (Figure 2B2). 
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Figure 1. Dose response curves of rat DR-H4IIE and human DR-HepG2 cells exposed to TCDD 
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Figure 2. (A) Maximum fold induction for rat DR-H4IIE and human DR-HepG2 cells exposed to 
TCDD or FICZ in culture medium with (MEM) and without Trp (DMEM w/o Trp) from 2h to 24h 
induction. (B) The respective EC50 values, only EC50 values of TCDD after 4h induction and EC50 
values of FICZ before 10h induction were considered since their appropriate sigma dose response 
curves could be attained. 
 
3.2. Rat and human aryl hydrocarbon receptor transcriptional activities of the 
polyphenols and the mixture 
The seven individual polyphenols and their mixture were tested for AhR transcriptional 
activities in DR-H4IIE and DR-HepG2 in four different culture medial conditions (DMEM w/o 
Trp, MEM, and in DMEM w/o Trp added either FICZ or TCDD EC50). Two exposure times 
(4h and 8h) resulting in relatively stable AhR responses to FICZ and TCDD (section 3.1) were 
chosen for this experiment in order to avoid the complication of FICZ degradation through the 
metabolic feedback loop. The spike-in TCDD EC50 for 4h and 8h exposure were, respectively 
85 pM and 15 pM in the rat DR-H4IIE, and 650 pM and 250 pM in the human DR-HepG2, 
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The polyphenols and mixture induced no cytotoxicity in both cell lines, except curcumin at 50 
M in the rat cells, which was excluded from the data presented. Their activity increased from 
4h to 8h post-exposure and vanished after 24h (only tested in MEM) in both cell lines, except 
chrysin which retained a moderate AhR activation after 24h exposure in the human cells with 
FImax = 3.4  0.5 fold (data not shown). 
 
Daidzein and genistein, the two isoflavones, agonized the rat AhR significantly. Daidzein 
exerted FImax = 4.7  0.4 fold after 8h exposure in DMEM w/o Trp (Figure 3A1), compared to 
the 12-fold maximal induction by TCDD in the condition. In the co-exposure experiment, 
daidzein surprisingly boosted the rat AhR responses to both FICZ or TCDD EC50, remarkably 
increasing the cells’ response to FICZ EC50 up to maximum relative response RRmax = 744  
63% and that to TCDD EC50 up to RRmax = 361  60% after 8h exposure (Figure 3A2). This 
resulted in a final 18  3 and 9  2 fold induction, respectively for FICZ and TCDD cotreatment 
after the spike-in EC50 reference subtraction, showing an almost 4 and 2-fold increase, 
compared to its respective agonistic activity alone. 
 
   
  
   
Figure 3. Dose response curves of rat DR-H4IIE cells responding to (A) daidzein or (B) genistein 
in (1) medium with (MEM) or without Trp (DMEM w/o Trp) or (2) cotreated with FICZ or TCDD 
EC50 in DMEM w/o Trp for 4h or 8h induction. 
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Genistein stimulated the rat AhR in both MEM and DMEM w/o Trp after 8h exposure with 
FImax = 7 fold (Figure 3B1). Genistein also exerted an enhanced effect when co-exposing only 
with FICZ EC50 and only in rat cells after 8h exposure (RRmax = 520  149%) (Figure 3B2), 
which resulted in a final 24  3 fold induction, showing a 1.7-fold increase compared to its 
agonistic activity alone. This mutual enhancement of the response suggests the presence of 
a synergistic effect of the isoflavones with FICZ/TCDD, resulting in several fold increases in 
the induction efficiency when co-exposing with FICZ/TCDD. 
 
Meanwhile, neither isoflavone displayed significant activities on the human AhR in DR-HepG2 
(Figure S1). Noticeably, daidzein but not genistein antagonized TCDD EC50 in the human cells 
(RRmax = 40%), but slightly increased the cells’ response to FICZ EC50 (Figure S1A2), 
indicating a selective AhR inhibitory effect of daidzein on TCDD induction in the human cells. 
 
   
   
   
Figure S1. Dose response curves of human DR-HepG2 cells responding to (A) daidzein or (B) 
genistein in (1) medium with (MEM) or without Trp (DMEM w/o Trp) or (2) cotreated with FICZ or 
TCDD EC50 in DMEM w/o Trp for 4h or 8h induction  
 
In contrast to what was observed with the two isoflavones, flavonol quercetin, flavones 
(baicalin and chrysin), and curcumin affected the AhR transcriptional activity more strongly in 
human DR-HepG2 than in rat DR-H4IIE. In rat cells, they induced a weak AhR activation of 
4h DMEM w/o Trp4h MEMα
8h DMEM w/o Trp8h MEMα
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2 fold only in MEM culture medium (containing Trp) at their highest concentrations (Figure 
S2). In human cells, quercetin, baicalin, and chrysin exerted an agonistic effect regardless of 
the presence of Trp in the culture medium with FImax = 3.2  0.2 (Figure 4A1), 3.7  0.1 (Figure 
4B1), 5.2  0.2 fold (Figure 4C1), respectively after 8h exposure in DMEM w/o Trp, compared 
to respective FImax = 12 fold of TCDD. A similar response pattern was observed when MEM 
was used as exposure medium. However, we observed a decrease in the response to the 
highest concentration (50 M) of quercetin (Figure 4A1) and baicalin (Figure 4B1) after 4h 
exposure in DMEM w/o Trp, and chrysin (Figure 4C1) after 4h and 8h exposure in MEM and 
4h in DMEM w/o Trp. 
 
On the other hand, only quercetin inhibited rat AhR activation by TCDD EC50 with RRmax = 33 
 8% after 8h exposure, but the other two flavones did not (Figures S2A2; B2; and C2). In 
human cells, quercetin was the strongest AhR antagonist, followed by the two flavones. 
Quercetin at 3 M totally abolished the activity of 30 pM FICZ (RRmax = 5  3%) (Figure 4A2), 
while 15.5 M of chrysin was needed for the same effect (RRmax = 9  5%) (Figure 4B2), 
regardless of exposure time. Baicalin also caused an antagonistic effect but to a lesser extent 
(RRmax = 46  7.5% at 50 M) after 8h exposure (Figure 4C2). Both flavones did not affect the 
human AhR response to TCDD EC50, while quercetin antagonized strongly TCDD after 4h and 
8h exposure, in presence of respectively 650 pM and 250 pM TCDD, showing a V-shaped 
response curve (Figure 4A2). The lowest tested concentration of quercetin (0.3 M) already 
reduced by half the TCDD EC50-induced AhR response of the human cells after 8h exposure 
or completely after 4h exposure, while quercetin with 3 M totally ablated the AhR activity of 
TCDD EC50 at both exposing times. The relative response increased to around RRmax = 50% 
at higher concentrations, probably reflecting the agonistic activity of quercetin at these 
concentrations. 
 
Curcumin is a pure AhR inhibitor in the human cells, but not in the rat cells. In human cells, it 
antagonizes even the DMSO baseline of the human AhR response (Figure 4D1), and both 
TCDD EC50 and FICZ EC50 regardless of exposure time (Figure 4D2). 
 
Resveratrol induced relatively similar AhR agonistic responses in both rat and human cells 
(Figures 5A1 and C1). Similar to the two isoflavones, resveratrol seems to have a synergistic 
activity with FICZ EC50 in the rat cells after 8h exposure (Figures 5A2). Meanwhile, in the 
human cells, similar to quercetin, only 6.3 M resveratrol strongly antagonized TCDD EC50 to 
RRmax = 25  7% after 8h induction in DMEM w/o Trp but without a distinct V-shaped dose 
response curve (Figure 5C2). 
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Figure 4. Dose response curves of human DR-HepG2 cells responding to (A) quercetin, (B) 
baicalin, (C) chrysin, or (D) curcumin in (1) medium with (MEM) or without Trp (DMEM w/o Trp) 
or (2) cotreated with FICZ or TCDD EC50 in DMEM w/o Trp for 4h or 8h induction.  
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Figure S2. Dose response curves of rat DR-H4IIE cells responding to (A) quercetin, (B) baicalin, 
(C) chrysin, or (D) curcumin in (1) medium with (MEM) or without Trp (DMEM w/o Trp) or (2) 
cotreated with FICZ or TCDD EC50 in DMEM w/o Trp for 4h or 8h induction 
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Figure 5: Dose response curves of rat DR-H4IIE cells responding to (A) resveratrol or (B) the 
mixture and of human DR-HepG2 cells responding to (C) resveratrol or (D) the mixture in (1) 
medium with (MEM) or without Trp (DMEM w/o Trp) or (2) cotreated with FICZ or TCDD EC50 in 
DMEM w/o Trp for 4h or 8h induction. 
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The polyphenol mixture induced a weak AhR activation response relatively similar in both 
human and rat cells (Figures 5B1 and D1). However, while the mixture increased the rat AhR 
activation by FICZ EC50 after 8h exposure (Figure 5B2), as did the two isoflavones and 
resveratrol, it strongly antagonized both FICZ and TCDD EC50 AhR activation in the human 
cells with a dose-response curve reminiscent of that seen with quercetin (Figure 5D2). Only 4 
M of the mixture totally abolished the activity of 650 pM TCDD (RRmax = 1  2% for 4h or 
even RRmax = 0  2% for 8h in DMEM w/o Trp). The results are summarized in Table 1. 
 
Table 1. AhR activities of the seven polyphenols. Activation (, orange), inhibition (, green) 





MEMα DMEM w/o Trp 
+ FICZ EC50 
DMEM w/o Trp + 
TCDD EC50 




   
 











Human     
Baicalin Rat 
    






Human    
 
Curcumin Rat 
    
Human     
Resveratrol Rat     
Human   
  
Mixture  Rat    
 
Human     
 
3.3. Human aryl hydrocarbon receptor inhibitory activity of resveratrol, quercetin and 
the mixture  
The TCDD inhibitory potentials in the human cells of resveratrol, quercetin, and the mixture at 
low concentrations were further tested in DMEM w/o Trp for 8h exposure. Figure 6A shows 
that the two polyphenols and the mixture exhibited a strong inhibitory effect against the human 
AhR activated by TCDD EC50. While 5 M resveratrol inhibited the AhR activity induced by 
TCDD EC50 (650 pM) to RRmax = 20%, 2.5 M quercetin or the mixture at blood concentration 
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( 2.5 M) was able to totally abolish this activity. Their TCDD inhibitory effects started at 
concentrations as low as 0.2 to 0.3 M (Figure 6A), and their IC50 were 1  0.08, 0.6  0.03, 
and 0.8  0.06 M, respectively, for resveratrol, quercetin, and the mixture. Co-exposing these 
polyphenols at the same concentration (5µM) or the mixture with various concentrations of 
TCDD (0.15 to 20 nM) (Figure 6B) revealed that resveratrol was less efficient (a reduction of 
only 30% of TCDD 20 nM), while the mixture and quercetin blocked totally TCDD-induced 
AhR activation even the highest (20 nM) concentration. 
 
  
Figure 6: Dose response curves of DR-HepG2 cells responding to (A) the mixture, quercetin 
and resveratrol co-exposed with 650 pM TCDD, (B) various TCDD concentrations co-exposed 
with 5 M of these polyphenols, (C) the predicted and measured dose response curve of the 
mixture after 8h induction, and (D) distribution of effect units of the 4 active AhR antagonists 
in the mixture. 
 
The inhibitory effect on TCDD EC50 of the mixture in the human cells at 8h was predicted using 
concentration addition (CA) and independent action (IA) models32 (Figure 6C) using the 
information of the four AhR antagonists namely, daidzein, quercetin, curcumin, and 
resveratrol. Thus, the human AhR elevated activation of the mixture observed at 
concentrations higher than 5 M was not considered. Detailed calculations are presented in 
supplementary information “Calculations of mixture effect and effect unit”. Both the CA and IA 
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measured curve. The IA model predicted an IC50= 3.5 M, close to 2.5 M of the CA model, 
compared to 0.8 M measured. Quercetin contributed for 56% of the effect of the mixture, 
while 39% was contributed by resveratrol (Figure 6D). 
 
4. Discussion 
4.1. Rat and human aryl hydrocarbon receptor responses to FICZ and TCDD 
This study is the first to show a direct and cross-species (rat and human) comparison of AhR 
transactivation by FICZ and TCDD in hepatoma cells. We found that FICZ potency was similar 
on both rat and human AhR. However, FICZ was 40-fold more potent than TCDD in human 
cells (Figures 1 and 2). In a mouse knock-in model where the endogenous mouse Ahr gene 
was entirely replaced with the human AHR gene, a reduction of TCDD-induced CYP1A family 
genes expression was observed27. This is in agreement with our results showing that the 
human AhR has a lower affinity for TCDD than the rat AhR32. There is currently no data 
available for interspecies (rat and human) comparisons of AhR responses to FICZ. However, 
in an intraspecies comparison, the low affinity murine isoform (AhRd) which is the result of an 
Alanine to Valine change at residue 375, showed a four-fold lower binding affinity for TCDD 
than the AhRb high affinity variant33. Nevertheless, both variants exhibited similar sensitivity to 
FICZ. Also, FICZ functioned similarly between the two mouse strains, exerting no differences 
in the induction of T helper 17 immune cells24. Additionally, the binding of different ligands 
(e.g. FICZ versus TCDD) has been suggested to cause different AhR conformational changes, 
resulting in different downstream consequences34, such as in modulating the recruitment of 
various coactivators and transcription factors35. For example, a comparison of TCDD and FICZ 
in an in vivo mouse model for infection by the influenza virus revealed that they differentially 
affected various cell-specific AhR activators, most likely due to the different conformational 
changes that they induced36. 
 
In this study, depletion of Trp in the medium (DMEM w/o Trp) did not affect the AhR responses 
in human cells, but led to an almost 3-fold higher induction by both TCDD and FICZ after 4h 
to 10h treatment in rat cells (Figure 2A1). A “pure” AhR antagonist, GNF31537 at 10 M 
inhibited half (reduced 64%) of the basal luciferase signal of the rat DR-H4IIE in MEM after 
6h treatment, but it had no significant effect (reduced only 16%) on the basal response in DR-
HepG2 (data not shown). Thus, it is likely that on top of the activities of the FICZ added, the 
rat AhR responded to the high level of basal AhR activation caused by endogenously produced 
ligands derived from Trp upon addition of fresh medium. These ligands were unstable, as the 
difference in medium with and without Trp tended to vanish after 12h treatment. In human 
cells, the AhR transactivation of both TCDD and FICZ was not affected by the presence of Trp 
Chapter 3: Differential rat and human AhR response to different ligands  
 105 
in culture medium (Figure 2A2). This could result from a lower conversion rate of Trp to AhR 
endogenous ligands, or conversion to different compounds in human cells.  
 
Moreover, we showed that FICZ clearance was high in the human cells. It appears that if FICZ 
clearance is blocked, such as by inhibiting the FICZ/AhR/CYP1A1 feedback loop, FICZ could 
also induce toxicity. In an in vivo research on zebrafish, Wincent et al., (2017)38 showed a 
toxic effect of FICZ after knockdown of the cyp1a1 gene, while a combined knockdown of 
cyp1a1 and ahr2 (homologous to AhR in humans) significantly reduced this toxicity. The 
authors concluded that the toxicity of FICZ was at least partially Ahr2-dependent in zebrafish 
embryos, similar to that of TCDD, but observed only when its degradation by Cyp1a1 is 
blocked. 
 
Thus, it is at present difficult to pinpoint the reason for the ligand-intrinsic differences in AhR 
responses while different susceptibility to metabolism complicates the issue. However, the 
conservation in high FICZ potency in inducing AhR activation across different species and 
among different AhR isoforms suggests its physiological importance as an endogenous AhR 
ligand during evolution16.  
 
4.2. Rat and human aryl hydrocarbon receptor responses to the polyphenols and the 
mixture 
This study, for the first time, reports the species-specific AhR transcriptional activity in cells 
exposed to different polyphenols. Isoflavones (daidzein and genistein) were more active in the 
rat DR-H4IIE, while the flavonol quercetin, flavones (baicalin and chrysin) and curcumin 
strongly affected the AhR activity in the human DR-HepG2. The stilbene resveratrol acted 
equally on both cell lines. Although further investigations involving larger numbers of 
polyphenols are necessary to evaluate the AhR species-responses of different polyphenol 
subclasses, the data are valuable for selecting polyphenols as active compounds specifically 
for human-aimed research and also raise a concern for traditional rodent-to-human 
extrapolation in risk assessments. It is important to stress here that these activities were only 
observed after short term exposures (4h or 8h), only chrysin maintained some of its activity 
after 24h. 
 
The two isoflavones exerted AhR agonistic effects in the rat cells and dramatically enhanced 
the rat AhR response in the presence of FICZ EC50 (4 and 3.5-fold higher than acting alone 
for daidzein and genistein, respectively).  Several previous studies revealed stronger FICZ 
induction after 24 or 48h by interfering with the clearance of FICZ via the FICZ/AhR/CYP1A1 
feedback loop 39,40, however we chose to perform our experiments at 4 and 8 h post-exposure, 
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before degradation kicks in, therefore we most likely can rule out this mechanism for the 
observed synergistic effects. An enhanced induction was previously observed for the 
glucocorticoid receptor-mediated transcription due to sodium arsenite-induced chemical 
stress, or for progesterone or androgen stimulation by a combined treatment with forskolin (an 
activator of adenylate cyclase) and trichostatin A (an inhibitor of histone deacetylases)41. 
Likewise, a rat AhR synergistic activity of genistein with 300 pM TCDD was observed 
previously that was explained by the various cellular functions of genistein29. Thus, in our case, 
the synergistic effects of daidzein and genistein co-exposing with FICZ EC50 were likely due 
to their activity on other pathway(s) which helped to enhance AhR transactivation more 
efficiently.  
 
On the other hand, these isoflavones did not affect FICZ-induced AhR activation in the human 
cells. Instead, daidzein, but not genistein strongly inhibited the TCDD-activated AhR 
transcription in the human cells (Figure S1 A2), which is in agreement with the finding that 
daidzein inhibited the transcription of Cyp1 genes induced by a xenobiotic 7,12-
dimethylbenz(a)anthracene39. 
 
The flavonol quercetin and the two flavones (baicalin and chrysin) exerted significant AhR 
agonistic and antagonistic effects in the human cells cultivated in media with or without Trp 
(Figures 4A1; B1; and C1) but not in the rat cells. Several mechanisms could explain the AhR 
agonistic activity of quercetin. Jin et al., (2018)42 reported that quercetin was an inducer of 
CYP1A1 in CaCo-2 cells, and they also showed the interaction of quercetin with AhR using in 
silico tools. In addition, quercetin was shown to significantly increase the AhR translocation by 
activating protein kinases C in rats, facilitating the transcriptional activity of AhR in 
osteoblasts43. Phosphorylation by e.g. protein kinases C is required for AhR activity in DNA 
binding and gene transactivation and for the transformation of the unliganded AhR into a fully 
functionally active AhR/ARNT heterodimer44. 
 
AhR antagonism of quercetin and chrysin at concentrations higher than 5 M was previously 
shown for DR-HepG2 after 6h exposure29. However, another original finding of this study is 
the strong AhR antagonistic activity of quercetin at very low concentrations (≤ 5 M) in the 
human DR-HepG2 cells co-exposed to quercetin and increasing concentrations of TCDD 
(Figures 6A and B). One could suggest that quercetin was a TCDD competitive antagonist, 
strongly competing to TCDD for binding sites in the human AhR. However, the agonistic 
activity of quercetin in human cells was very low or absent at concentrations < 5µM, indicating 
its low AhR affinity (Figure 4A1). These observations indicate that quercetin may not be a 
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TCDD competitive antagonist. For example, quercetin was found to induce AhRR (AhR 
repressor) mRNA expression in human Caco-2 cells, thereby facilitating AhRR-dependent 
transrepression of AhR and inhibiting the BaP-AhR activation45. However, there could be 
additional underlaying mechanism(s) for the strong antagonistic effect of quercetin in the 
human DR-HepG2, which deserves further investigations. 
 
Resveratrol was an AhR agonist in both rat and human cells. It also enhanced the response 
to FICZ of the rat AhR in the same manner as the two isoflavones did. It was also a strong 
AhR antagonist in the human cells, although less potent than quercetin (Figures 6A and B). 
Lee and Safe (2000)46 showed that resveratrol did not exhibit AhR agonistic or antagonistic 
activity in human mammary carcinomaT47D or MCF-7 cells. Instead, it inhibited CYP1A1 
mRNA expression and CYP1A1-dependent activity via an AhR-independent post-
transcriptional pathway. It promoted the nuclear translocation and/or DNA-binding activity of 
AhR, showing partial AhR-agonistic features. On the other hand, it reduced AhR-inducible 
gene expression without interfering with AhR-DRE binding, displaying its AhR-antagonistic 
effect when cells were co-exposed to TCDD. Similarly, another study showed that resveratrol 
provoked the translocation and binding of the AhR to DREs as well as competed with and 
displaced TCDD from AhR binding sites in T-47D and HepG2 cells, but without the subsequent 
transactivation of several dioxin-inducible genes including CYP1A147. Likewise, it inhibited in 
vivo rat testicular CYP1A1 expression by decreasing the BaP-induced AhR protein level, AhR 
nuclear translocation and subsequent promoter activation48. Meanwhile, Perdew et al. 
(2010)49 showed that CYP1A1 repression by resveratrol was dependent on estrogen receptor 
(ER) since siRNA against ER was able to completely abolish the repressive effect of 
resveratrol on TCDD-inducible CYP1A1 mRNA accumulation in MCF-7 cells, but not in Caco-
2 cells, indicating cell-specificity. 
 
We showed that curcumin exerted an AhR antagonistic activity only in the human DR-HepG2 
cells. This activity is probably due to the inhibition of TCDD-induced AhR phosphorylation. 
Nishiumi et al. (2007)50 showed that in mouse Hepa-1c1c7 cells, curcumin accelerated the 
TCDD-induced AhR translocation, but inhibited heterodimerization of the AhR with ARNT by 
dose-dependently inhibiting the TCDD-induced phosphorylation of both the AhR and ARNT, 
thereby suppressing AhR activation. Furthermore, Cho et al. (2008)51 revealed the 
involvement of oxidative stress in mediating the curcumin-induced degradation of AhR and 
ARNT. Similarly, Nakai et al. (2018)52 found that curcumin suppressed TCDD-induced protein 
expression and activity of CYP1A1 in human HepG2 cells and mouse Hepa-1c1c7 cells by 
inhibiting phosphorylation of AhR. These mechanisms might be less involved, or carried out 
by different cell components in the rat DR-H4IIE cells53, thus explaining the nearly complete 
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absence of AhR antagonism of curcumin in this study. To conclude, it seems that the effect of 
polyphenols on the AhR transcriptional activities is far more complicated and rarely solely as 
a direct AhR ligand, instead involving multi-cellular pathways. 
 
The mixture of the seven polyphenols exerted an AhR agonistic activity in both rat and human 
cells. Interestingly, similarly to quercetin, it also inhibited strongly the AhR activation induced 
by TCDD at various concentrations in the human cells (Figure 6B). Both CA and IA models 
resulted in an acceptable prediction of the antagonistic mixture effect (Figure 6C), indicating 
that the activities of these polyphenols were additive in the mixture with a similar or dissimilar 
mode of actions. 
 
Quercetin and resveratrol acted together, contributing to 95% of the AhR antagonism of the 
mixture, which was able to totally abolish the AhR activation of 650 pM TCDD in DR-HepG2 
cells, at a concentration of 2.5 M (Figure 6A). At this concentration, the mixture contained 
0.33 M quercetin and 0.44 M resveratrol, corresponding to theoretical calculated blood 
levels (Table S1). According to literature, these concentrations could be realistic in human 
blood after dietary polyphenol ingestion. Quercetin is naturally found in onions, apples, 
broccoli, and berries54,55, while resveratrol is abundant in red grapes, red wine, peanuts, and 
ground nuts56. Two main metabolites of quercetin, quercetin-30-sulphate and quercetin-3-
glucuronide, accumulated in human plasma with maximum concentration of 0.665 μM and 
0.351 μM respectively after less than an hour after the ingestion of 270 g fried onions57. 
Similarly, the blood concentration of resveratrol can peak at 2 μM after an hour of single 
administration of an oral dose of 25 mg of trans-resveratrol to healthy volunteers58. 
 
In our previous study32, we showed that a mixture of 29 persistent organic pollutants, the total 
POP mixture, prevalent in Scandinavian human blood, also caused an AhR antagonistic 
effect, which could be realistic. While this total POP mixture can cause a persisting AhR 
antagonism, the AhR antagonistic effects of quercetin, resveratrol, and the mixture of 
polyphenols are only transient due to their fast metabolism. However, the health impact of the 




We showed for the first time a side-by-side comparison of the effects of an endogenous AhR 
ligand (FICZ) and exogenous ligand (TCDD) on two hepatoma cell lines from two different 
organisms (rat and human). FICZ was 40 times more potent than TCDD in the human cells, 
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and displayed similar potency in both rat and human cells, indicating its physiological 
importance as an endogenous AhR ligand during evolution. Furthermore, we showed a huge 
effect of Trp depletion on AhR activation in rat cells, but none in human cells, probably due to 
the higher production of endogenous ligands from Trp in rat cells, along with a faster 
degradation of the ligand FICZ in human cells. The effect of seven polyphenols and their 
mixture thereof on AhR transactivation alone and after co-exposing with FICZ or TCDD was 
also investigated. Both agonistic and antagonistic effects were observed, in line with the 
expected complexity of a system where differential degradation of the tested compounds was 
certainly playing a role, as well as interactions of the compounds, and their metabolites, with 
various components of the cellular machinery. Antagonistic activity of quercetin, resveratrol, 
and the mixture towards TCDD-induced human AhR activation was observed in this study at 
nanomolar concentration, which is realistic in human exposure levels.  
 
FICZ and other endogenous ligands together with the either agonistic or antagonistic activities 
of polyphenols, in concert, regulate and maintain the physiological functions of AhR in 
balance. This balance can be disrupted by xenobiotic exposure or mis-applications of natural 
supplements but also can be used to treat diseases related to AhR disfunctions. Further 
studies are required to fully understand the interference of these dietary polyphenols on the 
AhR mediated activity of both endogenous and persistent xenobiotic AhR ligands in order to 
assess the health impact of their use as drugs or food supplements. 
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Supplementary materials. 
Calculations of mixture effect and effect unit. The predicted antagonistic mixture effect 
was calculated by using models of concentration addition (CA) and independent action (IA)32. 
CA model is applied for chemicals acting in the same mode of action, calculating the effect 
concentration (ICmix,j) of the mixture inducing a specific antagonistic effect j (from 1% to 100%) 
by considering the concentration partition (p i) of compound i and its respective effect 
concentration (ICij) inducing the same effect j (Eq. (S1)). Previously published formulae were 
adapted59–61: 









For each compound i, ICij inducing the effect j is calculated using its IC i,50 and hillslope (Hi) 
from their fitted curves using Eq. (S2) (Graphpad PRISM): 
 







To generate the full dose-response curves, the hillslope and top (Hmix and Tmix) of the mixture 
response were calculated as the average responses of the active components (n) due to their 
similarity (Eq. (S3a and b)), while the bottom (Bmix) was calculated by Eq. (S3c) considering 
their weight (pi) in the mixture: 
 













   









Deriving from CA model, effect units (i.e. the ratio of the concentration partition of a compound 
to its IC50 (pi/IC50,i), scaling the concentrations of the mixture components to its effect), has 
been applied to identify the main driver(s) for mixture effects in CA model59,62,63. 
 
IA model is applied for chemicals acting in different mode of action64. An antagonistic effect 
induced by compound i is obtained by subtracting the measured relative response (R ik) from 
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100% (100% being the relative response of TCDD EC50) and then converted into a probability 
(scale 0-1, by dividing by 100). The relative response of the mixture (0%-100%) is calculated 
from the combination of individual probabilities of each compound using the adapted formula 
Eq. (S4)60,62: 
 








At a specific concentration k, Rmix,k is the relative response of the mixture; Rik  is the relative 
response of compound i at that concentration k of the mixture, n is the number of the active 
components. 
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Chapter 4 
Access to safe drinking water is crucial for public health, however drinking water is also an 
unavoidable route exposing humans to pollutants, especially endocrine disruptors (EDs). 
Although there are several legislations imposing maximal limits of EDs in drinking water, there 
is still a need for research on protecting human health against the effects of EDs in drinking 
water, especially in mixture forms. Prioritizing chemicals posing threats is crucial, considering 
the cost of water treatment, remediation, and monitoring. 
 
The chapter 4 focuses on profiling the potential endocrine disrupting activities of the 18 
selected compounds prevalent in raw water intended for drinking water production in Wallonia 
found in the BIODIEN project (“search for EDs in waters”) funded by the Walloon Government 
in Belgium. A panel of reporter gene cell lines, including aryl hydrocarbon receptor (AhR) and 
the steroid receptors was used. Both agonistic and antagonistic activities of these compounds 
and their mixtures were investigated by using CALUX bioassays with a panel of seven 
transgenic cell lines: three (human and rat) responsive to dioxins through AhR and four 
(human) responsive to steroids through estrogen (ER), androgen (AR), progesterone (PR), 
and glucocorticoid (GR) receptors. The aims were to (a) assess both transcriptional agonistic 
and antagonistic activities of the 18 compounds individually and in mixtures towards the five 
receptors, (b) identify the most concerning endocrine disrupting compound(s), and (c) identify 
the main compound(s) responsible for the observed effects of the mixtures.  
 
The results obtained have been submitted to Chemosphere.  
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Abstract 
Access to safe drinking water is crucial for public health since drinking water is an unavoidable 
route of exposing humans to pollutants. Prioritizing chemicals of concern for monitoring of 
drinking water contaminants is crucial for legislation when also considering costs of water 
treatment and remediation. We profiled in vitro potential endocrine disrupting activities of 18 
compounds most frequently found in Walloon raw water intended for drinking water 
production. These compounds include pesticides, perfluorinated compounds, polycyclic 
aromatic hydrocarbons, and bisphenol A. Both agonistic and antagonistic activities of these 
compounds and their mixtures were investigated using a panel of CALUX bioassays 
incorporating seven reporter transgenic cell lines: three (human and rat) responsive to dioxins 
through the aryl hydrocarbon receptor (AhR) and four (human) responsive to steroids through 
the estrogen (ER), androgen (AR), progesterone (PR), and glucocorticoid (GR) receptors. 
Among them, ten caused at least one response in at least one receptor. Specifically, 
chlorpyrifos, bisphenol A, fluoranthene, phenanthrene, and benzo(a)pyrene displayed 
significant activities on several receptors. Bisphenol A agonized ER, but abolished the cells’ 
response to androgen and progesterone. While fluoranthene and phenanthrene strongly 
reduced human AhR and AR transactivation, benzo(a)pyrene strongly activated AhR and ER, 
but inhibited GR and AR. In human breast cancer cells, benzo(a)pyrene dramatically activated 
AhR, inducing a 10-fold higher response than dioxin at concentrations realistically found in 
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blood from highly exposed sub-populations or via food contamination incidents. The mixture 
of the 18 compounds exerted both ER and rat AhR agonism, with the main contribution being 
benzo(a)pyrene or its combination with bisphenol A. Moreover, the mixture significantly 
inhibited dioxin-induced CYP1A activity (detected only by EROD assays) in human liver cells. 
 
Keywords: Raw water; CALUX assays; Endocrine disrupting activities; Aryl hydrocarbon 






- Endocrine disrupting in vitro profile of 18 pollutants in drinking water resources. 
- Chlorpyrifos, BPA, fluoranthene, phenanthrene, BaP display significant activities. 
- BaP strongly induces AhR in human breast cancer cells, 10-fold higher than dioxin. 
- The mixture exerts ER and rat AhR agonisms, due to BaP or its combination with BPA. 
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1. Introduction 
Since drinking water is an unavoidable route exposing humans to pollutants, access to safe 
drinking water is crucial for public health1. Endocrine disruptors (EDs), a group of exogenous 
substances that can interfere with the endocrine system, thereby affecting the health of 
animals and humans, are of particular concern. Exposure to EDs even at low doses is 
associated with several health problems including abnormal reproductive activity, high 
incidence of cancers, metabolic disorders such as obesity and cardiovascular diseases2–4. 
Several legislations impose maximal limits of EDs in drinking water. The Safe Drinking Water 
Act (SDWA) in the US5, the Drinking Water Guidelines (ADWG) in Australia6, and the Drinking 
Water Directive 98/83/EC in the European Union (EU)7 have been enforced for the quality of 
water intended for human consumption. 
 
While there is still a need for research on protecting human health against the effects of EDs 
in drinking water4, especially in mixture forms, prioritizing chemicals posing the threats is 
crucial, considering the cost of water treatment, remediation, and monitoring. The Walloon 
Government in Belgium has recently funded the BIODIEN project (“search for EDs in waters”) 
aiming to quantify the contamination by specific EDs of several Walloon and Brussels water 
bodies (surface and groundwater intended or not for drinking water production, waste water 
treatment plant effluents, runoff, etc.). Among the 194 compounds monitored, 58 have been 
quantified at least once in 100 samples of raw water (surface and ground) intended for drinking 
water production8. However, the health effects associated with these 58 chemicals have not 
yet been investigated, thus it is difficult to prioritize the regulation of certain 
compounds/groups. 
 
Among methods evaluating the activity of EDs, the reporter gene “Chemically Activated 
LUciferase gene eXpression” (CALUX) cell-based assays have been introduced as a cost-
effective, high-throughput-amenable and routinely applicable screening technique. They have 
been internationally validated to provide mechanistic and semi-quantitative data9,10. EDs can 
alter the endocrine system in various ways, one of them is by affecting the transcriptional 
activities of the steroid (estrogen (ER), androgen (AR), glucocorticoid (GR), and progesterone 
(PR)) receptors, and the aryl hydrocarbon receptor (AhR) which controls xenobiotic 
metabolism4,11. 
 
These four ligand-activated steroid receptors are regulated by steroids such as 17β-estradiol 
(E2), 5-α-dihydrotestosterone (DHT), dexamethasone (Dex), progesterone (P4), respectively, 
while 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is the typical ligand of the AhR. The ligand-
bound receptors bind to their respective cognate DNA sequences located in the promotor 
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regions of the target genes to activate their transcription12,13. CALUX assays take advantage 
of this series of events to establish reporter cell lines that are able to respond to the presence 
of ligands/stimuli14. Therefore, the assays accurately reproduce the mechanism of action of 
these compounds as in a living organism15. They are also able to discriminate between 
agonistic and antagonistic activities (by co-exposing the test compound with a typical 
agonist)14. Moreover, a good correlation has been reported between in vitro results of CALUX 
assays and in vivo experiments for several EDs16,17. Plus, the assays are able to reveal 
unknown properties and the complex response to mixtures14. 
 
In this study, the endocrine disrupting activities of 18 compounds most frequently found in 
Wallonia raw water intended for drinking water production and their mixtures were investigated 
using reporter gene assays for five receptors (AhR, ER, AR, GR, and PR). The aims were to 
(a) assess both transcriptional agonistic and antagonistic activities of the 18 compounds 
individually and in mixtures towards the five receptors, (b) identify the most concerning 
endocrine disrupting compound(s), and (c) identify the main compound(s) responsible for the 
observed effects of the mixtures. 
 
2. Materials and methods 
2.1. Chemicals and suppliers 
We selected 19 compounds named from C1 to C19 based on their highest frequency of 
quantification (> 8%) in the raw water samples from the BIODIEN project. C4 (VIS01) was 
excluded as no analytical standard is available on the market. The main results of their 
monitoring during the BIODIEN project and their suppliers are given in Table 1. The 18 
selected compounds belong to several groups: pesticides, perfluorinated compounds (PFCs), 
polycyclic aromatic hydrocarbons (PAHs), and a plasticizer. The largest share of 
contamination was due to nine pesticides and pesticide metabolites: C1 to C7, C14, and C15, 
with C1 contributing for 83% of their total mass. Five PFCs: C9 to C13 and three PAHs: C17 
to C19, were also included with lower weight contribution, along with C8 (1H-benzotriazole), 
a versatile compound, and C16 (bisphenol A, BPA), a plasticizer. Reference standards, E2, 
DHT, Dex, and P4 were supplied by Sigma Aldrich (Missouri, USA), while TCDD was provided 
by Wellington (Campro Scientific, The Netherlands). All chemicals were dissolved in 
dimethylsulfoxide (DMSO) from Acros Organics, France, and stored at −20°C. Tested 
concentration ranged from 1.25 M to 40 M in a series of six 2-fold dilutions, which has been 
shown to be suitable for the CALUX assays without cytotoxicity18,19
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Table 1. List of the 19 compounds most frequently found in raw water samples in the Wallonia and Brussels areas8. 
Name Compound CAS  Supplier reference FOQ (%) Cmax (ng/L) Cm (ng/L) Ct (µM) 
C1 Desphenyl-chloridazon (DPC) 6339-19-1 AKOS-006278170 82 21500 1230 8.5 
C2 Methyl-desphenyl-chloridazon (Me-DPC) 17254-80-7 DRE-C11322500 69.7 1930 1320 8.3 
C3 Desethylatrazine 6190-65-4 Sigma 36629 67.4 122 111 0.59 
C4 VIS 01/Chlorothalonil SA  1418095-02-9 Not included 55.1 772 NA NA 
C5 Metolachlor ESA 171118-09-5 DRE-CA15171100  53.9 890 101 0.47 
C6 Atrazine 1912-24-9 Sigma 45330 44.2 101 450 1.3 
C7 Metazachlor ESA (BH479-8) 172960-62-2 DRE-CA14950020 40.4 186 130 0.4 
C8 1H-benzotriazole 95-14-7 Sigma 76457 34.7 186 NA 1.6 
C9 Perfluorooctanesulfonic acid (PFOS) 1763-23-1 Sigma 33829 29 19.95 NA 0.04 
C10 Perfluorooctanoic acid (PFOA) 335-67-1 Sigma 33824 28 5.51 NA 0.01 
C11 Perfluorohexanoic acid (PFHxA) 307-24-4 DRE-C15986910 23 11.53 NA 0.04 
C12 Perfluoroheptanoic acid (PFHpA) 375-85-9 Sigma 342041 18 2.18 NA 0.01 
C13 Perfluorohexanesulfonic acid (PFHxS) 355-46-4 Sigma 50929 13 15.02 NA 0.03 
C14 Simazine 122-34-9 Sigma 32059 10.5 23 28 0.14 
C15 Chlorpyrifos 2921-88-2 Sigma 45395 10.5 104 92 0.26 
C16 Bisphenol A (BPA) 80-05-7 Sigma 239658 9.1 31 NA 0.14 
C17 Fluoranthene 206-44-0 Sigma 45504 8.4 62 11 0.05 
C18 Phenanthrene 85-01-8 Sigma 695114 8.4 19 29 0.16 
C19 Benzo(a)pyrene (BaP) 50-32-8 Sigma B1760 8.4 70 29 0.12 
FOQ: frequency of quantification (% of samples), Cmax: maximum concentration quantified in raw water samples. Cm: measured concentration by 
LC-MS/MS and GC-MS/MS in the ED mixture. Ct: the maximum tested concentration in the ED mixture corresponding to 1,000 fold maximum 
water levels, except 100 fold for C1. NA: not applicable.
Chapter 4: Endocrine disrupting activities of drinking water pollutants 
 124 
2.2. Mixture preparation  
A mixture of the 18 chemicals called ED mixture, was constructed according to the maximum 
detected concentrations (Cmax) in the raw water samples by pooling each component from 
their respective stock solutions. The concentrations of pesticides and PAH in the mixture were 
measured by liquid chromatography- tandem mass spectrometry (LC-MS/MS) and gas 
chromatography-tandem mass spectrometry (GC-MS/MS) using in-house methods available 
in Société Wallonne des Eaux (SWDE) (see “measured concentration-Cm” in Table 1). PAHs 
were present in the mixture at lower concentration than expected, which could be due to their 
absorption by the glass container. To study the possible interactions among compound 
groups, a PFC mixture (C9-C13), a PEST mixture (C1-C8 and C14-C16), and a PAH (C17-
C19) mixture were also prepared. The tested concentrations of the mixtures are given as "fold 
maximal water levels" relative to their concentrations present in water samples (Table 1). The 
maximum final tested concentration (Ct) was 1,000-fold, except for C1 which was 100 fold, 
due to its very high concentration measured in the water samples. 
 
2.3. Transgenic cell lines 
The transcriptional activity of these chemicals and the mixtures was investigated using seven 
genetically modified cell lines expressing the reporter gene luciferase. Three cell lines: rat 
hepatoma DR-H4IIE from BioDetection System (Amsterdam, The Netherlands), human 
hepatoma DR-HepG2 and human mammary gland DR-T47-D (both produced on site in Liege, 
Belgium)20, were used to compare the AhR transcriptional activity between species (rat and 
human) and tissues (liver and mammary gland). DR-H4IIE cells were stably transformed with 
a vector containing four native dioxin responsive elements (DREs) from the upstream 
promotor of the mouse Cyp1a1 gene with a MMTV (mouse mammary tumor virus) promoter21, 
while four synthetic DREs regulating the thymidine kinase promoter drive luciferase 
expression in both DR-T47-D and DR-HepG220. 
 
The four reporter cell lines addressed human steroid receptors, namely ER (ER-MMV), AR 
(TARM), PR (PR-TM), and GR (TGRM) as previously described14. ER-MMV cells were MCF-
7 cells transformed with a vector containing the luciferase gene controlled by a vitellogenin 
promoter. The other three steroid reporter cells were derived from T47-D cells sharing a 
common vector containing the MMTV-LTR (long terminal repeat) promoter, inducible by 
glucocorticoid, progesterone, and androgen receptors14. While ER-MMV and PR-TM 
responded through their endogenous human receptors, TGRM and TARM were stably 
transformed with an additional expression vector coding for, respectively human GR and AR. 
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The cells were maintained in MEM (ThermoFisher Scientific, Massachusetts, USA), except 
for ER-MMV in DMEM (ThermoFisher Scientific) supplemented with 1 µgm/L bovine pancreas 
insulin (Sigma Aldrich). These media were supplemented with 10% v/v fetal bovine serum 
(FBS) (Greiner, Kremsmünster, Austria), 50 IU/mL penicillin and 50 mg/mL streptomycin 
(Sigma Aldrich). The cells were incubated in a H20 saturated atmosphere containing 5% CO2, 
at 37oC. 
 
2.4. Reporter gene assays 
Different protocols for each cell line were described in detail elsewhere14,20. Briefly, after 24h 
of cell seeding in white clear-bottomed 96 well microplates (Greiner), the medium was 
refreshed and the cells were exposed in triplicate with a dilution series of the individual tested 
compound or the mixture mentioned above. A reference curve with the reference ligand was 
performed on each plate for quality control. For co-exposure tests, the same dilution series 
was used on cells that were cotreated with a constant EC50 concentration of the reference 
compound (Table S1). The AhR-reporter cells were exposed for 24h in MEM, while the 
steroids were exposed for 48h in DMEM without phenol red and supplemented with charcoal 
stripped FBS to eliminate natural steroid activators. After exposure, the cells were lysed by 
solutions containing Triton X100 (Sigma Aldrich). The luminescence signal was recorded by 
adding luciferin (Promega, Wisconsin, USA) and ATP (Roche Diagnostics, Rotkreuz, 
Switzerland) to the cell lysate and measured by a luminometer (ORION II, Berthold Detection 
System, Pforzheim, Germany). The final concentration of DMSO was 0.2% and 0.3% for the 
agonistic and co-exposure tests, respectively. All tests were performed in at least three 
independent experiments, each in triplicate. The cytotoxicity was examined by visually 
inspecting the cells under the microscope before cell lysis. 
 
Table S1 shows the characteristics of the seven reporter gene cell lines. In general, the cell 
lines performed similarly as in the previous studies i.e. similar EC50 and fold induction14,19,22, 
except a reduction of the maximal fold induction seen for TGRM (from around 2000 fold to 
320 fold), and an increase of EC50 of PR-TM (705 ± 40 x 10-9 M compared to 1.5 x 10-9 M), 
however this latter value was close to that observed in a recent study of 3.3 ± 0.9 x 10−7 M23. 
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Table S1. Characteristics of the seven reporter gene cell lines and the co-exposure EC50 concentrations. 




FImax Co-exposing EC50 (M) 
DR-H4IIE H4IIE: rat hepatoma AhR TCDD 25 ± 3 x10-12 12.5 ± 2x10-12 13 15 x10-12 
DR-HepG2 HepG2: human hepatoma AhR TCDD 624 ± 21x10-12 658 ± 28x10-12 12 650 x10-12 
DR-T47-D T47-D: human carcinoma mammary gland AhR TCDD 111 ± 14x10-12 100 ± 38x10-12 9 150 x10-12 
ER-MMV MCF-7: human breast cancer cell ER 17β-estradiol (E2) 5.3 ± 1x10-12 3.2 ± 2x10-12 4 12.5 x10-12 
TGRM T47-D: human carcinoma mammary gland GR dexamethasone (Dex) 6.2 ± 1x10-9 4.5 ± 1x10-9 320 10 x10-9 
PR-TM T47-D: human carcinoma mammary gland PR progesterone (P4) 705 ± 37x10-9 665 ± 46x10-9 183 1000 x10-9 
TARM T47-D: human carcinoma mammary gland AR 5α-dihydrotestosterone (DHT) 520 ± 180x10-12 176 ± 36x10-12 16 400 x10-12 
EC50: Concentration causing half-maximal response of the reference compound. FImax: maximum fold induction of the response of the reference compounds 
compared to the response of the vehicle DMSO. Co-exposing EC50: co-exposing concentration of the reference compound in the antagonistic tests. 
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2.5. EROD assays in DR-HepG2 and DR-T47-D 
The EROD assay measures ethoxyresorufin-O-deethylase (eroD) enzyme activity that is 
associated with CYP1A converting ethoxyresorufin to fluorescent resorufin. They were used 
to determine the CYP1A activity of the mixtures in DR-HepG2 and DR-T47-D. The EROD 
assays were performed according to Schiwy et al., (2015)24 with the exposure conditions as 
described in CALUX assays. However, to adjust to the much higher TCDD sensitivity of the 
EROD assays, the maximum TCDD concentrations were 20 and 40-fold lower (500 pM for 
DR-HepG2 and 250 pM for DR-T47-D) than in CALUX assays (10 nM for both), and the 
corresponding TCDD EC50 co-exposure in the antagonistic tests was respectively 100 pM and 
50 pM, instead of 650 pM and 150 pM in CALUX assays. After 24h exposure, 100 l of working 
solution, freshly prepared by dissolving 7-ethoxyresorufin (5 M) (Sigma Aldrich) in DMEM 
without phenol red, was added into 50 l lysed-cell extract, followed by an incubation for 30 
minutes at 37°C in the dark. To terminate the reaction, 100 l chilled to 4oC methanol (Merck, 
Massachusetts, USA) was added. The fluorescence signal of resorufin was measured at 
550/595 nm using a Perkin Elmer VICTOR X5 MultiLabel Plate Reader, Germany. 
 
2.6. Calculations of relative responses RR, EC50, IC50, and efficacy 
The cells’ responses were obtained as relative light units (RLUs). The activities of the 
compound/mixture (n) for both CALUX and EROD assays were presented as relative 










RRa(n) (Eq. 1) or RRi(n) (Eq. 2) was the percentage (%) of the agonistic (Ra(n)) or co-exposure 
(Ri(n)) response of the compound/mixture (n) compared to the maximum response (Rref-max) or 
to the response of the spike-in EC50 (Rref-EC50) of the reference. A value of RRi(n) (%) higher 
than 100% reflects an additive/enhancing action of the compound/mixture on top of the effect 
caused by the presence of the reference compound at EC50. Meanwhile, a value less than 
100% quantitates the antagonistic potential of the compound/mixture to inhibit the activity of 
the reference compound at EC50, thus, the lower the RRi(n) (%) is, the stronger the antagonistic 
activity. 
 
The dose-response curves were generated by fitting a four-parameter non-linear stimulation 
or inhibition regression for agonistic (Eq. 3) or antagonistic (Eq. 4) tests: 
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where x is the concentration of a tested compound/mixture inducing the relative response 
RRa(n)x or RRi(n)x. EC50 and IC50 are the half maximal effective concentrations for an agonist 
and antagonist, respectively25. B = bottom, T = Top, H = Hillslope. B was constrained higher 
than 0, respectively for the minimum and maximum responses in agonistic and antagonistic 
tests. A compound/mixture was considered active if its effect was significantly different from 
that of DMSO alone (ANOVA, Graphpad PRISM, p < 0.05). The efficacy (RRa/max or RRi/max 
(%) for agonistic or antagonistic activities, respectively) was determined as the significant 
maximum effect of the compound/mixture. When no full dose response curve was obtained, 




3.1. CALUX activities of the 18 compounds 
No cytotoxicity was recorded for any of the 18 compounds within the concentration range 
tested for both agonistic and co-exposure experiments. Among the pesticides, the most 
abundant compound C1 (desphenyl-chloridazon) did not show any activity, while C2 (methyl-
desphenyl-chloridazon), C3 (desethylatrazine), and C6 (atrazine) displayed activity in at least 
one cell line (Tables 2 and 3). C2 and C3 exerted a weak agonistic response that was best 
observed when cells were cotreated with EC50 TCDD, respectively in DR-H4IIE and DR-T47-
D (Figures 1B and 1F’), while C6, the parent compound of C3, antagonized the EC50 TCDD 
activity in DR-HepG2 with RRi/max = 70% (Figure 1D). The most active pesticide was C15 
(chlorpyrifos), inducing both weak agonistic (RRa/max = 10%) and significant antagonistic 
responses in DR-H4IIE (Figures 1A and 1B) and ER-MMV (Figures 1G and 1H) (RRi/max = 
62% and 43%, respectively), while it  was only agonistic (RRa/max = 27%) in DR-T47-D (Figure 
1E’), and only antagonistic (RRi/max = 68%) in PR-TM (Figure 1J). 
 
C16 (BPA) strongly induced the response of ER-MMV with a RRa/max = 119%, higher than the 
reference compound E2 (Figure 1G), but did not cause any effect when cells were co-exposed 
with EC50 E2. It also inhibited the responses of the four T47D-derived transgenic lines in the 
co-exposure tests, moderately in DR-T47D and TGRM (Figures 1F’ and 1I), and particularly 
strongly in PR-TM and TARM with RRi/max = 15% (Figures 1J and 1K). 
 





























(A) Agonistic test DR-H4IIE
C17 C19C15



























(B) Co-exposure test DR-H4IIE
C17 + 15 pM TCDD
C15 + 15 pM TCDD
C2 + 15 pM TCDD
C18 + 15 pM TCDD
C19 + 15 pM TCDD


























(C) Agonistic test DR-Hep G2
C19



























(D) Co-exposure test DR-Hep G2
C17 + 650 pM TCDD
C18 + 650 pM TCDD
C6 + 650 pM TCDD
C19 + 650 pM TCDD



























(E) Agonistic test DR-T47-D
C19C15C3




























(F) Co-exposure test DR-T47-D
C17  + 150 pM TCDD
C18  + 150 pM TCDD
C3  + 150 pM TCDD
C19  + 150 pM TCDD
C16  + 150 pM TCDD


























(E’) Agonistic test DR-T47-D
C15C3





























(F’) Co-exposure test DR-T47-D
C17  + 150 pM TCDD
C18  + 150 pM TCDD
C3  + 150 pM TCDD
C16  + 150 pM TCDD




Figure 1. Dose-response curves of the active chemicals in (A-B) DR-H4IIE, (C-D) DR-HepG2, 
(E-F’) DR-T47-D, (G-H) ER-MMV, (I) TGRM, (J) PR-TM, and (K) TARM, inducible respectively 
by aryl hydrocarbon, estrogen, glucocorticoid, progesterone, and androgen receptors. (Mean 
 SD, n = 3, 0.2% or 0.3% DMSO for agonistic or co-exposure tests, respectively). Dash lines 
(100%) are the maximum response or the response of the co-exposing EC50 of the 
corresponding reference compound in agonistic or co-exposure tests, respectively.  
 
The most potent group was PAHs, which caused a response in all seven cell lines, except 
C18 which displayed no response in ER-MMV, TGRM, and PR-TM. Interestingly, C17 
(fluoranthene) and C18 (phenanthrene) behaved differently from C19 (BaP). While C18 did 
not induce agonistic activities in any cell line, C17 caused a weak agonistic response, with 
RRa/max = 21% and 28% in DR-H4IIE and ER-MMV, respectively (Table 2). However, they both 
strongly inhibited the EC50 TCDD response with RRi/max = 40% in DR-H4IIE, and even more 



























(G) Agonistic test ER-MMV
C17 C19C16C15



























(H) Co-exposure test ER-MMV
C19 + 12.5 pM E2
C15 + 12.5 pM E2



























(I) Co-exposure test TGRM
C19 + 10 nM Dex
C16 + 10 nM Dex



























(J) Co-exposure test PR-TM
C19 + 1 µM P4
C16 + 1 µM P4
C15 + 1 µM P4
C17 + 1 µM P4



























(K) Co-exposure test TARM 
C19 + 400 pM DHT
C16 + 400 pM DHT
C17 + 400 pM DHT
C18 + 400 pM DHT
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strongly in DR-HepG2 and DR-T47-D (RRi/max = 10%). C17 also antagonized P4 in PR-TM 
and DHT in TARM with RRi/max = 62% and 16%, respectively, whereas C18 inhibited only the 
TARM response with RRi/max = 21% (Table 3). 
 
C19 (BaP) was a potent agonist in DR-H4IIE with RRa/max = 171%, nearly twice the cells’ 
maximum response to TCDD (Figure 1A). The effect remained when it was co-exposed with 
EC50 TCDD with RRi/max = 227% (Figure 1B), since this resulted in a final RRa(C19)/max = 126% 
after the spike-in EC50 reference was subtracted and the response RRa(C19) was compared to 
the maximum response of the reference compound. C19 was also agonistic to AhR in human 
hepatoma DR-HepG2 cells, but to a lesser extend (RRa/max = 27%) (Figure 1C), causing a 
partially antagonistic activity in this cell line when co-exposed with EC50 TCDD, showing an 
antagonistic activity up to 10 M and an agonistic activity at higher concentrations (Figure 1D). 
Surprisingly, C19 induced an extremely strong agonistic response in human mammary gland 
carcinoma DR-T47-D, with RRa/max = 1061% (Figure 1E), which remained similar in the co-
exposure test with RRi/max = 2713% or a final RRa(C19)/max = 1266% (Figure 1F), indicating that 
the presence of TCDD did not affect the C19 activity in this cell line. 
 
In ER-MMV, C19 induced a strong agonistic response of RRa/max = 253%, while in the 
presence of EC50 E2, an inhibition was observed at lower concentrations and an activation at 
higher concentration, parallel to the agonistic curve with a RR i/max = 233% or RRa(C19)/max = 
102%, less than half of RRa/max (Figure 1G and 1H). It also caused a similar response in PR-
TM, but only when co-exposing the cells with P4, with a RRi/max = 172% or RRa(C19)/max = 111% 
(Figure 1J). Moreover, C19 significantly antagonized both Dex and DHT in TGRM and TARM 
cells, with RRi/max = 44% and 9%, respectively. All data are summarized in tables 2 and 3. 
 
3.2. CALUX activities of the mixtures  
No activity was observed for the PFC mixture. In DR-H4IIE, the ED mixture showed an 
agonistic activity similar to that of the PAH mixture with RRa/max = 42% and 45%, respectively, 
while the PEST mixture activation was lower (RRa/max = 17%). In comparison, the ER-MMV 
responded similarly to both the PAH and PEST mixtures with RRa/max = 17% and 16%, 
respectively, while the ED mixture caused a strong agonistic effect (RRa/max = 32%) (Table 2). 
 
Additive responses of these mixtures were observed when the cells were co-exposed with 
TCDD or E2 (Table 3). However, the additive responses were not significant in DR-H4IIE with 
only RRi/max = 125% for both ED and PAH mixtures, and only 115% for the PEST mixture. A 
similar result was obtained in ER-MMV (RRi/max PAH and ED = 145% and PEST = 122%). 
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Table 2. EC50 and RRa/max values of the agonistic responses to the selected 18 chemicals and four mixtures (n = 3, 0.2% DMSO).  
Name Compound 
DR-H4IIE DR-HepG2 DR-T47 D ER-MMV 
EC50 (µM) ± SE RRa/max (%) EC50 (µM) ± SE RRa/max (%) EC50 (µM) ± SE RRa/max (%) EC50 (µM) ± SE RRa/max (%) 
C1 DPC - - - - - - - - 
C2 Me-DPC - - - - - - - - 
C3 Desethylatrazine - - -  24.1 ± 4.8 8 - - 
C5 Metolachlor ESA - - - - - - - - 
C6 Atrazine - - - - - - - - 
C7 BH479-8 - - - - - - - - 
C8 1H-benzotriazole - - - - - - - - 
C9 PFOS - - - - - - ND 7 
C10 PFOA - - - - - - - - 
C11 PFHxA - - - - - - - - 
C12 PFHpA - - - - - - - - 
C13 PFHxS - - - - - - ND 6 
C14 Simazine - - - - - - - - 
C15 Chlorpyrifos 10.5 ± 2.3 10 - - ND 27 22.6 ± 17.7 11 
C16 BPA   - - - - 1.2 ± 0.1 119 
C17 Fluoranthene 46.5 ± 94 21 - - - - 25.4 ± 6.4 28 
C18 Phenanthrene - - - - - - - - 
C19 BaP 44 ± 59 171 16.8 ± 2.3 27 4.2 ± 0.2 1061* 6.5 ± 0.4 253* 
PFAA - - - - - - - - 
PAH ND 45 - - - 7 ND 17 
PEST ND 17 - - - - ND 16 
ED ND 42 ND 6 ND 11 ND 32 
EC50: the concentration inducing half of the maximum activation response; SE: Standard Error; RRa/max: observed activation efficacy; ND: Not 
Determined. -: no response. *Maximum efficacy observed within the tested concentrations. 
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Table 3. IC50 and RRi/max values of the co-exposure responses to the selected 18 chemicals and four mixtures (n = 3, 0.3% DMSO). 
Name Compound 




























(%) C1 DPC  - - - - - - - - - - - - - - 
C2 Me-DPC 23 ± 14 125* - - - - - - - - - - - - 
C3 Desethylatrazine - - - - ND 140 - - - - - - - - 
C5 Metolachlor ESA - - - - - - - - - - - - - - 
C6 Atrazine - - ND 70* - - - - - - - - - - 
C7 BH479-8 - - - - - - - - - - - - - - 
C8 1H-benzotriazole - - - - - - - - - - - - - - 
C9 PFOS - - - - - - - - - - - - - - 
C10 PFOA - - - - - - - - - - - - - - 
C11 PFHxA - - - - - - - - - - - - - - 
C12 PFHpA - - - - - - - - - - - - - - 
C13 PFHxS - - - - - - - - - - - - - - 
C14 Simazine - - - - - - - - - - - - - - 
C15 Chlorpyrifos 24 ± 10 62 - - - - 6.8 ± 5.2 43* - - 44 ± 
159.7 
68* - - 
C16 BPA -  - - ND 71 - - 5.8 ± 1.7 44 8.5 ± 
6.3 
15 4.3 ± 3 15* 
C17 Fluoranthene 3 ± 0.3 47 11.6 ± 
0.8 
12 4.4 ± 0.3 8 - - - - 13.9 ± 
3.9 
62* 3.2 ± 2.6 16* 
C18 Phenanthrene 15 ± 4 35 12.3 ± 
1.2 
12 7.9 ± 0.6 7 - - - - - - 10.4 ± 
2.5 
21 
C19 BaP 43.2 ± 
72.4 
227* 1 .5 ± 
107 
50* 4.9 ± 0.2* 2713* 8.4 ± 0.5* 233 2.3 ± 881 44* 10.5 ± 3* 172* 2.3 ± 29 9* 
PFAA - - - - - - - - - - - - - - 
PAH 512 ± 241 124 - - - - 602 ± 
620 
145 - - - - - - 
PEST ND 115 - - - - ND 122 - - - - - - 
ED 571 ± 200 126 - - - - ND 145 - - - - - - 
IC50: the concentration inducing half of the maximum inhibition response; SE: Standard Error; RR i/max: observed inhibition efficacy; ND: Not 
Determined. -: no response. *Maximum efficacy observed within the tested concentrations.
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Since full dose response curves were not obtained within the tested concentration range, no 
values could be deduced for EC50, while some IC50 values have been determined (Tables 2 
and 3). 
 
From table 2, it seems that the observed agonistic effects of the PAH and the ED mixtures in 
DR-H4IIE were due to the agonistic activity of C19, while the agonistic effects seen in ER-
MMV were due to the combination of C16 and C19. Therefore, a test was performed using the 
concentrations of C19, C16 or C16+C19 corresponding to their concentrations in the mixtures, 
to confirm this assumption. The agonistic activity of C19 explained most of the agonistic 
activity of PAH and ED mixtures in DR-H4IIE as shown in Figure 2A1, while the combined 
agonistic effects of C16+C19 explained most of the agonistic effect of the ED mixture in ER-
MMV cells (Figure 2A2). No major contributor could be identified for the weak agonism of the 




Figure 2. (A) Dose-response curves of the mixtures and C16, C19 and C16+C19 in the DR-
H4IIE (A1) and ER-MMV (A2). (B) Dose-response curves of the mixtures in DR-T47-D (B1) 
and DR-HepG2 (B2) in EROD assays. (Mean  SD, n = 3, 0.2% or 0.3% DMSO for agonistic 
or co-exposure tests, respectively). Dash lines (100%) are the maximum response or the 
response of the co-exposing EC50 of the corresponding reference compound in agonistic or 


























































































































(B2) EROD  co-exposure test DR-HepG2
PAH + 100 pM TCDD
PEST + 100 pM TCDD
ED + 100 pM TCDD
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3.3. EROD assays with the mixtures in DR-HepG2 and DR-T47-D 
Recently, it was shown that EROD assays could be used as a sensitive alternative to reporter 
gene assays for AhR activity26. Thus, we decided to confirm the activity of the mixtures on the 
two human cell lines (DR-HepG2 and DR-T47-D) using this approach. In DR-T47-D, while 
only an agonistic effect was observed for the ED mixture in CALUX assays, there was a 
moderate agonistic response seen for the PAH mixture with RRa/max = 45% (Figure 2B1) and 
weak antagonistic responses seen for the PEST and ED mixtures (RR i/max < 80%) (data not 
shown). The PEST and ED mixtures induced the same antagonistic responses in the DR-
HepG2 with IC50 PEST = 180  25 and IC50 ED = 177  23 fold and RRi/max PEST = 16% and 




4.1. Endocrine disrupting activities of the 18 compounds 
This study is one of the few studies22,23,27,28 using a panel of multiple cell-based bioassays 
(seven reporter gene cell lines including five receptors (AhR, ER, GR, PR, and AR)) for in vitro 
profiling of the potential endocrine disrupting activity of multiple chemicals. Eighteen 
compounds frequently detected in Wallonia raw water intended for drinking water production 
were tested, belonging to several groups (pesticides, 1H-benzotriazole, PFCs, BPA, and 
PAHs). Appearing with relatively high frequency of quantification (FOQ) in water, several 
herbicides (C1, C5, C7, C14) and C8 (FOQ >40%), and PFCs (C9-C13) (FOQ = 20%) did 
not display a significant response in these bioassays, except a weak response (RRa/max < 10%) 
for C9 and C13 in ER-MMV. Hence, they are unlikely to induce any endocrine disrupting 
activity via these receptors. Three compounds (C2, C3 and C6) triggered an AhR response in 
a species- and cell type-specific manner. To our best knowledge, these results are the first 
recorded for these cell lines. The compounds were frequently detected in raw water samples; 
hence their activities may be a matter of concern. Meanwhile, C15, C16, C17, C18 and C19 
were active on several receptors. AhR and ER were more general targets for both agonistic 
and antagonistic activities than the other receptors, responding to respectively eight and six 
compounds, while GR, PR and AR were targets only for antagonism (see Figure S1 for 
detailed clusters). 
 
C15 (chlorpyrifos) caused both agonistic and antagonistic activities towards AhR and ER, and 
only antagonized PR. Therefore, C15 appears to be a potential ED. The result was consistent 
with previous in vitro reports concerning this compound showing activation of AhR29 and ER30–
32 and with in vivo estrogenic activity observed in mammary gland in female rats33. The EU 
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legislation imposes a limit of 0.1 g/L in drinking water for total pesticides7, which is equivalent 
to 0.3 pM chlorpyrifos, 10,000 fold lower than the lowest observed effect concentration of 
chlorpyrifos at 5 M (Figures 1B, E’, H, and J). However, due to a high bioconcentration factor 
(e.g. 100 to 5100 in fish34), a high documented toxicological activity32,33,35, and a considerably 
high contamination potential due to the current use in the US and a very recent ban in the EU, 
the monitoring of chlorpyrifos should be specifically indicated in the legislation. 
 
 
Figure S1. Clustering of compounds inducing an (A) agonistic activity and (B) 
antagonistic/additive activity on one or several receptors. AhR: rat and/or human aryl 
hydrocarbon receptor; ER: human estrogen receptor; PR: human progesterone receptor; GR: 
human glucocorticoid receptor; AR: human androgen receptor. The compounds which showed 
either agonistic or antagonistic/additive effects towards any of the five receptors, were 
grouped into clusters of, respectively two and five levels corresponding to the number of 
receptors they act on. In level 1, each circle displays the name of the compound and the 
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the previous level, and, if the receptor was mentioned in the previous level, connecting arrows 
are used to indicate the relationship between the compounds and the receptors. 
 
BPA (C16) is an ubiquitous contaminant, prevalent also in water36–38, whose ability to activate 
ER-mediated pathways is well documented39–41 and has been confirmed in this study. 
However, its activity does not always involve estrogen-mediated mechanisms as shown in 
human endometrial stromal fiboblasts42 or in human endometrial adenocarcinoma cells where 
it prevented the proteasome-mediated degradation of ER43. In addition, BPA inhibited the 
activities of all the reference compounds in the T47-D transgenic cell lines: DR-T47-D, TGRM, 
TARM, and PR-TM, while only anti-androgenic was previously shown in in vitro reporter gene 
assays27,28,44. BPA was present in Wallonia raw water at Cmax = 31 ng/L but rarely detected 
(FOQ = 9.1%)8. Currently, BPA does not appear to pose a threat to these drinking water 
sources. However, due to its significant activity, BPA should be listed for monitoring in the 
Council Directive 98/83/EC7. 
 
PAHs are a diverse class of toxicants. They activate AhR45–47 as one of their major toxicity 
pathways and interfere with estrogenic signaling through direct or indirect estrogen-like 
effects48,49 and anti-estrogenic effects49,50. We not only confirmed the finding of weak, but 
significant induction of the rat AhR response to C17 (fluoranthene) (but not for C18 
(phenanthrene) in DR-H4IIE47, but also showed that C17 and C18 strongly antagonized 
TCDD-induction in the human DR-HepG2 and DR-T47-D. We also newly discovered the 
strong antagonistic effects of both C17 and C18 towards androgens in TARM (Table 3). 
Neither fluoranthene nor phenanthrene are in the list of the EU legislation for water intended 
for human consumption7. Regarding their significant endocrine disrupting activities, especially 
anti-AhR and anti-AR towards human-based cell lines and their presence in water sources, 
we propose to add fluoranthene and phenanthrene to the list of raw water monitoring in the 
EU. 
 
C19 (BaP) is known as a potent endocrine and growth disruptor, particularly altering the AhR 
pathway and displaying both estrogenic and anti-estrogenic activity in several systems51,52. In 
this study, BaP significantly modified the transcriptional activities of all five receptors in all 
seven cell lines. It was a strong AhR agonist in DR-H4IIE and caused both agonistic and 
partially antagonistic activities in DR-HepG2, as documented previously45,46. BaP also 
displayed an agonistic and a partial antagonistic activity in ER-MMV. It was shown that the 
estrogenic activity of BaP in MCF-7 cells required the activation of AhR to produce estrogenic 
BaP metabolites, most notably 3-OH-BaP53. Indeed, BaP failed to stimulate ER-dependent 
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reporter luciferase activity in AhR-knockout MCF-7 cells, indicating that the estrogenic-activity 
of BaP is a “secondary” response driven by its activation of the AhR signaling pathway. 
 
However, the most striking result was the enhanced response observed in DR-T47D exposed 
to BaP with a response 10-fold higher than the maximum response to TCDD. A “pure” AhR 
antagonist, GNF31554 at 10 M inhibited the BaP-induced AhR activation in DR-T47-D by 
more than half, from RRa/max = 1061% to RRa/max = 346% (Figure S2). However, the other AhR 
antagonist, CH-223191 did not affect the BaP activity. CH-223191 had also failed to inhibit the 
stimulation of AhR-DNA binding of beta-naphthoflavon (a PAH like chemical)55. Meanwhile, 
ER antagonists (fadrozole and fulvestrant) at 1 M did not affect the cells' response to BaP 
(data not shown). Thus, the BaP-induced enhancement of AhR activation seems to be partially 
dependent on the activity of the AhR, but unrelated to the activity of ER. This enhancement 
could be due to some mechanism acting downstream of AhR activation that is triggered by 
BaP specifically in mammary gland cells. This is consistent with the observed enhancement 
(2.5-fold) of ER activation in ER-MMV, also derived from human mammary gland cells (MCF-
7). T47-D cells are also used in the reporter cell-assays for progesterones, glucocorticoids 
and androgens. We also observed an enhanced response (about 2-fold) to progesterones in 
PR-TM, consistent with a specific enhancement mechanism in these cells, but antagonism 
against glucocorticoids and androgens. It is important to mention here that the parent T47-D 
cells produce their endogenous PR, which is thus also present in the TGRM and TARM that 
contain a transgene coding, respectively for exogenous GR or AR. This explains why the initial 
antagonism of GR and AR observed in these lines at lower BaP concentrations is dominated 
at higher concentrations by the enhanced PR response. Further investigations will be required 
to fully understand the actions of BaP in these cells. 
 
Figure S2. Dose response curves of DR-T47-D cells co-exposed to C19 and AhR antagonists 
(GNF315 or CH-223191) after 24h exposure (Mean  SD, n = 3, 0.3% DMSO). Dash line 
(100%) is the TCDD maximum response. 





























C19 + GNF315 10 µM 
C19 + CH-223191 10 µM 
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Such an enhancement is extremely concerning in terms of human exposure to BaP which is 
mostly via food consumption rather than via drinking water. BaP exposure results in a maximal 
response (10-fold higher than TCDD) at only 10 M, while inductions similar to that of TCDD 
are already observed at 2.5 µM in the human mammary gland DR-T47-D cells. Although BaP 
is rapidly metabolized and thereby quickly eliminated from the body56, BaP is still the 
ubiquitous PAH contaminants in human samples57. BaP contamination can be found at 7.1 
nM in the follicular fluid of women who smoke58 or 20 nM in serum samples from autopsy 
cases of African American females57. Therefore, a 100-fold increased exposure up to 2.5 µM 
of BaP in blood could be realistic due to the chronic exposure of highly exposed sub-
populations or acute exposure due to food contamination incidents. 
 
4.2. Activities of the mixtures 
The ED, PAH, and PEST mixtures caused an agonistic effect on AhR in DR-H4IIE and on ER 
in ER-MMV. The AhR agonistic effect of ED and PAH could be reproduced using only their 
main component, C19, while the very weak activity of the PEST mixtures was probably due to 
the addition of the activities of its components, each individually being too weak to be detected. 
In contrast, the ER agonistic activity can be attributed to the presence of either C16 (in PEST), 
C19 (in PAH), or both (in ED). 
 
None of the mixtures displayed any effect in either DR-HepG2 or DR-T47-D in CALUX assays, 
except for a weak agonistic effect of the ED mixture for both cell lines (Table 3 and 4). In 
contrast, EROD assays revealed a significant antagonistic effect for the three mixtures (PAH, 
PEST and ED) in DR-HepG2 and a significant agonistic effect for the PAH mixture in DR-T47-
D (Figure 2B). The micro-EROD assays developed by Schiwy et al., (2015)24 revealed the 
highest sensitivity to TCDD, allowing the detection of lower effective concentrations compared 
to CALUX assays26. This may be due to the fact that 7-ethoxyresorufin O-dealkylation can be 
catalyzed in humans by two enzymes, CYP1A1 and CYP1A259, encoded by endogenous AhR 
target genes, while CALUX assays measure AhR-induced expression of an artificially inserted 
reporter gene. Moreover, the co-exposing TCDD EC50 for EROD was several times lower than 
that for CALUX assays, which makes the detection of antagonism of the mixtures easier. This 
greater sensitivity of the EROD assays for measuring CYP1A activity in the two human cell 
lines allows for better detection of agonistic activities of the mixtures, but also leads to better 
sensitivity for antagonistic activities, due to the lower concentration of the co-exposed TCDD 
at their respective EC50. Note that, contrary to CALUX assays, however, antagonism in EROD 
assays can also result from inhibition of the enzyme activity, which is impossible to detect in 
the reporter assay. 
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Conclusions 
We tested the endocrine disrupting activities of 18 compounds shown to be present at trace 
concentrations in raw water intended for drinking water production in Wallonia. Both pure 
solutions of each compound and mixtures were studied for their ability to agonize and 
antagonize the transcriptional activities of a panel of five receptors, listed as AhR, ER, AR, PR 
and GR. Among these compounds, chlorpyrifos, BAP, fluoranthene, phenanthrene, and BaP 
demonstrated significant activities which involved more than one mechanism. Their presence 
in raw water source should be monitored more strictly. BAP as well as fluoranthene and 
phenanthrene should be added to the list of monitoring due to their significant endocrine 
disrupting activities. BaP alone or with BPA were the main contributors for the agonistic 
activities of the ED and PAH mixtures towards the AhR in DR-H4IIE and ER in ER-MMW. 
EROD assays were able to reveal the antagonistic effect of the mixtures in DR-HepG2 cells, 
which has not been observed in CALUX assays. The results revealed the multi-endocrine 
disrupting activities of several contaminants in raw water intended for drinking water 
production, some of them not being mentioned in the EU legislation relating to water 
monitoring. Their (anta-)agonistic effects on different receptors with the potential for additive 
or inhibitory effects in the mixtures should be considered in their risk assessment. 
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Chapter 5: Discussion, General Conclusions 
and Future Direction 
1. The AhR antagonistic activity of the persistent organic pollutants (POPs) prevalent 
in Scandinavian human blood 
Our study showed that, among the 29 compounds included in the total POP mixture derived 
from blood levels found in a Scandinavian population, 16 chemicals exerted antagonistic 
effects on AhR, while only four showed AhR agonism. Their antagonistic activities were AhR-
dependent and seemed to act through competition with TCDD for the same binding site, 
except for t-nonachlor and -chlordane. Such AhR antagonistic activities of POPs had been 
previously observed in several screening studies1,2 and mixture studies3,4. As expected, the 
total POP mixture, and sub-mixtures thereof were found to induce only antagonistic effects on 
AhR. Moreover, our antagonistic tests indicated that the total POP mixture would antagonize 
the activity of the dioxin like-compounds contaminating the Scandinavian population in real 
life. 
 
Since its discovery, the AhR has been considered as a master receptor in xenobiotic 
metabolism and toxicity due to the fact that it mediates the effects of the halogenated aromatic 
hydrocarbon environmental pollutants. Therefore, the AhR agonistic activity of POPs 
especially dioxins, has been studied for decades, while the antagonistic counterpart has not 
yet received much attention, especially regarding its physiological consequences on an 
organism’s health.  
 
However, increasing evidence supports important roles of AhR in normal development and 
homeostasis, while toxicity induced by AhR xenobiotic ligands could be due to perturbation of 
these normal processes5. Studies in cell lines and rodent models pointed out that the 
deregulation of these AhR dependent pathways is associated with several life-threating 
diseases such as cancer, immune and cardiovascular disorders, and infertility6,7. For example, 
AhR knockout (KO) mice display various developmental abnormalities, highlighting the roles 
of AhR in perinatal growth8,9, regulation of blood pressure, central nervous system, cell 
proliferation, production of peripheral lymphocyte counts10,11, and in female fertility9. 
 
On the other hand, AhR is also induced by a wide range of endogenous and natural ligands, 
which may actually contribute to normal physiological functions. Organisms are exposed to a 
complex mixture of compounds via their diet. The diet provides nutrients and/or other 
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physiological values, but some components may be toxic for the animals. A biological ‘cocktail’ 
of endogenous, pseudo-endogenous (pseudo-endogenous AhR ligands are defined as any 
metabolite that is produced by the gut microbiota and capable of binding to the AhR12) and 
dietary AhR ligands exists, suggesting their predominance in modulating AhR biological 
functions. Dietary derived AhR modulators induce the expression of detoxification enzymes 
for their own metabolism, leading to a negative feedback loop. We showed that all seven 
commercially available polyphenols were able to alter the transcriptional activities of both rat 
and human AhR. At the onset of ingestion, they are likely metabolized mainly within the 
gastrointestinal tract in phase I cytochrome P450 and hepatic first-pass to detoxify/eliminate 
potentially harmful dietary constituents13. 
 
Moreover, other physiological processes such as immune surveillance and microbiota/host 
interactions are also controlled by the dietary AhR ligands6,14–16. For example, the activation 
of AhR is essential for maintaining and functioning of intraepithelial lymphocytes and gut ILC22 
cells, providing a mechanistic link between dietary components to the innate gut immunity and 
the microbiota17–19. AhR induced by FICZ which is a highly potent endogenous  AhR ligand, 
suppressed IL-6 and claudin-2 expression in a mouse induced colitis model, protecting the 
intestinal epithelial barrier from IL-6-induced disruption, thus maintaining the intestinal 
barrier20. 
 
2. Tissue and species-specific AhR response  
The cell response to AhR ligands is tissue- and species-specific. For the groups of POPs and 
other xenobiotic compounds such as PAHs, the rat AhR was more sensitive than the human 
AhR. In our study, 16 out of the 29 POPs antagonized the rat AhR in hepatoma DR-H4IIE 
cells, while only five did in human hepatoma DR-HepG2 cells and seven in human mammary 
gland DR-T47-D cells. In our study about EDs in drinking water resources, benzo[a]pyrene 
(BaP) induced a maximum response of 171% of the maximal response induced by TCDD in 
DR-H4IIE cells, and only 27% in DR-HepG2 cells. In addition, we also saw a synergistic 
response in DR-T47-D exposed to BaP, 10-fold higher than the cell response to TCDD alone, 
which was not observed in DR-HepG2 cells. The ED mixture displayed an AhR agonistic effect 
only in rat DR-H4IIE cells, and not in human DR-HepG2 cells.  
 
The potency of FICZ to activate different AhR isoforms has been shown to be well conserved 
among various species such as fish21, frog22, and birds23,24. However, we showed for the first 
time that the endogenous ligand FICZ was able to activate AhR to a similar extent in rat DR-
H4IIE cells and in human DR-HepG2 cells. Moreover, FICZ was more potent than TCDD in 
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the human cells (40 times more potent than TCDD), while both exhibit a similar potency in the 
rat cells (after 6h of exposure). As mentioned above, the toxicity of TCDD is probably due to 
its persistent activity on the AhR, while endogenous ligands such as FICZ will only act 
transiently. Our results, showing a high FICZ sensitivity and fast clearance rate of FICZ in 
human DR-HepG2 cells, could mean that FICZ is an essential agonistic ligand for the human 
AhR. In addition to the duration of AhR activation, the cell types in which the receptor is 
activated also contributes to the difference in the response of these two ligands25, which is 
likely linked to the “quality” of activation through recruitment of various coactivators and 
transcription factors26.  
 
We also reported for the first time the species-specific AhR transcriptional activity in cells 
exposed to different polyphenol groups. Isoflavones (daidzein and genistein) were more active 
in the rat DR-H4IIE cells, while the flavonol and flavones (quercetin, baicalin, and chrysin) and 
curcumin strongly affected the human AhR activity in DR-HepG2 cells. Non-flavonoid 
resveratrol acted equally on both cell lines. It is important to stress here that these activities 
were only seen after short term exposures (4h or 8h). Since the persistent AhR ligands are 
more stable and remain longer in the body than natural ligands, depending on the natural 
ligand levels and the cell context, persistent ligands may have different influences (e.g. 
agonistic-mimicking, antagonistic-blocking or synergism) on the effects of the natural ligands. 
 
3. Risk assessments and mixture effects 
3.1. Risk assessment of exposure to mixtures of POPs, EDs, and polyphenols 
Our findings showed that the total POP mixture induced significant and dose-dependent 
antagonistic responses already at concentrations of 125-, 250- and 500-fold blood levels, 
respectively, in DR-H4IIE, DR-T47-D and DR-Hep G2 cells, although the concentrations of 
the 29 compounds in this mixture were below their respective lowest observed effect 
concentrations (LOECs). These levels may realistically be reached after a contamination 
incident or in exposed populations.  
The mixture of ED found in raw water intended for drinking water production in Wallonia was 
able to activate the AhR transcriptional activity in DR-H4IIE and DR-T47-D cells. The main 
activity of the ED mixture was due to BaP, which was found in trace amounts. Hence, the 
possible in vivo effect resulting from this ED mixture exposure via drinking water could be 
minimized by only eliminating this compound from the drinking water.  
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The polyphenol mixture induced a weak AhR agonistic response relatively similar in both 
human DR-HepG2 and rat DR-H4IIE cells but it strongly antagonized both FICZ and TCDD 
AhR transcriptional activation in the human cells with a dose-response curve similar with the 
one obtained for quercetin. Polyphenols as well as other AhR natural ligands exerted only 
transient activities due to their rapid metabolic rate. However, in case of continuous or 
repeated intake of high doses of polyphenols, adverse effects on human health could occur 
due to the alteration of the AhR transcriptional activity, as polyphenols showed a high 
antagonistic activity on the human DR-HepG2 cells. 
 
3.2. Predictions of mixture effects 
Risk assessment of chemicals in mixture forms is gaining more interest not only in scientific 
but also in legislation bodies. Albeit acknowledging the threat of human exposure to multiple 
chemicals, due to a number of challenges, especially the complexity of the problematic 
formulation and the amount of data involved in the toxicological profiles and exposure 
patterns, the current risk assessment method mainly relies on a chemical-by-chemical 
approach with few exceptions (i.e. Dioxin TEFs). However, international guidance on mixture 
risk assessment recently introduced by OECD27 and EFSA28, and the Cumulative Risk 
Assessment (CRA) approach to address the presence of multiple pesticide residues in food, 
confirms the possibility of risk assessment in case of exposure to mixtures of chemicals.  
 
Our study also contributes to the study of mixture effects, by proposing several modifications 
of formulas to calculate combined effects and to predict full dose-response curves of mixture 
effects of chemicals. For the total POP mixture, the best prediction results were obtained using 
the CA (concentration addition) and GCA (generalized concentration addition) models, a CA 
derivative. They performed well in predicting ICmix,50 = 784-fold blood levels, within a two-fold 
range from the measured value (374-fold blood levels). In contrast, the IA (independent action) 
was badly performing to predict the mixture effect of the total POP mixture. On the other hand, 
IA and CA both performed well in predicting the combined effects of the mixture of seven 
polyphenols with only a 2-fold overestimation in the dose response curve, probably due to 
their different mode of actions. 
 
All numerical models (CA, GCA or IA) are approximations, based on the assumption of 
additivity of the effects or on independent action. Their implementation takes place in order to 
establish general regulatory guidelines for toxicity assessment of mixtures. While IA seems to 
violate the systematic instinct of biological organisms by considering strictly independent 
actions of chemicals in the mixtures, CA (and GCA) is more conservative in assuming strictly 
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additive effects. The latter have been applied for wider groups of compounds, both with similar 
and dissimilar mode of actions and the are considered as the “general solution” for risk 
assessment of mixture toxicity29.  
 
However, the classical CA model allows only the calculation of effect concentrations (EC or 
IC) without giving the mixture response or  generating the full dose-response curves. In 
chapter 2, we presented a way to predict the hillslope and maximal response of the mixture 
from the data of the components, which allowed us to obtain a good predicted dose -response 
curve. In contrast, both the IA and GCA models allow to generate the full dose-response curve 
by using only the information from single compounds. However, GCA requires also data from 
full dose-response curves (the maximum response and the hillslope) of single compounds, 
which could be sometimes not realistically attained since some compounds may not reach the 
maximum response in their realistic tested concentration. Therefore, several approaches can 
be used to predict the mixture effects taking into considerations, all with their pros and cons.  
 
Assessing only the most effective compound(s) could be considered to select the models for 
mixture predictions and even to perform the calculations. For example,, the antagonism of the 
total POP mixture was due to chlorinated compounds and, in particular, to PCB-118 and PCB-
138, which caused 90% of the antagonistic activity in the POP mixture. The agonistic activity 
of BaP explained most of the agonistic activity of the total ED mixture in DR-H4IIE cells, while 
the combined agonistic effects of BaP and bisphenol A explained most of the agonistic effects 
of the ED mixture in the ER-MMV cells. Similarly, the antagonistic activity of quercetin and 
resveratrol made up the antagonism of the polyphenol mixture on the DR-HepG2 cells. 
Because the POPs seem to act in the same mode of actions via competing with TCDD to bind 
to the AhR, CA and GCA models were able to predict their effects. Meanwhile, the polyphenols 
(quercetin and resveratrol) seem to affect the TCDD-induced AhR activation in several MOAs, 
therefore, IA model could also explain the mixture activity. This study suggested that the 
endocrine disrupting activities of chemicals in human daily life exposure involve more than 
one mechanism, and that their (anta-)agonistic effects on different receptors, in addition to 
their potential additive or synergistic effects in the mixture, should be considered in risk 
assessments. 
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General conclusions 
• AhR antagonistic activities of the POPs 
- A majority of POPs contaminating human blood (16 out of 29) are AhR antagonists. 
- Total POP mixtures relevant for human exposure are AhR antagonistic.  
• Species and tissue-specific AhR responses  
- The rat AhR is more sensitive than the human AhR to POP and isoflavones (daidzein and 
genistein) exposure. 
- The human AhR is more sensitive than the rat AhR to the following ligands: FICZ, the flavonol 
quercetin and two flavones (baicalin and chrysin), curcumin, and the mixture of the seven 
polyphenols. 
- Benzo(a)pyrene induces a synergistic response in AhR-reporter human mammary gland 
cells (DR-T47-D) co-exposed to TCDD, inducing a 10-fold higher response than in the cells 
exposed to TCDD alone. 
• Identifying the actual chemical(s) which are the most active in the mixtures 
- Chlorinated compounds are the drivers of the activity of the total POP mixture, in which PCB-
118 and PCB-138 contribute for 90% of the total POP mixture effect. 
- Benzo(a)pyrene and bisphenol A contribute the most to the activities of the ED mixture. 
- Quercetin and resveratrol cause the antagonism of the polyphenol mixture. 
• Predicting the effect of the mixtures based on the activity of single compounds 
- The dose-response curve of the total POP mixture was predicted successfully by 
concentration addition and general concentration addition models.  
- Both concentration addition and independent action are able to predict the activities of the 
polyphenol mixture. 
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Future directions 
Mixed exposure is more realistic for chemical exposure in human daily life. Assessing mixture 
effects is the appropriate approach for risk assessment of chemicals. Our work contributes to 
go forward in this direction. We could further study the applicability of the models for predicting 
the combined effects of the real contaminated samples. We have also opened some avenues 
for future research. For example, the antagonism of the total POP mixture deserves further 
investigation regarding their associated health effects. The endocrine disrupting activities of 
the identified chemicals (chlorpyrifos, bisphenol A, fluoranthene, phenanthrene, and 
benzo(a)pyrene) in raw water should be investigated further in vivo. In addition, the potential 
of using polyphenols (quercetin and resveratrol) for antagonizing dioxin-induced AhR 
activation could be investigated in vivo.  
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While humans are exposed to mixtures of persistent organic pollutants (POPs), their risk assessment is
usually based on a chemical-by-chemical approach. To assess the health effects associated with mixed
exposures, knowledge on mixture toxicity is required. Several POPs are potential ligands of the Aryl
hydrocarbon receptor (AhR), which involves in xenobiotic metabolism and controls many biological
pathways. This study assesses AhR agonistic and antagonistic activities of 29 POPs individually and in
mixtures by using Chemical-Activated LUciferase gene eXpression bioassays with 3 transgenic cell lines
(rat hepatoma DR-H4IIE, human hepatoma DR-Hep G2 and human mammary gland carcinoma DR-T47-
D). Among the 29 POPs, which were selected based on their abundance in Scandinavian human blood,
only 4 exerted AhR agonistic activities, while 16 were AhR antagonists in DR-H4IIE, 5 in DR-Hep G2 and 7
in DR-T47-D when tested individually. The total POP mixture revealed to be AhR antagonistic. It
antagonized EC50 TCDD inducing AhR transactivation at a concentration of 125 and 250 and 500 fold
blood levels in DR-H4IIE, DR-T47-D and DR-Hep G2, respectively, although each compound was present
at these concentrations lower than their LOEC values. Such values could occur in real-life in food
contamination incidents or in exposed populations. In DR-H4IIE, the antagonism of the total POP mixture
was due to chlorinated compounds and, in particular, to PCB-118 and PCB-138 which caused 90% of the
antagonistic activity in the POP mixture. The 16 active AhR antagonists acted additively. Their mixed
effect was predicted successfully by concentration addition or generalized concentration addition
models, rather than independent action, with only two-fold IC50 underestimation. We also attained good
predictions for the full dose-response curve of the antagonistic activity of the total POP mixture.
© 2019 Elsevier Ltd. All rights reserved.1. Introduction
The aryl hydrocarbon receptor (AhR) was originally character-
ized as a xenobiotic mediator (Hankinson, 1995). It is often called
the “dioxin receptor” as 2,3,7,8-tetrachlorodibenzo-p-dioxine by Wen Chen.
he last authors.(TCDD) and several dioxin-like (dl) compounds are AhR agonists.
Adverse health effects associated with exposure to these AhR ag-
onists are widely studied, including abnormal reproduction and
development, impaired immune system, liver toxicity and cancers
(Consultation, 2000).
AhR physiological roles have recently gained more attention
since AhR is activated by a wide range of structurally diverse
endogenous and exogenous compounds (Denison and Nagy, 2003).
Also, AhR-deficient rodents suffer from various physiological de-
fects in the immune system (Harrill et al., 2015), liver (Gonzalez and
Fernandez-Salguero, 1998), kidney (Harrill et al., 2015; Harrill et al.,
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(Butler et al., 2012), etc. Additionally, AhR homologues are pre-
served in animal evolution for 600 million years (Hahn et al., 2017),
while invertebrate AhR homologues cannot bind dioxin (Butler
et al., 2001), indicating that dioxin detection was not the primary
role of this protein. Increasing evidence supports important roles of
AhR in normal development and homeostasis, while toxicity
induced by AhR xenobiotic ligands could be due to perturbation of
these normal processes (Marlowe and Puga, 2005).
Upon ligand binding, the AhR is translocated from cytosol into
the nucleus where it joins its dimerization partner, aryl hydrocar-
bon receptor nuclear translocator (ARNT). This AhR/ARNT complex
then binds to a DNA sequence called dioxin responsive element
(DRE) to activate the expression of a battery of genes, including
both phase I and phase II xenobiotic metabolism enzymes, of which
cyp1a1 is the best characterized. Hence, methodsmeasuring cyp1a1
gene expression are widely accepted for determining AhR activa-
tion (Wall et al., 2015), among which cell-based screening methods
such as Chemical-Activated LUciferase gene eXpression (CALUX)
are the most common (Murk et al., 1996; Scippo et al., 2004;
Goeyens et al., 2010).
Many potential AhR ligands are persistent organic pollutants
(POPs). POPs are resistant to degradation and widely distributed in
the environment. They can be detected in almost every human
sample, including fetuses and embryos (Vizcaino et al., 2014). They
tend to bioaccumulate and biomagnify in living organisms, result-
ing in toxic health effects to both humans and wildlife (Convention,
1997).
Presently, chemical risk assessment mainly relies on a chemical-
by-chemical approach (Bopp et al., 2018). In real life, humans are
exposed not to an individual POP, but to highly complex POP
mixtures (Kortenkamp, 2007). Understanding mixture toxicity is
crucial to assess the potential adverse health effects associatedwith
such real life exposure to mixtures of POPs (EC COM, 2012). The
mixture effects may be additive, synergistic, or antagonistic
depending onwhether they are equal, stronger, or weaker than the
sum of the effects of individual components, respectively
(Berenbaum, 1985). The concepts called “something from nothing”
and “a lot from a little” were introduced to describe the mixture
effect (Kortenkamp et al., 2009) and proved in a study on fish when
a significant effect was observed for a mixture combining individ-
ual compounds each at “no observed effect” concentrations
(Thrupp et al., 2018).
Due to the various mixture forms and doses, models using the
information of components to predict the combined effects are
required. Three mathematical models have been developed for this
purpose: i) the concentration addition (CA) model was designed for
chemicals with similar mode of actions (MOAs) (Loewe and
Muischnek, 1926), but has also proven useful for mixtures with
dissimilar compounds (Thrupp et al., 2018; Birkhøj et al., 2004;
Orton et al., 2014); ii) independent action (IA) (Bliss, 1939), suc-
cessful in several applications (Backhaus et al., 2004; Payne et al.,
2000), applies for chemicals which act independently and have
different MOAs; and iii) the generalized concentration addition
(GCA) (Howard and Webster, 2009), a CA modified model, was
developed for predicting the effects of mixtures containing partial
agonists (Howard and Webster, 2009; Howard et al., 2010;
Brinkmann et al., 2018).
In an effort to fill the gap in the knowledge of mixture toxi-
cology, a defined mixture of 29 POPs (total POP mixture) was
constructed based on their prominence in blood and/or food and
breastmilk with the concentration being average blood values from
recent Scandinavian studies (Småstuen et al., 2010; Knutsen et al.,
2008; Polder et al., 2008) published prior to 2012 (Berntsen et al.,
2017). To mimic the exposure of cells (in a tissue) to chemicalsthat are in the blood stream, reporter gene assays involving cancer
cell lines from different tissues (liver and mammary gland) and
species (rat and human) were used in this study to determine the
AhR transcriptional activities of the selected 29 POPs, individually
and in mixtures (the total POP mixture and six sub-mixtures
(Berntsen et al., 2017)). The aims were to (a) assess both AhR
agonistic and antagonistic activities after exposing the cell lines to
the 29 POPs and to themixtures, (b) identify themain compound(s)
responsible for the observed effects of the mixtures, and (c) predict
the mixture activity by applying the three available models (IA, CA
and GCA).
2. Materials and methods
2.1. Chemicals and suppliers
The total POP and six sub-mixtures were designed and premade
by the Norwegian University of Life Sciences, Oslo, Norway as
described (Berntsen et al., 2017). The former consists of 29 POPs,
where most of them are listed as POPs under the Stockholm
Convention on Persistent Organic Pollutants, belonging to three
groups: six perfluorinated compounds (PFAAs), seven brominated
compounds (BFRs), and 16 chlorinated compounds with seven
polychlorinated biphenyls (PCBs) and nine organochlorine pesti-
cides (OCPs). The latter consist of either one single class of com-
pounds (PFAA, Br and Cl) or two combined classes (ClþBr, ClþPFAA,
BrþPFAA). This way of mixture preparationwas to enable the study
of the effect of adding or removing one chemical group on different
endpoints. As the design of the mixtures was focused on com-
pounds occurring at high concentrations, most dl-PCBs (with the
exception of PCB-118) and polychlorinated dibenzodioxins/poly-
chlorinated dibenzofurans (PCDD/PCDF) were deliberately
excluded. These compounds were also omitted due to their high
toxicity at low concentrations in several systems to allow the study
of the effect of the non-dl and most prevalent compounds. The
components included in the mixtures and their respective con-
centrations are given in Table S1.
Along with the mixture testing, 29 POPs from the total POP
mixture were also examined individually. They were bought from
Sigma Aldrich (Missouri, USA) except o-chlordane from Toronto
Research Chemicals (North York, Canada) and PCB-118 from Dr
Ehrenstorfer (Augsburg, Germany). All chemicals were dissolved in
dimethylsulfoxide (DMSO) (Acros Organics, Molinons, France),
except HCB in hexane (Merck, Massachusetts, USA).
The 29 individual POPs and the mixtures were stored as stock
solutions at 20 C. Working solutions were prepared from the
stock solutions to reach the concentrations mentioned in Table S1.
The highest tested concentration was 50 mM for all PCBs and PFAAs
and 20 mM for BFRs except BDE-100, BDE-153, BDE-154 and BDE-
209 (1 mM) due to stocks available. OCPs were tested at the
maximum concentration of 100 mM for g-HCH and dieldrin, or
80 mM for all the others. The concentrations for mixture exposure
are presented as “fold blood levels”, relative to the average
contaminant levels found in human blood of the Scandinavian
population. The total POP mixture and sub-mixtures were tested at
concentrations between the estimated concentrations in human
blood and maximum 3000 fold blood levels.
2.2. Determination of aryl hydrocarbon receptor agonistic and
antagonistic activities
2.2.1. Cell-based assays
Rat and human dioxin responsive (DR) cell lines were used. Rat
hepatoma DR-H4IIE cells were from BioDetection System
(Amsterdam, The Netherlands) while both human cell lines
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were previously home-made (Liege, Belgium) (Van der Heiden
et al., 2009). A vector containing an AhR-controlled luciferase re-
porter gene was stably integrated into these cells. The vector in-
tegrated into DR-H4IIE cells contained four native DREs (from the
upstream promotor of the mouse cyp1a1 gene), leading the MMTV
(Mouse Mammary Tumour Virus) promoter (Garrison et al., 1996),
while both DR-T47-D and DR-Hep G2 cells were transfected with a
vector containing four synthetic DREs regulating the thymidine
kinase promoter (Van der Heiden et al., 2009). The cells were
routinely cultured in MEMa (Thermo Fisher Scientific, Massachu-
setts, USA) supplemented with 10% v/v fetal bovine serum (Greiner,
Kremsmünster, Austria), 50 IU/mL penicillin and 50 mg/mL strep-
tomycin (Sigma Aldrich, Missouri, USA), and incubated in a H20
saturated atmosphere containing 5% CO2, at 37 C.
The methodology for the DR-CALUX (Dioxin Responsive
Chemical-Activated LUciferase gene eXpression) bioassays was
described in detail elsewhere (Van der Heiden et al., 2009; Scippo
et al., 2005). Briefly, cells were first seeded in white clear-
bottomed 96 well microplates (Greiner, Kremsmünster, Austria)
and incubated for 24 h to reach about 90% of confluence in the well.
After 24-h exposure, the cells were washed with phosphate buff-
ered saline (Sigma Aldrich, Missouri, USA) and treated with lysis
solution (containing Triton X100, Sigma Aldrich, Missouri, USA).
Luciferin (Promega, Wisconsin, USA) and ATP (Roche Diagnostics,
Rotkreuz, Switzerland) were then added to the cell lysate to pro-
duce luminescence, which was measured by using a luminometer
(ORION II, Berthold Detection System, Pforzheim, Germany). The
cells were exposed, in triplicates, to a dilution series of the tested
compound/mixture in both agonistic and antagonistic tests. For the
latter, the cells were co-exposed with a constant concentration of
15 pM, 150 pM and 650 pM TCDD corresponding to TCDD EC50 in
DR-H4IIE, DR-T47-D and DR-Hep G2 cells, respectively.
In order to verify whether AhR antagonists compete for the
same, single site on the AhR with the agonist (TCDD), additional
antagonistic tests were performed for selected compounds by co-
exposing DR-H4IIE cells to different concentrations of the tested
compounds and a constant saturating TCDD concentration (20 nM).
Using the agonist (TCDD) at clearly saturating concentrations
would make it impossible for a lower affinity antagonist to affect
transcriptional activation at all.
All the exposure experiments were repeated at least three times
independently. The final concentration of DMSO in the culture
medium for the single POPs was 0.2% and 0.3% for agonistic and
antagonistic tests, respectively, while they were 0.3% and 0.4% for
the mixtures. For quality control, a TCDD reference curve was
performed on each plate.
MTT cell viability and LDH cell cytotoxicity were performed
along with visual inspection of cell morphology and attachment.
The former was carried out in a replicate plate to the DR-CALUX
assays. After 24-h exposure, 25 mL MTT dye solution (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, 5mg/ml,
Sigma Aldrich, Missouri, USA) was added into each well, followed
by a 4-h incubation at 37 C to form insoluble purple formazan.
Then, 100 mL isopropanol (Merck, Massachusetts, USA) was added
into the plates to dissolve the formazan for 2 h. The MTT formazan
absorbance was read at 550/630 nm by a spectrophotometer
(ELx800™ BioTek, Winooski, USA). Because the MTT data need to
be interpreted with caution and are not necessarily related to cell
death, we performed the LDH cell cytotoxicity as well. The Pierce™
LDH Cytotoxicity Assay Kit was purchased from Thermo Fisher
Scientific (Massachusetts, USA) and operated according to the
manufacturer's instructions (absorbance at 490/630 nm).2.2.2. Calculations of EC50, IC50 and efficacy (RPCMax)
Final results were presented as relative responses, i.e. percent-
ages of the cell response to the tested compound/mixture
compared to the maximum response of the cells to TCDD on the
same plate for agonistic activities, or to spike-in TCDD EC50 for
antagonistic activities. Dose-response curves were generated by
Graphpad PRISM software, version 7 (San Diego, California, USA) by
fitting a four-parameter non-linear regression for agonistic (Eq. (1))











where x is the concentration of a tested compound/mixture
inducing the relative response Yagonistic or Yantagonistic. EC50 and IC50
are the half maximal effective concentration for an agonist and
antagonist, respectively (OECD, 2016). B¼ bottom, T¼ Top, H ¼
Hillslope.
The lowest observed effect concentration (LOEC) is the lowest
tested concentration at which a significant effect (p< 0.05) was
observed. The maximum observed effect concentration (MOEC) is
the lowest tested concentration causing the maximum effect
(p< 0.05). ANOVA (Graphpad PRISM) was used to determine sta-
tistical significance. Prior to ANOVA, tests for homogeneity of
variance and normal distribution (transformation if needed) were
performed. When no full dose-response curve was achieved, MOEC
was considered as the highest concentration of the test series. Ef-
ficacy was determined as RPCMax (%), which is the maximum effect
induced by the tested compound (OECD, 2016): AhR agonistic
RPCMax was the maximum relative response of the compound/
mixture compared to the maximum TCDD response, while AhR
antagonistic RPCMax was the minimum relative response observed
by the maximum inhibition of the test compound/mixture to the
spike-in TCDD EC50. The compound/mixture was accepted as active
when its relative response was higher than the threshold level
RPCMax  10% for AhR agonists and lower than RPCMax  70% for
AhR antagonists (OECD, 2016).2.2.3. Calculations of the predicted mixture antagonistic effects
2.2.3.1. Concentration addition (CA). CA model is based on a dilu-
tion principle, all the chemicals behave as they are simply the
dilution of one another in the mixture. Hence, the effect contri-
bution of one compound to the mixture effect can be totally or
partially replaced by the effect of the other. It calculates the effect
concentration (ICmix,j) of the mixture inducing a specific antago-
nistic effect j (from 1% to 100%) by considering the concentration
partition (pi) of compound i and its respective effect concentration
(ICij) inducing the same effect j (Eq. (3)). Previously published
formulae were adapted (Loewe and Muischnek, 1926; Birkhøj et al.,








The concentration partition pi can either consider or not the
non-active (NA) compounds. Because nonactive compounds do not
give ICij, n is the number of the active compounds.
For each compound i, ICij inducing the effect j is calculated using
its ICi,50 and hillslope (Hi) from their fitted curves using Eq. (4)
(Graphpad PRISM):






Because the CA model allows only the calculation of ICmix,j, to
generate the full dose-response curves, we proposed several
possible methods to calculate the hillslope and bottom (Hmix and
Bmix) of the mixture response, while the top was set to 100% as no
response.
- the Weighted Mean Hillslope and Bottom (WMHB) (Eq. (5a))
considering pi to weight the hillslope and bottom of the indi-
vidual compounds:














- the Averaged Hillslope and Bottom (AvBH) considering the










- the Formulated Hillslope and Bottom (FoBH) (Eq. (5c)) using the
formulae of the CA:











(5c)2.2.3.2. Independent action (IA). This method assumes that the ef-
fect of each component is an independent event (Bliss, 1939). Thus,
the probability to exert a specific effect of the mixture is the joint
probability of the effect of each compound applied independently.
For calculating the relative response of the mixture, the data for
individual compounds were converted into a probability.
An antagonistic effect induced by compound i is obtained by
subtracting the measured relative response (Rik) from 100% (100%
being the relative response of TCDD EC50) and then converted into a
probability (scale 0e1, by dividing by 100). The relative response of
the mixture (0%e100%) is calculated from the combination of in-












At a specific concentration k, Rmix,k is the relative response of the
mixture; Rik is the relative response of compound i at that con-
centration k of the mixture, n is the number of the active
components.2.2.3.3. Generalized concentration addition (GCA). GCA (Eq. (7))
assumes that the hillslope for each component is equal to 1 and
considers also their RPCMax31 . It was adapted for AhR antagonistic





1þ Pni¼1 CikIC50i (7)
where Rmix,k is the relative response of the mixture at a specific
concentration k, Cik is the concentration of compound i in the
mixture at that specific mixture concentration k. RPCMax,i is the
maximum effect of compound i and IC50i is the IC50 of compound i.3. Results
In DR-H4IIE cells, while a-chlordane caused cytotoxicity at the
highest tested concentration of 80 mM, t-nonachlor already did at
62.5 mM in three cytotoxicity tests (data not shown). Theywere also
cytotoxic for the DR-T47-D at lower concentrations of 30 and
30.5 mM, respectively. These cytotoxic concentrations were
excluded from the data analyses. None of the other compounds or
mixtures induced cytotoxicity at any tested concentration.3.1. Aryl hydrocarbon receptor activities of the 29 POPs
3.1.1. AhR e mediated agonistic activities
Only four out of the 29 tested POPs presented AhR agonistic
activities (RPCMax 10%). BDE-153, PCB-138, and PCB-118 were
active in DR-H4IIE, while BDE-99 was active in DR-T47-D. BDE-99
and BDE-154 were able to trigger a weak agonistic activity
(5%< RPCMax< 10%) in DR-H4IIE, as well as g-HCH in DR-T47-D
(Table S2). No agonistic response was recorded in DR-Hep G2
cells for any of the 29 POPs.3.1.2. AhR e mediated antagonistic activities
Sixteen out of the 29 individually tested POPs displayed AhR
antagonisms. No antagonistic activities were observed for any of
the PFAAs in all three cell lines. In contrast, in DR-H4IIE cells, AhR
antagonistic responses were recorded for 16 POPs including all
PCBs, most of the OCPs (except p,p’-DDE, a-HCH and b-HCH), and
three out of the seven BRFs (BDE-47, BDE-99 and HCBD) (Table 1).
PCB-118 and PCB-138 displayed a V-shaped dose-response curve,
switching from antagonistic to agonist behavior at concentrations
above 3.5 mM and 27.5 mM, respectively. Hence, their IC50 values
were determined by only the antagonistic part of the curve. The
dose-response curves obtained from DR-H4IIE cells co-exposed to
TCDD EC50 and the 16 AhR antagonistic POPs are shown in Fig. S1
(solid lines) with a detail in Table S3.
DR-Hep G2 cells were less responsive to the POPs than DR-H4IIE,
with only five compounds exerting antagonistic activities, namely
PCB-28, PCB-118, PCB-138, HCB and BDE-47 (Table 1). PCB-28 was
the most potent compound, almost completely abolishing the ac-
tivity of 650 pM TCDD in DR-Hep G2, displaying an RPCMax of
7.2± 3.6% and an IC50 of 6.1± 1.4 mM. In DR-T47-D cells, seven out of
the 29 POPs showed AhR antagonistic activities (PCB-28, PCB-118,
PCB-138, HCB, a-chlordane, t-nonachlor and g-HCH). The highest
potencies were found for a-chlordane and t-nonachlor with RPCMax
of 7.4± 12.5% and 27.8± 3.5%, respectively.3.1.3. Evaluating competitive inhibition of 16 antagonists in DR-
H4IIE
The AhR antagonistic activities were abolished for all com-
pounds (except a-chlordane and t-nonachlor with RPCMax of 56.6%
and 56.8%, respectively) when co-exposing with excessive 20 nM
TCDD, indicating they are possible AhR competitive antagonists
(Fig. S1, dashed lines).
Table 1
AhR antagonistic responses (LOEC, MOEC, IC50 and RPCMax) of 16 POPs in DR-H4IIE, DR-Hep G2 and DR-T47-D cell lines (n¼ 3, 0.3% DMSO).
Compounds DR-H4IIE DR-Hep G2 DR-T47-D
LOEC (mM) MOEC (mM) IC50± SE (mM) RPCMax (%) LOEC (mM) MOEC (mM) IC50± SE (mM) RPCMax (%) LOEC (mM) MOEC (mM) IC50± SE (mM) RPCMax (%)
PCB-28 2.5 25 6.8± 1.7 36.6± 4.3 2.5 25 6.1± 1.4 7.2± 3.6 3.5 25 11.4± 1.5 48.3± 5.9
PCB-52 2.5 50* 7.3± 1.2 17.1± 5.5 e e e e e e e e
PCB-101 12.5 50* 17.9± 3.8 54.3± 3.6 e e e e e e e e
PCB-118 0.5 2.5 0.3± 0.05 67± 4.7 12.5 25 9± 2.7 38.3± 16.5 12.5 27.5 13.6± 2.4 49.2± 4.9
PCB-138 0.5 2.5 0.6± 0.07 42.8± 2.8 3.5 25 ND 50.2± 9.5 12.5 50* ND 42.6± 2.5
PCB-153 0.01 50* 18.5± 2.8 16.7± 4.6 e e e e e e e e
PCB-180 1 50* 7.4± 3.3 16± 1.4 e e e e e e e e
HCB 0.075 37.5 17.9± 11.6 42± 8.7 3.75 37.5 4.5± 2.3 39.4± 12.7 0.075 30 16.4± 2.1 51.7± 6.7
a-Chlordane 0.4 50* 28.3± 3.3 15± 1.1 e e e e 10 30 20.2± 2.1 7.4± 12.5
ο-chlordane 20 40* 26.5± 19.4 26.3± 1.5 e e e e e e e e
t-nonachlor 25 50* 34.3± 1.8 34.2± 8.1 e e e e 25 25 16.8± 2 27.8± 3.5
g-HCH 0.5 50 27.5± 2.7 40.7± 3.5 e e e e 50 75 61.2± 2.9 65.4± 13.7
Dieldrin 6.25 50 22.4± 11.4 59.6± 1.9 e e e e e e e e
BDE-47 0.25 20* 3.1± 0.5 17.9± 2.7 1.25 12.5 ND 55.3± 7.2 e e e e
BDE-99 0.25 10 5.2± 1.9 36.3± 1.5 e e e e e e e e
HBCD 0.25 15 35.8 ± 63.9** 58.1± 3.1 e e e e e e e e
LOEC: lowest observed effect concentration (p< 0.05); MOEC: maximum observed effect concentration (p< 0.05); IC50: the concentration inducing half of the maximum
inhibition response; SE: Standard Error; RPCMax: observed efficacy expressed as a percentage of the cell response exposed to 15 pM, 650 pM and 150 pM TCDD, respectively for
DR-H4IIE, DR-Hep G2 and DR-T47-D, corresponding to the MOEC; ND: Not Determined. * Corresponds to the highest tested concentration. ** IC50 estimated beyond tested
concentrations. -: no response.
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3.2.1. AhR e mediated agonistic activities
Exposure to the total POP mixture or to the six sub-mixtures
described in Table S1 did not induce any significant
(RPCMax 10%) AhR agonistic response in any of the cell lines (data
not shown), as it could be expected with the exclusion of dl-PCBs
and PCDD/F.
3.2.2. AhR e mediated antagonistic activities
The total POPmixture triggered an AhR antagonistic response in
all cell lines (Table 2, Fig. 1A). At a concentration in the culture
medium corresponding to the blood level, the total POPmixture did
not interfere with the response of the cells to EC50 TCDD. In
contrast, significant and dose-dependent antagonistic responses
were already observed at concentrations of 125, 250 and 500 fold
blood levels, respectively, for DR-H4IIE, DR-T47-D and DR-Hep G2,
although the concentrations of all 29 compounds were below their
respective LOEC at these levels or even at 1000 fold blood levels
(Table S1). In DR-H4IIE, the POP mixture displayed a significantly
high AhR antagonistic efficacy of 52.5± 2.1% at 1000 fold blood
levels and an IC50¼ 374± 52 fold blood levels, while in both human
cell lines, a significant response was observed, but did not reach
below 80%, making the calculation of an IC50 not possible.
In parallel, six complementary sub-mixtures (PFAA, Br, Cl, ClþBr,
ClþPFAA, BrþPFAA) were also tested to study the possible in-
teractions between these groups of compounds. Antagonism was
seen for all Cl containing mixtures (the total POP, Cl, ClþBr andTable 2
AhR antagonistic responses (LOEC, MOEC, IC50 and RPCMax) of the total POPmixture and Cl
cells (n ¼ 3, 0.4% DMSO).
Mixtures DR-H4IIE DR-Hep G2
LOEC (x bl) MOEC (x bl) IC50± SE (x bl) RPCMax (%) LOEC (x bl) MOEC (x bl
POP 125 1000 374± 52 52.5± 2.1 500 1000
Cl 250 1000 562± 54 53± 0.9 250 2000
ClþBr 125 2000 468± 38 64.6± 1.7 500 1000
ClþPFAA 75 2000 461± 78 41± 1.3 500 500
LOEC: lowest observed effect concentration (p< 0.05); MOEC: maximum observed effe
inhibition response; SE: Standard Error; RPCMax: relative response at MOEC expressed in %
H4IIE, DR-Hep G2 and DR-T47-D) corresponding to the MOEC; x bl: fold blood levels; NClþPFAA mixtures) in DR-H4IIE and DR-Hep G2, while only the
total POP and ClþPFAA mixtures showed responses in DR-T47-D
(Table 2).
In DR-H4IIE cells, the three Cl containing sub-mixtures and the
total POP mixture gave more or less similar responses with
IC50y 400e500 fold blood levels and RPCMax y 50%. This indicates
that the chlorinated compounds were responsible for the antago-
nism of all mixtures where they are present. Also, the antagonistic
response curve of ClþPFAA mixture overlapped that of the total
POP mixture, which placed below those of the Cl and ClþBr
(Fig. 1B). These observations suggest that the effect of the Cl
mixture was somehow enhanced in the ClþPFAAmixture, resulting
in a dose-response curve overlapping that of the total POP mixture.
3.3. Predictions of the rat aryl hydrocarbon receptor antagonistic
activities of the total POP mixture and Cl containing sub-mixtures
We evaluated the capacity of the three different mathematical
models (concentration addition (CA), independent action (IA), and
generalized concentration addition (GCA)) to predict the IC50 and
dose-response curves of the total POPmixture in the most sensitive
cell line, the DR-H4IIE.
3.3.1. Calculation of bottom and hillslope values
Because the 16 rat AhR antagonists contributed only 4.3% for the
mass of the total POP mixture, along with considering all of the 29
POPs to calculating pi, we also considered only the active com-
pounds, subtracting the weight of the non-active compounds (sNA)containing sub-mixtures (Cl, ClþBr, ClþPFAA) in DR-H4IIE, DR-T47-D and DR-Hep G2
DR-T47-D
) IC50± SE (x bl) RPCMax (%) LOEC (x bl) MOEC (x bl) IC50± SE (x bl) RPCMax (%)
ND 80.1± 5.8 250 1000 ND 86.6± 2.2
ND 59± 1.6 e e e e
534± 253 76.1± 3.9 e e e e
243± 104 77± 3.8 500 500 ND 77± 3.8
ct concentration (p< 0.05); IC50: the concentration inducing half of the maximum
of the response of TCDD EC50 15 pM, 650 pM and 150 pM TCDD (respectively for DR-
D: Not Determined. -: no response.
Fig. 1. (A) Dose-response curves obtained from DR-H4IIE, DR-T47-D and DR-HepG2
cells co-exposed to 15 pM, 150 pM and 650 pM TCDD, respectively, and the total
POP mixture. (B) Dose-response curves obtained from DR-H4IIE cells co-exposed to 15
pM TCDD, and the total POP mixture, or the Cl, ClþBr and ClþPFAA sub-mixtures
(Mean ± SD, n ¼ 3, 0.4% DMSO).
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dict both bottom and hillslope values. AvBH and FoBH showed
reasonable predicted values, especially AvBH and sNA FoBH for the
total POP mixture and the three Cl containing sub-mixtures
(Table S4).3.3.2. Prediction of mixture effects of the three models
The results obtained after running the three models are shown
in Fig. 2. While the IA predicted a really strong response even at the
lowest concentrations of the mixture, far out of the range of the
measured curve, both the CA (CA-AvBH and CA-sNA FoBH) and GCA
predictions resulted in calculated curves comparable to the
measured curve. This refers that the 16 active compounds in the
total POP mixture acted additively rather than independently.
The measured IC50 of the total POP mixture (374± 52 fold blood
levels) was lower than the predicted value (784 fold blood levels for
both the GCA and CA models), while the IA model predicted
IC50¼ 2153 fold blood levels. Thus, both CA and GCA models
underestimated IC50 of the total POP mixture by about two folds,much less than one order of magnitude.
Concerning the calculated dose-response curves, the two addi-
tive models appeared to diverge: GCA produced a somewhat better
prediction in the low concentration range, both CA (CA-AvBH and
CA-sNA FoBH) closely followed the experimental curve and only
diverged at concentrations higher than around 1000 fold blood
levels (Fig. 2). Similar predictions were also shown for the three
active Cl, ClþBr, ClþPFAA sub-mixtures (Table S4, Fig. S2).3.3.3. Toxic units
Derived from CA model, toxic units (i.e. the ratio of the con-
centration partition of a compound to its IC50 (pi/IC50,i)) scales the
concentrations of the mixture components to its toxicity, repre-
sented by the transcriptional activity of the Cyp1a1 promotor. Thus,
it has been applied to identify the main driver(s) for mixture effects
in CA model (Loewe and Muischnek, 1926; Backhaus et al., 2004;
Evans et al., 2012). Fig. 3A clearly shows that PCB-138 and PCB-118
were the twomain contributors for the AhR antagonism of the total
POP mixture, constituting to 90% of the total combined activity.
Since theywere also partial agonists, it is likely that, in the presence
of TCDD, they behaved mainly as antagonists especially at low
concentrations. Following this prediction, a binary mixture of PCB-
138 and PCB-118 was generated according to their concentration in
the total POP mixture. The dose-response curve of this mixture
followed that of the total POP mixture very closely, with an IC50 of
505± 67 fold blood levels (while IC50¼ 374± 52 fold blood levels
for the total POP mixture) (Fig. 3B).4. Discussion
4.1. AhR transactivation activities of the 29 POPs and the mixtures
This study shows that amajority of the chemicals composing the
realistic total POP mixture are actually AhR antagonists (16 in DR-
H4IIE, five in DR-Hep G2 and seven in DR-T47-D cells). As ex-
pected, the total POP mixture and the Cl containing mixtures were
also shown to be antagonistic. These activities were AhR-
dependent, and seemed to act through competition for the TCDD
binding site, except for t-nonachlor and a-chlordane.
In our study, we tested the AhR transcriptional activity of POPs
and POP mixtures using a transcriptional reporter assay, which
basically reports the canonical AhR-driven pathways via AhR-
ARNT-DRE interactions. However, we observed that two of the
compounds (a-chlordane and t-nonachlor) do not seem to exert
their antagonistic effect through competitive binding to AhR.
Several possible non-canonical AhR-driven pathways could
contribute to the observed results, such as crosstalk with other
nuclear receptors, regulation of cell cycle and MAP kinase cascades,
or novel AhR DNA-binding partners (Wright et al., 2017; Jaeger and
Tischkau, 2016). Further studies of these mechanisms are required,
but were outside of the scope of this paper.
Our results concerning single compound testing are in general
consistent with previously published studies, where available. For
agonistic activity, PCB-118 displayed highest RPCMax¼ 61.3% at
50 mM, with EC50¼ 25± 13 mM similar to previously finding
(9.3± 2.5 mM) (Brenerova et al., 2016). EC50¼ 4± 0.8 mM of BDE-99
was lower than previous report (EC50> 15 mM) (Hamers et al.,
2006). For PCB-138, we observed an agonistic effect with a high
EC50¼ 28 ± 6.4 mM, which was not reported before (Brenerova
et al., 2016) (Table S2).
For antagonistic activities, in this study, IC50 of PCB-28 and PCB-
138 were 6.8± 1.7 and 0.6± 0.07 mM (Table 1), close to previous
estimates of 9.0± 2.9 mM and 1.4± 0.1 mM, respectively (Brenerova
et al., 2016). BDE-47 activity (IC50¼ 3.1± 0.5 mM) was similar to
Fig. 2. Measured and predicted dose-response curves obtained from rat DR-H4IIE cells co-exposed to 15 pM TCDD and the total POP mixture, and from three prediction models.
CA ¼ Concentration addition, IA ¼ Independent action, GCA¼Generalized concentration addition, AvBH¼ averaged hillslope and bottom, and sNA FoBH¼ subtracted nonactive
compounds, formulated hillslope and bottom. Green dashed lines represent the 95% confidence interval of the measured response.
Fig. 3. (A) Distribution of toxic units of the 16 active AhR antagonists. (B) Dose-
response curves obtained from rat DR-H4IIE cells co-exposed to 15 pM TCDD and
the total POP mixture or a binary mixture consisting of PCB-138 and PCB-118
(Mean ± SD, n¼ 3, 0.4% DMSO).
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(3.7± 0.8 mM) (Brenerova et al., 2016). However, the
IC50¼ 5.2± 1.9 mM for BDE-99 found in this study was lower than
that previously reported (13± 0 mM) (Hamers et al., 2006). This
study reports for the first-time data for the AhR transcriptional
activity of the 29 POPs in both human mammary gland carcinoma
DR-T47-D and hepatoma DR-Hep G2 cells.
Differences between IC50 or EC50 values of this study and those
from previous findings (Brenerova et al., 2016; Hamers et al., 2006)
may result from differences in the experimental design and the
regression methods (i.e. the number of concentration points,
availability of a maximum effect if a full curve is generated,
extrapolation if the maximum effect is not reached, and the
regression function used with either four or three parameters). Our
study not only confirms and consolidates previous findings
(Brenerova et al., 2016; Hamers et al., 2006), but it also contributes
new data including full dose-response curves with four parameter
fit (see Table S3) which can be used for further data treatment or
calculation of the joint effect of any mixture made from these 29
POPs for the rat DR-H4IIE cells.
We observed species and tissue differences in the AhR tran-
scriptional activities of the individual POPs and of the mixtures. In
general, the rat DR-H4IIE cells were more sensitive than the two
human cells towards the effects on AhR transactivation when
exposed to individual POPs or POPmixtures. Several considerations
may explain this result. Interspecies differences in AhR structure
will obviously shape the sensitivity. Rats are 1000 folds more sen-
sitive to TCDD than guinea pigs (Hulme and Trevethick, 2010).
Mouse AhR has a higher affinity than human AhR due to the
different position of the important amino acid Valine (V381 in
humans corresponding to V375 in mice) (Ramadoss and Perdew,
2004). Human AhR has shown a higher relative affinity for
certain structurally compounds i.e. endogenous ligands or poly-
phenols (Flaveny et al., 2009). Moreover, the difference in genetic
modification (origins of the integrated promotor and DREs) of the
rat DR-H4IIE compared to the two human cell lines could also play a
role for the specific responses. Differences in regulatory processes
downstream of AhR binding may be responsible, such as differen-
tial binding to transcriptional coactivators (Flaveny et al., 2008).
Finally, in the antagonistic tests, the POPs have to compete with
increasing TCDD concentration (15 pM, 150 pM and 650 pM,
respectively for DR-H4IIE, DR-T47-D and DR-Hep G2), which could
lead to the lower sensitivity to detect an antagonistic activity of the
POPs in the two human cells compared to the rat cells.
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activation
The most striking result of this study is that the total mixture of
29 POPs, derived from concentrations found in the blood of a
Scandinavian population, and sub-mixtures thereof were found to
exert only antagonistic effects on AhR. This observation is consis-
tent with our results obtained from testing each compound alone,
revealing amajority of antagonistic compounds. AhR antagonism of
POPs has been observed in several screening studies (Brenerova
et al., 2016; Hamers et al., 2006) and mixture studies (Harper
et al., 1995; Long et al., 2007). However, while the AhR agonistic
activity of POPs has been studied for decades, the antagonistic
counterpart has not yet received much attention, especially
regarding its physiological consequences on an organism's health.
This finding challenges the method of using toxic equivalency
factors (TEFs) and toxic equivalent quantities (TEQ) for risk as-
sessments of mixtures of AhR ligands. The World Health Organi-
zation assigned TEFs for PCDDs/PCDFs/dl-PCBs, expressed as
relative effect potencies compared to the most toxic form TCDD.
Regarding their additive mechanism, TEFs are also used to estimate
TEQ for a mixture of compounds by adding up the TEF fraction and
the concentration of each compound within the mixture (Van den
Berg et al., 2006). However, PCB mixtures alone or in combination
with PCDDs/PCDFs (usually TCDD) have shown additive but also
non-additive responses (Safe, 1998; Safe, 1997). Also, several envi-
ronmentally abundant biphenyls antagonize the cyp1a1 induction
by TCDD (Wall et al., 2015), while some dl-mono-ortho-substituted
PCBs revealed both agonistic and antagonistic properties (Clemons
et al., 1998; Hestermann et al., 2000). In many environmental
samples, the ratio between PCBs and AhR agonists is above 1000,
indicating that antagonisms, resulting from interactions between
AhR agonists and PCBs (Fiedler, 2003), are not irrelevant. Therefore,
the antagonistic effect of these compounds should be also consid-
ered to calculate the effect of mixtures. Since they are more
abundant in real-life mixtures, their antagonisms may undermine
or even abolish the overall dioxin potency of the environmental
mixtures (Wall et al., 2015).
Our finding also raises the issue of the biological significance of a
predominantly AhR antagonistic mixture in the blood of a human
population. We found antagonistic activities at levels of 125 fold
blood levels in rat liver cells or 250 or 500 folds in human mam-
mary gland and liver cells, levels that may realistically be reached
after an accident or in exposed populations.
It is important to note that in the total POP mixture used here
(Berntsen et al., 2017), no dioxins and dl-compounds were
included. That allows us to study the antagonism of the human-
exposure relevant POP mixtures by isolating them from the
dioxin and dl-compounds. But the roles of the dioxin and dl-
compounds in human exposure should have also been consid-
ered. Therefore, we attempted to estimate the effect of the total POP
mixture in a real-life situation. According to Kvalem et al. (2009),
the median of dl-compounds in Norwegian human blood was
33.1 pg TEQ/g lipid, which is equal to 0.6 pM in blood assuming that
blood contains 0.6% fat and 1ml blood¼ 1 g. Thus, the respective
LOECs (for the POP mixture AhR antagonistic activity) in DR-H4IIE,
DR-T47-D and DR-Hep G2 of 125, 250, and 500 fold human blood
level correspond to 75 pM, 150 pM and 300 pM of dl-compounds,
respectively. This concentration is close to the TCDD EC50 (15 pM
TCDD in DR-H4IIE, 150 pM in DR-T47-D and 650 pM in DR-Hep G2
cells) used in our antagonistic assays. Therefore, it is likely that the
total POP mixture would antagonize the activity of these dl-
compounds in the Scandinavian population.
Furthermore, the question arises whether an overall AhRantagonistic exposure would actually cause health problems by
interfering with the normal AhR function. Increasing evidence
suggests that endogenous AhR ligands exist (Rannug et al., 1987;
Rannug and Rannug, 2018), complemented by dietary
phytochemical-derived AhR agonists/antagonists (Powell and
Ghotbaddini, 2014; Jin et al., 2018). AhR induced functions are
essential for a variety of normal physiological functions. In mam-
mary tissue, AhR likely plays a physiological role in coordinating
development, differentiation, cell growth, and signaling of hor-
mones (Hubbard et al., 2018; Quintana et al., 2008; Roman et al.,
2018; Casado, 2016; Hushka et al., 1998). Knock out mice or mice
with low affinity AhR variants display impaired survival, growth,
fertility, liver function and innate and adaptive immunity (Larigot
et al., 2018). It is thus conceivable that the presence of highly sta-
ble POPs may interfere with the essential function of AhR
controlled by mostly short-lived endogenous and dietary ligands,
and thus impair cellular AhR mediated processes. The risk caused
by AhR antagonism as the major effect of POPs could well exceed
that due to their agonistic effect, however the health effect asso-
ciated to AhR antagonism is unclear and deserves further
investigation.
4.3. Predictions of mixture effects
Risk assessment for mixture exposure is crucial to protect the
health of both humans and wildlife. The individual chemical
approach underestimates the mixture exposure and decreases the
accuracy of risk assessment (Kortenkamp et al., 2009; Thrupp et al.,
2018; Silva et al., 2002). In addition, the risk of exposure to multiple
chemicals at doses below their threshold, which is the most com-
mon case in real-life, should not be underestimated or assumed as
no-effect.
In this study, the best prediction results were obtained using the
CA (concentration addition) and GCA (generalized concentration
addition) models. They performed well in predicting ICmix,50¼ 784
fold blood levels within two folds from the measured value (374
fold blood levels). This is considered as well accepted in predicting
the combined effect of complex mixtures i.e. the total POP mixture
with its components present at low concentration (lower than their
LOECs at 1000 fold blood levels) and belonging to different com-
pound groups.
CA is often chosen as the default model (Hardy et al., 2018) for
predicting mixture activities, first for mixtures with similar com-
pounds (Loewe and Muischnek, 1926) then expended to dissimilar
compounds (Thrupp et al., 2018; Birkhøj et al., 2004; Orton et al.,
2014). Previous studies have shown the capability of the CA
model to predict the mixture effect using the information of indi-
vidual chemicals obtained in vitro (Birkhøj et al., 2004; Evans et al.,
2012; Ghisari et al., 2015; Liu et al., 2015), ex vivo (Gaudriault et al.,
2017) or in vivo (Thrupp et al., 2018; Birkhøj et al., 2004). In vitro
research has mainly focused on an equimolar mixture with less
than ten components and at high exposure concentrations. Birkhøj
et al. (2004) successfully applied the CA model to predict the
antiandrogenic effect of amixture of five commonly used pesticides
at 10 mM each. In contrast, the CA model was unable to predict the
effect on thyroid hormone function and AhR transactivation of
another mixture of five different pesticides at the maximum con-
centration of 50 mM each, due to the presence of an inhibitory
compound (Ghisari et al., 2015). Other studies focused on more
complex mixtures with multiple components at lower doses,
typically below their threshold doses, or on human or environ-
mentally relevant exposure scenarios. Two complex mixtures of 17
estrogenic chemicals were screened for estrogenic activities,
reporter-gene (ERLUX) and cell proliferation (ESCREEN) endpoints
(Evans et al., 2012). This represents one of the most comprehensive
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the effects of the two mixtures.
GCA, on the other hand, has been recently developed and
proven useful specifically for calculating mixtures containing par-
tial agonists (Howard and Webster, 2009; Howard et al., 2010;
Brinkmann et al., 2018), but has not been applied before to calculate
the activity of AhR antagonists. It allows to consider theoretically
the fact that some agonists never reach the full activity of TCDD, or
that some antagonists present partial agonistic activities.
The difference between CA and GCA models resides in the
predicted dose-response curve of the mixture and in the maximum
predicted activity of the total POP mixture (Fig. 2). GCA predicting
the mixture response, allows to generate the full dose-response
curve of the mixture using only the data from testing the individ-
ual compounds (i.e. RPCMax, concentration and IC50). The reason
why this predicted curve diverged from the experimental curve at
higher concentrations could result from the assumption that the
hillslopes of all components, and so of the POPmixture, are equal to
1, which is clearly not the case (Table S3). However, GCA predicted
the bottom (RPCMax¼ 52%) very close to the observed value for the
total POP mixture (52.5%) thanks to its consideration of the RPCMax.
On the other hand, CA provides a prediction of ICmix,j without
the full dose-response curve. Therefore, we calculated the hillslope
and the bottom values for the mixture response based on its
components by formulating several possibilities. The dose-
response curve generated by CA with averaged bottom hillslope
(CA-AvBH) resulted in the best fit with reasonable hillslope and
bottom values (1.7 and 21%) compared to 1.3 and 52.5%, respec-
tively of the measured POP mixture curve. Subtracted non-
activated compounds and formulated bottom hillslope (sNA
FoBH) predicted an overlapped curve with the observed up to 1000
fold blood levels because of its closer Hmix¼ 1.5, but overestimated
the extension of antagonism at higher concentration, leading to the
prediction of Bmix¼ 0% for the total POP mixture. Bmix is important
when predicting the activity of a mixture for risk assessment.
Therefore, CA-AvBH rather than CA-sNA FoBHwas chosen as amore
suitable prediction in our case. The CA model also provides a good
prediction of ICmix,50 for the response of the DR-H4IIE cells to the
active sub-mixtures as to the total POP mixture, and reasonable
predicted dose-response curves (Table S4, Fig. S2).
Finally, IA (independent action) was designed specifically for
mixtures of compounds with clearly different MOAs to combine
probabilities of action of individual compounds. Previous studies
showed that IA outperformed CA (Thrupp et al., 2018) or was
comparable to CA with equal (Payne et al., 2000) or not more than
five-fold differences (Backhaus et al., 2004; Faust et al., 2003) in
predicting the combined effects for chemicals having different
MOAs. The bad performance of IA to predict either ICmix or the
dose-response curve clearly results from the mixture studied here,
where we showed that most components act through the same
MOAs. At low doses, accumulation of the individual, low proba-
bilities derived for a high number of individual compounds pre-
sumably resulted in the dramatic overestimation of the
antagonistic effect.
5. Conclusions
We tested the AhR agonistic and antagonistic activities of 29
POPs shown to contaminate human blood, both in individual and
mixture forms. AhR transactivation activities in three reporter cell
lines exposed to the 29 POPs and themixtures were different due to
the species and tissue-specific responses. The predominant indi-
vidual activities of the POPs were AhR antagonism, as shown for 16
compounds out of 29 in rat DR-H4IIE cells, and for seven and five
compounds in human DR-T47-D and DR-Hep G2, respectively. Thetotal POP mixture already induced a significant AhR antagonistic
activity at concentrations of 125, 250, and 500 fold human blood
levels, respectively in DR-H4IIE, DR-T47-D and DR-Hep G2,
although each individual compound was present at concentrations
lower than its LOEC at these levels. Such blood levels of POPs could
realistically occur in food or environmental contamination in-
cidents or in highly exposed sub-populations. Chlorinated com-
pounds, among which PCB-118 and PCB-138 contributed 90% to the
activity of the total POP mixture, were the drivers for AhR antag-
onism in DR-H4IIE cells. Finally, CA and GCA proved to be good tools
to predict the mixed effect of the total POP mixture with only two-
fold underestimated IC50 and acceptable does response curves.
Hence, the compounds acted additively in the mixtures. Although
limitations remain to fully describe the effects of realistic mixtures
due to biological complexity, the predictions obtained using CA and
GCA seem suitable for establishing general regulatory guidelines
for mixture toxicity assessments. In addition, the data generated in
this study for individual compounds will be useful to predict the
effect of other complex mixtures constituted by these compounds.
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ABSTRACT
The aryl hydrocarbon receptor (AhR) plays an important role in
several biological processes such as reproduction, immunity and
homoeostasis. However, little is known on the chemical-structural
and physicochemical features that influence the activity of AhR
antagonistic modulators. In the present report, in vitro AhR antag-
onistic activity evaluations, based on a chemical-activated luciferase
gene expression (AhR-CALUX) bioassay, and an extensive literature
review were performed with the aim of constructing a structurally
diverse database of contaminants and potentially toxic chemicals.
Subsequently, QSAR models based on Linear Discriminant Analysis
and Logistic Regression, as well as two toxicophoric hypotheses
were proposed to model the AhR antagonistic activity of the built
dataset. The QSAR models were rigorously validated yielding satis-
factory performance for all classification parameters. Likewise, the
toxicophoric hypotheses were validated using a diverse set of 350
decoys, demonstrating adequate robustness and predictive power.
Chemical interpretations of both the QSAR and toxicophoric mod-
els suggested that hydrophobic constraints, the presence of aro-
matic rings and electron-acceptor moieties are critical for the AhR
antagonism. Therefore, it is hoped that the deductions obtained in
the present study will contribute to elucidate further on the struc-
tural and physicochemical factors influencing the AhR antagonistic
activity of chemical compounds.
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The aryl hydrocarbon receptor (AhR) is an evolutionary conserved transcription factor
member of the basic helix–loop–helix (bHLH) family of receptors [1]. The AhR acts as
a cytoplasmatic chemical sensor mediating intracellular and cellular signals [2] with its
main transcriptional regulatory function being the up-regulation of cytochrome P450
family 1 (CYP1) of metabolizing enzymes [3]. The AhR Ligand Binding Domain (LBD) has
been suggested to be one of its two PER-ARNT-SIM (PAS) domains, the PAS-B [4].
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However, comprehensive understanding of the structural and functional profile of the
AhR has been limited by the unavailability of an experimentally determined AhR structure
co-crystallized with the corresponding functional domains. Consequently, studies aimed
at elucidating the interaction modes involved in the AhR signal transduction pathway
have relied on homologous systems [5].
AhR owes its first discovery to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), which is one
of the most toxic synthetic compounds known to date and whose effects in biological
systems are attributed to the AhR binding and activation [3]. Along with TCDD, several
dioxin and dioxin-like compounds have been studied for their AhR agonistic activity and
associated toxicological effects [6,7]. However, the ability of AhR to interact with
a structurally diverse spectrum of xenobiotic and endogenous ligands suggests that it is
highly promiscuous [8].
The induction of the AhR/CYP1A1 axis, as a consequence of AhR agonism, has been
reported to enhance oestrogenic detoxification [9], regulate the oxidative balance and to
propagate the metabolism of proinflammatory and tumour-promoting metabolites,
among other effects [10]. Moreover, AhR plays an important role in the physiological
functions of reproductive organs, immune system, liver and vascular development, car-
diac function, cell growth, differentiation, homoeostasis and circadian rhythms [2,11–13].
On the other hand, several toxicants and high concern substances have been reported as
antagonists of AhR transcriptional activity [7,14]. However, in contrast to AhR agonism,
little attention has been paid to the analysis of the biochemical consequences of AhR
antagonism and even less on the subsequent toxicological implications [15–17].
Computational models, coupled with in vitro assays, have in the recent times gained
increasing utility as alternative tools for providing insight on the pharmacological and/or
toxicological effects of chemical compounds [18]. Indeed when proper interpretations are
feasible, these techniques jointly provide solid understanding on the structural and
functional characteristics relevant for studied bioactivity profiles [19], in addition to
their inherent ethical, economic and predictive advantages [20].
It should be noted that most of the AhR computational models reported in the
literature have been based on the binding affinity as the endpoint, which is an important
drawback since it does not discriminate between agonists and antagonists [21,22]. In
addition, as an experimentally determined AhR structure including the respective func-
tional domains is unavailable, in silico initiatives have relied on homology models of the
PAS-B domain to provide insights on the possible ligand binding modes [5]. The differ-
ences observed in these studies between the agonistic and antagonistic interaction
modes suggested greater distortions in the structure of the LBD in case of the latter
[5,23]. Nonetheless, little is still known on the chemical structural and functional features
that favour the binding of AhR antagonists [24].
Therefore, further analyses of the agonist and/or antagonist responses following AhR
binding are needed to gain better understanding of role of the AhR in both toxicological
and pharmacological contexts [25]. Certainly, informative experimental bioassays will be
necessary to obtain greater insight on the AhR-ligand interaction modes, and particularly
to discriminate between agonistic and antagonistic modulations. One of the most popu-
larized assays is the in vitro AhR Chemically Activated LUciferase eXpression (CALUX)
bioassay, which has been reported to be useful in the detection of the AhR antagonistic
and agonistic effects of dioxin and dioxin-like chemical compounds [26,27]. This assay is
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based on the analysis of the induced luciferase response in a recombinant cell line driven
by several CYP1A1 dioxin response elements (DREs) as a direct reflection of AhR-mediated
transcriptional activity.
The goal of the present manuscript is to analyse the factors, from a chemical perspec-
tive, that influence the AhR antagonism of chemical compounds using a combination of
in vitro and in silico methods. Firstly, a CALUX reporter gene assay for the AhR antag-
onistic activity for a set of selected xenobiotics with known toxicity profiles was per-
formed. Then, based on the results obtained from the in vitro assays and an extensive
literature review, QSAR and toxicophoric models were built to examine the chemical
structural and physicochemical features that modulate AhR antagonism. It should be
noted that while QSAR methods have been employed to model and predict the AhR
binding capacity [28,29], this is the first time that in vitro, QSAR and toxicophoric




A set of 68 chemical compounds was tested in vitro for their AhR antagonistic activity due
to their suspected or suggested toxic effects. Twenty-nine of them correspond to
Persistent Organic Pollutants (POPs) prevalent in Scandinavian human blood [30] and
the remaining 39 corresponded to a chemical library belonging to the Laboratory of Food
Analysis of the University of Liège. The tested compounds were mostly obtained from
Sigma-Aldrich (Missouri, USA), for details see Supporting Information SI-1. All the chemi-
cals were dissolved in dimethyl sulphoxide (DMSO) (Acros Organics, Molinons, France) as
the stock solution of 20 mg/mL and kept in −20°C. The standard solution of 2,3,7,8-tetra-
chlorodibenzodioxin (TCDD) (purity > 98%) in DMSO was supplied from Wellington
laboratories (Guelph, Canada). The reagent 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra-
zolium bromide (MTT) was obtained from Sigma Aldrich (Missouri, USA).
AhR CALUX assay
The AhR-CALUX bioassay was developed based on a stably transfected dioxin response
(DR) rat hepatoma (H4IIE) cell line, consistent with previous reports in the literature [6,31].
These cells were obtained from BioDetection System (BDS) (Amsterdam, The Netherlands)
transfected with four native dioxin response elements from the upstream region of the
mouse cyp1a1 gene leading the Mouse Mammary Tumour Virus (MMTV) promoter and
controlling expression of the luciferase gene were stably integrated into the cell’s gen-
ome. The AhR transactivation activity of the compounds was reported as the expression of
the inserted luciferase and measured by light production.
The cells were maintained in α-MEM (ThermoFisher, Massachusetts, USA) with 10% v/v
foetal bovine serum (Greiner, Kremsmünster, Austria) and 50 IU/mL penicillin and 50 μg/mL
streptomycin (Sigma Aldrich, USA) and were incubated at 37°C in a water saturated atmo-
sphere injected with 5% CO2.
The AhR antagonistic tests for dioxin responsive chemical-activated luciferase gene
expression (AhR-CALUX) bioassays were performed as indicated by the provider BDS.
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Briefly, after reaching about 90% of confluence in the culture flask, the cells were
trypsinized and seeded homogenously in white clear-bottomed 96 well microplates
(Greiner, Kremsmünster, Austria). The cells were then incubated for 24 h and afterwards
treated with the test compounds for another 24 h. The experiment was terminated by cell
lysis using lysis solution containing Triton X100 (Sigma Aldrich, Missouri, USA). After
adding luciferin (Promega, Wisconsin, United States) and ATP (Roche Diagnostics,
Rotkreuz, Switzerland) to the cell lysate, the plates were read by a luminometer (ORION
II, Berthold Detection System, Pforzheim, Germany).
For antagonistic tests, the cells were co-exposed to the test compounds and 15 pM
TCDD corresponding to TCDD EC50 in DR-H4IIE. All the experiments were repeated at least
three times independently. The maximum concentration tested to determine the AhR
antagonistic activity was 40 μM with some exceptions (see SI-1), and the final concentra-
tion of DMSO in the culture mediumwas 0.4%. To ensure the adequacy of the test method
and provide a basis for comparisons, a reference curve of the positive control TCDD, as
well as concurrent negative and solvent controls were added on each plate.
Cell viability assay
An analysis of the MTT cell viability as well as a visual inspection of the cell morphology
and attachment were performed to detect the cytotoxic compounds. After exposure to
the test compounds, 25 μL of MTT solution 5 mg/mL was added into each well. The plates
were then incubated for 4 h at 37°C to allow for the formation of the purple metabolite
formazan from the tetrazolium dye MTT via the activity of the mitochondrial succinate
dehydrogenase. Later, the formazan crystals were dissolved during 2 h by adding 100 μL
of isopropanol. The MTT formazan absorbance was read at 550/630 nm using a microplate
spectrophotometer (ELX800TM BioTek Inc., Winooski, USA).
Results for both reporter gene and MTT assays were presented as relative responses,
either as the percentage of the cell response to the tested compound compared to the
cell response to TCDD EC50 on the same plate for CALUX assays, or to solvent control
DMSO for MTT test. A compound was considered an AhR antagonist when it was able to
reduce the activity of the TCDD EC50 from 100% to at least 70%, while reductions in cell
population greater than 15% were considered cytotoxic [32].
QSAR models
Based on both the experimental in vitro results obtained herein and those compiled from
an extensive review of the literature, binary classifiers of AhR antagonism were built using
statistical modelling methods. Themolecular characterization was conducted by means of
simple and interpretable chemical structural descriptors.
Structures, descriptors and activity
A dataset of 116 chemicals was built to develop the QSAR classification models. This set
comprised of 68 compounds tested in the present report for their AhR antagonistic
activity and 48 compounds retrieved from literature. From this dataset, compounds
with undetermined or inconsistent activity were excluded from the analysis and therefore
minimizing potential error sources (for details see SI-1). A binary scale of activity values
was considered in the sense that the compounds observed or reported in the literature to
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induce the AhR antagonistic effect, based on the AhR-CALUX method, were labelled as
active while those that did not induce any effect were considered as inactive.
The calculated molecular descriptors were implemented in-house, based on definitions
obtained from DRAGON [33] and PADEL [34] software. Consistent with the parsimony
principle, only the simplest characterizations of the molecular structures were considered.
A total of 1929 DRAGON descriptors were calculated corresponding to: constitutional
descriptors, information indices, functional group counts, atom-centred fragments, 2D
binary fingerprints and 2D frequency fingerprints. From this set, constant variables or
those with pair-correlations greater than 0.9 were removed, retaining only 171 descrip-
tors. As for the PADEL software, the Estate and MACCS fingerprints were computed
yielding 245 descriptors from which 15 constants were removed. Globally, a total of 401
molecular descriptors were retained and subsequently used as input variables for the
chemoinformatic modelling.
Variables and QSAR methods
The selection of molecular descriptors for modelling the AhR antagonistic activity was
carried out using the information gain filter as provided by IMMAN software [35]. The
information gain defined as the reduction in variable entropy (or uncertainty) given that
another variable (response variable in this context) is known. This measure allows vari-
ables to be ranked based on their capacity to discriminate cases that belong to different
classes and consequently filter out informative variables.
A Principal Components Analysis (PCA) was performed on the selected set of variables
and 10 principal components (PCs), explaining more than 90% of the total variance, were
obtained. Subsequently these PCs were used as input variables for modelling the AhR
antagonistic activity. The PCs were rotated using the orthogonal rotation scheme varimax
to maximize the sum of variances of the squared loadings. For the PCA the MATLAB
software [36] was employed.
Linear Discriminant Analysis (LDA) and Logistic Regression (LReg) methods were
employed for the classification model building. The metrics considered to evaluate the
performance of the built classification models were the accuracy, precision, sensitivity and
specificity (see below) where: TA = true active; FA = false active; TI = true inactive and
FI = false inactive.
Accuracy ¼ TAþ TIð Þ
TAþ FIþ FAþ TIð Þ  100%
Precision ¼ TA
TAþ FAð Þ  100%
Sensitivity ¼ TA
TAþ FIð Þ  100%
Specificity ¼ TI
TIþ FAð Þ  100%
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Validation methods and applicability domain
Internal and external validation experiments were designed to assess the robustness and
predictiveness of the built classification models. To this end, a cluster analysis was
performed to rationally divide the dataset in training and test sets, based on the following
procedure: first, with hierarchical clustering (based on the square-Euclidean distance as
the similarity criterion) an optimal number of clusters (k) was established using the graph
of the amalgamation schedule. Then, k-means method was employed to stratify the
structures into clusters according to their similarity. An appropriate distribution of active
and inactive compounds was considered during the clustering. With this procedure, two
subsets of compounds were generated with 75% of the data comprising the training set
and the 25% test set. Internal leave-group-out cross validation (25% of the training set
was held out for validation for each fold) was performed to check for possible overfitting
during the model building procedure. Ten different combinations of training and test sets
were created using cluster analysis and a 10-fold external validation was performed to
evaluate the average predictive capacity of the models. This approach has been recom-
mended as the most stringent validation protocol for QSAR models [19]. For the cluster
analysis, the STATISTICA [37] software was employed.
The applicability domain (AD) of the built QSAR models was established by using the
Euclidean distances and Tanimoto coefficients as the structural similarity measures and
the k-nearest neighbour algorithm (k-NN) as the feature space approximator. For this AD
analysis the AmbitDiscovery software [38] was used.
Toxicophoric modelling
A diverse set of active AhR antagonistic compounds was selected from the dataset built in
the present report for mapping the toxicophoric hypothesis. The selection criterion was
based on the hierarchical and k-means clustering previously described. Additionally,
a Tanimoto matrix score provided by the PubChem [39] platform was considered. For
this study, the PHASE module of Schrödinger [40] software was used.
The three-dimensional structures of the selected set of active AhR antagonistic compounds
were generated and employed to build toxicophoric models following a ligand-dependent
approach exclusively. The mapped space was unrestricted by considering all volumes and
shapes, but with locations and orientations in 3D-spaces allowing the enantiomeric discrimi-
nation by absolute coordinated distances. All the available features included in PHASE were
analysed at distances of 1.8 Å and with a tolerance of 2.0 Å to match the hypothesis. These
features were represented in the toxicophoric models as (A) acceptor, (D) donor, (H) hydro-
phobic, (N) negative ionic, (P) positive ionic, and (R) aromatic ring. The best alignment was
searched considering 50 conformations for each compound. The generated hypotheses were
accepted if they fitted at least 50% of the training set. Three to seven features were considered
as optimum for hypothesis acceptability.
The goodness of fit of the toxicophoric hypotheses was evaluated using the
Boltzmann-enhanced discrimination of receiver operating characteristic (BEDROC),
which is a generalization of the ROC metric to deal with the early recognition problem.
The difference criterion between toxicophoric models was set to 0.5, while the Phase
Hypo Score was employed as the scoring function. The mathematical definitions for all
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these metrics are detailed elsewhere and the performance is measured from 0–1 values
where 1 represents perfect fitness [41].
Finally, an external set of decoy structures was generated using as seeds the diverse set
of active AhR antagonistic compounds employed in the toxicophore hypothesis building.
For decoy structure generation, the Directory of Useful Decoys (DUD•E) online platform
was employed. DUD•E constitutes the largest and most comprehensive public dataset for
benchmarking virtual screening programs and was employed here to validate the pre-
dictive capacity of the toxicophoric hypotheses. DUD•E is designed to provide sets of
structures with similar physicochemical properties but dissimilar topology to the active
compounds being, therefore, unlikely binders [42].
Results and discussion
In vitro results
Out of the 68 test compounds evaluated with the AhR-CALUX assay, 24 of these induced
AhR antagonistic transactivity, suppressing the cell response to the spike-in control 15 pM
TCDD from 100% to at least 70%. Three of these, two insecticide isomers (α-endosulfan
and β-endosulfan) and the fungicide thiram, reduced the cell viability by more than 15%.
Moreover, the former two showed cytotoxic effects in more than 60% of the cell popula-
tion at a concentration of 40 μM while the latter showed a similar effect even at 20 μM.
These three chemicals were therefore excluded from the analysis of AhR antagonism (see
SI-1). The remaining 41 chemicals did not show any AhR antagonistic potential and were
thus considered as inactive.
QSAR modelling
Database of structures and AhR antagonism
A dataset of 116 chemical compounds with defined AhR antagonistic activity profiles
based on the DR-H4IIE cell line was constructed. This database contained organo-
halogenated (chlorinated, brominated, fluorinated), polyaromatic hydrocarbon, flavonoid,
quinone, imidazole, bisphenol and pyrethroid chemical classes. Although a few antibiotics
and phytochemicals were included, most of the modelled structures are or have been
used as industrial chemicals, pesticides, fungicides, algaecides, insecticides, rodenticides
and herbicides. Many of these profiled compounds are reported as potential endocrine
disruptors or have been already banned due to their toxic spectrum through different
mechanisms.
During the construction of the dataset, interest was placed on the homogeneity of the
results obtained from the experimental protocols, in order to obtain logical and inter-
pretable conclusions. Therefore, compounds with ambiguous and/or unclear experimen-
tal determinations were discarded, especially for those results extracted from literature.
Such stringent selectiveness has been strongly supported by several reports in the
literature [19].
The hexachlorocyclohexane (HCH) conformational isomers (α-, β-, γ-, δ-HCH) were
excluded since they possessed contrasting activity profiles (the descriptors used in the
present study are insensitive to stereochemical differences). For the same reason, two
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polycyclic aromatic hydrocarbons were excluded. The hexabromocyclododecane (HBCD)
in vitro activity was the only one considered, while the rest of the isomers (α-, β-, γ-HBCD)
reported in the literature were discarded. Finally, one structural outlier (chlormequat
chloride) was removed during the modelling due to disconnected fragments in the
molecular structure.
Moreover, BDE-49 (i.e. 2,2ʹ,4,5ʹ-tetrabromodiphenyl ether) [43] and nine polychlori-
nated biphenyls (PCBs) [7] were excluded as their activity profiles were not clearly defined
in the literature (see SI-1). Three cytotoxic compounds in the MTT assay were not
considered (see above).
A standard protocol was followed to guarantee the homogeneity of the final dataset
presented in this study that included 93 compounds, 40 active AhR antagonists and 53
inactive. Therefore, this dataset may be considered of acceptable quality and is, to the
best of our knowledge, the largest for AhR antagonistic activity reported so far.
Selection and transformation of molecular descriptors
The calculated molecular descriptors were all based on simple and interpretable features
of the chemical compounds. Due to the large number of generated descriptors, dimen-
sionality reduction was deemed necessary.
From the calculated 401 molecular descriptors, a set of 96 descriptors was retrieved
using the aforementioned information gain filter, and subsequently used to generate
orthogonal descriptors using the PCA method. Ten PCs were determined to be the
optimum number of PCs based on the eigenvalues of the generated covariance matrix
and these described 90% of the total variance in the dataset. The matrix of the PCs
coefficients obtained for the set of molecular descriptors and the scores for all the PCs are
provided as supplementary information (SI-2).
QSAR models obtained
For the QSAR modelling of the AhR antagonistic activity, simple and interpretable
classification algorithms were preferred. Hence, five models were selected following
commonly established criteria [19], three corresponding to LDA and two corresponding
to LReg methods. The training metrics obtained for these models are shown in Table 1
and additional parameters are provided as SI-3. One of the significant advantages offered
by these statistical models, compared to most machine learning algorithms such as
random forest, support vector machine or artificial neural networks, is the straightforward
Table 1. Evaluation metrics of the QSAR models.
Modela PCs
Accuracy Precision Sensitivity Specificity
Trainb Ext.Vc Trainb Ext.Vc Trainb Ext.Vc Trainb Ext.Vc
LDA 10 88.51 81.48 87.02 73.49 88.01 83.56 89.21 79.95
LDA 9 83.02 81.94 87.02 73.58 88.12 83.33 78.11 79.62
LDA 6 78.01 74.07 76.04 65.33 63.23 77.58 89.30 68.95
LReg 7 88.50 73.61 88.51 64.89 88.20 74.78 89.22 72.14
LReg 6 93.51 78.24 87.01 70.32 88.14 74.89 99.03 79.00
a QSAR models based on linear discriminant analysis (LDA) and logistic regression (LReg).
b Value of the classification metrics obtained during the training of the models (Additional parameters in SI-3).
c Average of the classification metrics made during the 10-fold external validation procedure.
216 E. GOYA-JORGE ET AL.
interpretation and consequently applicability in the rationalization of the influence of the
different chemical structural features on the modelled property [44].
Moreover, both the internal and external validation procedures yielded adequate
statistical parameters, demonstrating the robustness and predictive capacity of the five
QSAR models obtained herein. Indeed, all the selected models showed good external
validation performance, yielding percentages higher than 60% for accuracy, precision,
sensitivity and specificity (Table 1).
These models are the first QSARs for AhR antagonistic activity of which we are aware.
Previous QSAR models reported in the literature focused on AhR agonism or non-specific
AhR-ligand binding [28,45]. Moreover, the models presented herein were built over
a diverse dataset of chemicals and were observed to be consistent with the OECD
validation principles [46]. Therefore, these models can reliably predict the AhR antago-
nistic potential of untested chemicals in their AD.
Toxicophoric mapping
Toxicophoric (or Pharmacophoric) models are defined as an ensemble of steric and
electronic features that are necessary to ensure the optimal supramolecular interactions
with a specific biological target and to trigger (or block) its biological response [47].
Toxicophoric modelling aims to identify a set of features or restrictions in the molecules
and/or their receptors that determine their capacity to interact in any mode and conse-
quently cause toxic effects. These models may be built following structure-based or
ligand-based approaches depending on whether the information of the target receptor
is employed or not [48,49].
Herein, as a fully crystalized structure of the AhR protein (containing the PAS-B ligand
binding domain) is not yet available [25], a ligand-based toxicophoric modelling was
performed. The cluster analysis performed during the QSAR modelling was employed to
select the most dissimilar compounds for the toxicophoric mapping.
Seven most dissimilar structures were selected (Figure 1) and used to explore toxico-
phoric hypothesis of AhR antagonism. These chemical compounds are considered to be
an environmental and health threat and they showed strong antagonistic activity in the
in vitro AhR-CALUX assay.
A total of 8 toxicophoric hypotheses were obtained and their performance assessed
based on the internal validation enrichment metrics. Consequently, two toxicophoric
models were selected as they showed adequate performance and contributed dissimilar
structural information.
Figure 2(a,b) show the spatial representations of the selected Toxicophoric-AhR antag-
onistic hypotheses for the first: Hydrophobic_Hydrophobic_Hydrophobic_ Aromatic Ring
(HHHR) and the second: Acceptor_Hydrophobic_Hydrophobic_ Aromatic Ring (AHHR)
models, respectively. Both arrangements included a common segment of two hydropho-
bic constraints and an aromatic ring as critical features. On the other hand, the latter
model included an electro-acceptor group while the former possessed an additional
hydrophobic constraint.
An external validation of the two selected AhR-antagonistic toxicophoric models was
conducted as recommended [42], using a diverse dataset of 350 decoy structures gener-
ated from the seven active molecules employed in the hypotheses exploration.
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The training and the corresponding external validation results of the HHHR and AHHR
toxicophoric hypotheses are shown in Table 2. Overall, the built hypotheses showed good
performance as all validation metrics were greater than 0.5 and thus demonstrating their
robustness and predictive capacity.
Several pharmacophoric models considering nuclear receptors ERα and ERβ as drug
targets [50,51] have been reported in the literature. However, limited distinctions
between agonist and antagonistic ligands have been suggested [52]. Furthermore, the
few toxicophoric considerations available are generally restricted to drug-safety contexts
Figure 1. Active structures selected for toxicophoric modelling (For details see SI-1).
Figure 2. Representation of the toxicophoric models designed in Schrödinger software.
Hydrophobic (green-ball), ring (orange ring), acceptor group (pink ball with signalling arrows).
a. HHHR: Hydrophobic_Hydrophobic_Hydrophobic_Aromatic Ring. b. AHHR: Acceptor_Hydro
phobic_Hydrophobic_Aromatic Ring.
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[48,49]. Nevertheless, some successful and experimentally validated studies on enzymatic-
mediated endocrine disruptive mechanisms have been reported based on the inhibition
of 17β-hydroxysteroid dehydrogenases [53].
The first pharmacophoric/toxicophoric estimations based on the blocking capacity of
chemicals over AhR are herein proposed. Moreover, considering the good predictive
power offered by these computational models, they could be a useful virtual screening
tool for chemical compounds with potential AhR antagonistic activity.
Structural and physicochemical interpretations
As an essential receptor whose cellular implications are still being discovered, the disrup-
tion of the AhR functions could lead to toxic effects that are yet to be fully understood
[3,8,11,12]. Hence, the mapping of chemical structural features critical for the AhR ago-
nistic/antagonistic potential could enhance the identification of specific modulators with
possible toxic profiles. In this sense, based on the developed QSAR and toxicophore-
based models, analyses were performed to further understand how different chemical-
structural features influence the AhR antagonistic activity.
The interpretation of computational models is highly recommended by the OECD
guidelines to enhance the utility of the QSAR predictive results [46]. Here, only simple
0-2D descriptors were calculated and used for the model building, therefore the elucida-
tion of their contribution to the AhR antagonistic activity in chemical structural terms is
straightforward. On the other hand, the toxicophore-based methods provide information
on the steric and electrostatic features deemed critical for a given toxicity (or activity)
profile. Hence both QSAR and toxicophore models may serve as complementary
approaches providing a more complete outlook of the structural and physicochemical
factors that influence the AhR antagonistic activity.
The molecular descriptors with relevant contribution were determined based on the
PCA factor loadings (SI-2). It has been previously reported that coefficients greater than
0.7 are considered remarkably influential to the generated PCA components [54].
Therefore, the same cut-off was considered to identify the most influential descriptors
on the modelled AhR antagonism. Definitions and SMARTS [55] representations of the top
five variables obtained are provided in Table 3.
From the toxicophoric models, hydrophobic interactions were identified as an impor-
tant constraint in active AhR antagonistic molecules. Moreover, the presence of an
aromatic ring and an electron acceptor group was suggested as relevant for AhR
Table 2. Results of the training and the external validation for HHHR and AHHR
toxicophoric hypotheses.
Hypothesis
Training performance External validation
PHASEc BEDROCd PHASEc BEDROCd
HHHRa 0.93 0.68 0.93 0.98
AHHRb 0.82 0.69 0.82 0.92
a HHHR: Hydrophobic hydrophobic hydrophobic aromatic ring.
b AHHR: Acceptor hydrophobic hydrophobic aromatic ring.
c Scoring function phase hypo score [41].
d Boltzmann-enhanced discrimination of receiver operating characteristic (BEDROC) [41].
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antagonism. These features will now be analysed in detail and the possible complemen-
tarity with the QSAR model variables also explored.
Hydrophobic constraints
The hydrophobic features comprising the toxicophoric model and the QSAR model
descriptors codifying information on hydrophobicity (i.e. hydrocarbon chains without
attached heteroatoms (H-046) and closed hydrophobic circuits (nCIR) of saturated cyclic





H attached to C (sp3) no X attached to next C
nCconj
Sum of the number of non-aromatic conjugated C(sp2) belonging to any conjugated system, excluding
aromatic rings. Including the following atom types: = C<, = N-, = P-, = B-, = N<, = P<, = S<, >P(=)-, >B
(=)-, = O, = S
H-052
H attached to C(sp3) with 1X attached to next C
nBM Multiple bonds
nCIR Number of circuits
* Brief definitions/representations of the descriptors using the SMARTs [55] formats of the codified features are provided.
The range of values obtained was: H-046 [0–10]; nCconj [0–6]; H-052 [0–12]; nBM [0–26]; nCIR [0–28].
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hydrocarbons) suggest that non-polar structural segments probably play an important
role in AhR-ligand interactions. Indeed, early studies on TCDD where AhR was simply
considered as an intracellular, soluble and unknown receptor protein, already recognized
its hydrophobic character [56].
Some other reports in the literature have also highlighted the importance of hydrophobi-
city in AhR-LBD interactions e.g. a strong correlation has been found between the suppression
of AhR on TCDD-induced activity and the hydrophobicity of curcumin derivatives [17]. It has
also been suggested that the affinity of stilbene derivatives of resveratrol to AhR is enhanced
by substituents with high hydrophobicity, among other factors [57]. Moreover, an analysis of
the AhR ligand binding pocket revealed that it is comprised predominantly of hydrophobic
residues with some polar segments located near the medial positions of the ligands [58].
Therefore, structural fragments with strong hydrophobic character should probably be prior-
itized in the design of ligands with possible AhR antagonistic activity.
Ring feature
Similarly, both the toxicophoric hypotheses and the QSAR models included ring features
[circuit number (nCIR), in the case of the latter] as critical for AhR antagonism. Bearing in
mind that the name AhR is attributed to the polycyclic aromatic hydrocarbons (PAHs),
which were in fact the very first ligands found to interact with this receptor, it is
unsurprising that ring features are suggested to play a critical role in AhR-mediated
interactions probably through non-covalent interactions (i.e. between electron-rich and
electron-deficient aromatic moieties) [59]. These interactions, also named aromatic
donor–acceptor interactions, have been analysed for several decades in the AhR context
[60,61]. Firstly, early studies hypothesized that π-π-interactions with phenyl and tyrosyl
groups of the AhR protein occurred in the TCDD-mode of action [56]. Also, these inter-
actions have been evoked to rationalize the effect of PBDEs and PCBs upon contact with
dissolved organic matter in the environment [28], and have been suggested to play an
important role in endocrine disruptive mechanisms e.g. in ER disruption [62].
Nonetheless, it is important to highlight that there ligands without the neutral, hydro-
phobic and non-polar molecular characteristics of PAHs that have also been shown to
have effects on AhR, demonstrating that these interactions depend on the contribution of
multiple factors [2,63].
Acceptor-group presence
The charge transfer between molecules and biological systems commonly influences the
potential toxicity of the former [64]. Herein, one of the proposed toxicophoric hypothesis
suggested the presence of an acceptor group as a relevant structural feature for AhR
antagonistic activity. Likewise, the QSARmodels comprise various key molecular descriptors
that could be related to this toxicophoric feature. For example, heteroatoms attached to sp3
carbons (H-046 and H-052), non-aromatic conjugated systems (nCconj) or multiple bonds
(nBM) in general could all contribute to electron deficient fragments in the ligand’s structure
whose interactions may potentially influence the AhR antagonistic effects.
Altogether, the results obtained herein suggest that the presence of electron acceptor
groups, connected ring systems (preferably aromatic or delocalized moieties), and most
importantly hydrophobic groups seems to be critical for the potential AhR antagonistic
effects.
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Conclusions
Structural and physicochemical determinants of the AhR antagonistic capacity were
assessed using a combination of in vitro (AhR-CALUX bioassay) and in silico (QSAR and
toxicophoric mapping) methods. In the former, several chemical compounds were eval-
uated, and their antagonistic activity profiles determined. In the latter, QSAR algorithms
based on LDA and LReg were obtained and validated. These models were shown to
possess adequate robustness and predictive power, based on the quality of the obtained
statistical validation parameters. Moreover, toxicophoric models were derived and the
structural features potentially favouring the AhR antagonistic potential analysed.
Interpretations of the QSAR and toxicophore models revealed that electron acceptor
groups, aromatic or delocalized ring systems, as well hydrophobic moieties probably
favour the AhR antagonistic activity, demonstrating the complementarity of the two
approaches notwithstanding their dissimilar conceptual basis. The models proposed
herein could be useful in the prediction of the AhR antagonistic capacity of chemical
compounds with toxicological and pharmacological applications.
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